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Preface 
When looking back on this thesis, I am reminded of one of my favorite readings as a 
young adult.  This well-known scientific novel/novella, ―Flatland‖, depicts the adventure 
of a triangle who is whisked out of his two-dimensional reality into three dimensions by 
an ambitious and instructive sphere.  The actions and thoughts of the triangle are bounded 
within the two-dimensional reality of his plane (via both geometric and philosophical 
constraints).  However, the perceptions of his existence change as he views his life and 
family from a new perspective, within a third dimension. 
This book is such a fascinating view about the limitations put on ourselves 
through our life experiences and, more pervasively, the boundaries of our minds.  For 
example, I often debate matters such as the existence of God, or other deities, and the 
boundaries of our existence.  Is it possible that the presence of a higher level of existence 
(e.g. post-mortem) may be entirely hidden from our current reality as due to the set rules 
and foundations of our existence?  The ways that we conceptualize our reality may be 
flawed or, at the very least, simplistic compared to the actual reality.  As a toy example, 
the number 5 itself does not exist as 5 in a modulus 3 rule, but rather as the number 2 
(e.g. 5%3=2).  It is interesting to question how such mathematical abstractions and 
conceptions relate to existence.  Our reality likely exists as a defined set of rings and 
fields within, adjacent to, or even overlapping other realities and as yet inconceivable 
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domains.  With this in mind, our ideal goal is to somehow extend beyond these rules and 
expand our perceptions and understanding of the universe(s) despite such limitations. 
This thesis attempts to tackle comparatively simpler problems within defining 
reality.  We will embark on an excursion through the realms of machine learning, systems 
biology, and pathway analysis, with the hopes of furthering our understanding within 
biology and medicine.  A novel set of computational approaches are introduced which 
attempt to draw us, the triangles (and sometimes squares and circles, puns as 
necessitated) away from traditional approaches within our dogmatic plane to achieve new 
perspectives.   
One of the foundational questions giving rise to our specific aims is how we can 
conceptualize the reality of biology using a set of computational (and more or less 
philosophical) rules.  How do we identify as yet uncharacterized biological interactions 
and molecular entities which interact with sets of known molecular entities and their 
biological roles and interactions?  How might we generate such predictions using 
minimal knowledge in order to save some knowledge for later comparison and validation 
(e.g. non-circular reasoning)?  Finally, how are our computationally-predicted 
representations of the biological reality similar to and/or different from existing 
biological knowledge, and how do they both compare to the ―real‖ underlying biology? 
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Abstract 
This thesis focuses on the computational analysis of cellular and immune 
pathways of living cells in response to molecular signals using machine learning 
approaches such as Bayesian networks.  Bayesian networks (BN) have been applied to 
the reconstruction of these pathways (e.g. gene regulatory and protein signaling 
pathways) as network models using existing biological data.  However, many biological 
interactions and molecular entities (e.g. genes and proteins) are not yet known which 
participant in the pathways of interest.  For example, understanding the key biological 
interactions and participants of Jak/Stat pathway members in progressive kidney disease, 
a complication of diabetes, is necessary for refined understanding of the disease as well 
as future drug development.  In order to resolve this issue, two major Bayesian network 
approaches are presented and applied in this thesis to allow refinement and expansion of 
known biological pathways to identify new interactions and molecular entities involved 
in the pathway model for future experimental analysis.   
   In Chapters One and Two, an overview of modeling approaches and assumptions 
for pathway refinement and expansion, including Bayesian network analysis, is 
presented.  I introduce the major assumptions used when generating computational 
models such as Bayesian networks for known biological pathways from existing 
knowledge repositories.  The major pathways analyzed in the thesis, including synthetic, 
the reactive oxygen species (ROS) pathway in E. coli, B cell receptor signaling pathway 
xx 
 
in Mus musculus, and Jak/Stat signaling pathway in the H. sapiens’ progressive kidney 
disease, are also introduced.  Chapter Two specifically focuses on the Bayesian network 
theory implemented in the thesis and two major developed approaches. 
 In Chapter Three, the issue of how to refine existing Bayesian networks to 
identify the well-supported interactions predicted using underlying biological data and 
also remove false positive interactions is explored.  I introduce a refinement algorithm 
called EdgeClipper which was developed to identify the most well-supported network 
edges in a distribution of saved Bayesian networks.  The EdgeClipper algorithm 
implements a posterior weighting-based approach to prioritize these hypothesized 
interactions, and includes methods to remove poorly-supported interaction hypotheses.  
The approach was tested using synthetic and Escherichia coli reactive oxygen species 
(ROS) pathways and shown to faithfully identify many of the known interactions, as well 
as improve specificity with some sensitivity loss.  The algorithm was demonstrated to 
have comparable performance to bootstrapping approaches with significantly faster 
computational time, and is effective for Bayesian network modeling with small datasets. 
 In Chapter Four, I introduce an effective expansion approach to identify yet 
unknown though potentially novel pathway members which likely influence the 
biological activities of the pathway.  I developed an algorithm called BN+1 which can 
prioritize and identify which unknown pathway entities (e.g. genes, proteins) are involved 
in the biological pathway functions and activities.  BN+1 was applied to the expansion of 
several synthetic, prokaryotic, and eukaryotic pathways.  Major findings included the 
identification of genetic interactions between genes gadX and uspE and their direct 
xxi 
 
regulation of biofilm activities in E.coli, all of which were verified experimentally. Other 
novel findings were achieved for a B cell receptor (BCR) signaling pathway using 
eukaryotic murine data. 
In Chapter Five, the expansion and refinement algorithms were combined to 
achieve powerful predictions in both prokaryotic and eukaryotic pathways.  As a test 
example, a small ROS pathway sub-network generated by EdgeClipper and later 
expanded by BN+1 recovered a known acid fitness island and new putative acid fitness 
regulators in the ROS pathway.  This finding established the combinatorial approach of 
both methods.  The EdgeClipper and BN+1 approaches were then applied in tandem 
towards understanding the roles of Jak/Stat pathway regulation during progressive kidney 
disease in two kidney compartments in H. sapiens.  Our results revealed that Jak/Stat 
pathway shows relatively low overlap in supported interactions for the glomerular and 
tubule compartments, though the expanded pathway genes identified through BN+1 
reflect the appropriate biological functions and stages of disease progression for the 
respective kidney compartments. 
In Chapter Six, a novel web infrastructure (MARIMBA, 
http://marimba.hegroup.org) developed to facilitate Bayesian network, EdgeClipper 
refinement, and BN+1 expansion analysis is discussed.  This tool, developed and used 
exclusively for the previous thesis chapters, allows researchers to freely execute all of the 
BN expansion and refinement methods and visualize and interpret results.  The web-
based tools are being improved and updated for increased public use. 
xxii 
 
In Chapter Seven, a summary of the major findings and results are discussed 
along with future directions.  The refinement and expansion methods and their 
applicability to other next-generation and high-throughput datasets are discussed.   
Overall, my results demonstrate that it is possible to refine and expand a protein-
level signaling pathway representation using transcriptional microarray data, Bayesian 
network-based expansion and refinement algorithms, as well as other relevant 
bioinformatics approaches.  The overlap between the generated and computational 
networks may vary according to the extent and type of biological data and type of 
selected pathway, though novel pathway members and interactions are discoverable using 
these approaches and underlying assumptions.  The methods have been applied to a 
variety of biological systems with varying biological complexity, and are applicable to a 
wide variety of other biological and computational systems as well as high-throughput 
datasets. 
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Chapter 1  
 
Introduction and Overview 
 
1. Introduction 
This thesis focuses on novel computational strategies for investigating biological 
pathways in a variety of living organisms.  A set of powerful techniques will be explored 
which can identify likely interactions amongst sets of molecular components and 
elucidate novel mechanisms of disease and biological change.  First, the increased need 
for computational models in pathway analysis is discussed.  Second, common 
terminology and ideas will be introduced.  Third, after defining some of the major 
dogmatic concepts throughout the thesis, the major questions and aims are introduced.  
Finally, an overview of the upcoming chapters is presented.   
1.1 Driving Philosophical Questions 
How are biological and computational networks (e.g. Bayesian networks) similar to and 
different from each other?  Which entities in the biological networks are predicted by the 
computational networks (and vice versa), and which are missed?  How can we identify 
novel interactions and interactors via computational analysis which are not yet included 
in existing biological models and knowledge repositories, or is this even feasible? 
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1.2 Defining computational and biological models of reality 
1.2.1 Common Terminology and Definitions 
In this section, some of the major terms and definitions which appear throughout the 
thesis are defined. 
Dataset: a collection of data which represent selected experimental or synthetic data 
collected under specified conditions.  Mathematically, the dataset can be considered a 
matrix with one dimension defined by experimental conditions or observations, and the 
other defined as the variables or nodes of interest (e.g. genes, proteins). 
Network:  a graphical model or concept which includes nodes that may be connected by 
edges or arrows.  Networks are often used to model biological or other processes such as 
genetic regulatory and protein signaling pathways. 
Edge: usually a directed or undirected arrow, this will represent some type of relationship 
between two nodes or variables in a network model.  In the Bayesian network dogma, 
edges reflect a statistical influence from one node towards another node.  These 
influences can also be represented via conditional probability tables. 
Nodes:  sometimes referred to as variables, these are both mathematical and graphical 
representations of some biological entity.  Nodes are commonly used to represent 
selected genes, probes/probesets, proteins, various phenotypic measurements, or other 
entities.  The actual type of node in each network may vary, and will be defined within 
the respective study. 
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Biological model: a network model generated using a combination of curated literature, 
database, and experimental data which reflect experimentally-derived results and 
conclusions.  Biological models are often defined within specific experimental contexts 
or studies, and as such are considered to be more contextual. 
Computational model: a variety of network models which incorporate information from 
a variety of experimental, literature, and other sources to study and infer behavior 
amongst network nodes and variables.  Computational models require some prior or 
starting information as well as a set of mathematical rules to predict biological behaviors. 
1.2.2 Defining Computational Models Based on Existing Biological Knowledge 
A common approach for computational modeling is the generation of mathematical and 
programmatic models which can simulate some known set of variables and their 
interactions.  These models require certain assumptions about the biological system, such 
as what biological entities (e.g. genes, proteins, miRNA) to represent as variables in the 
models, the types of interactions, as well as the type(s) of data included as either training 
or test information.   
Figure 1.3 provides one such example of a biological model, the Nf- B signaling 
pathway, and the assumptions imposed to construct a computational model.  Figure 1.3A 
represents the sequence of events required for gene Nfkb1 to regulate some target gene in 
the pathway.  After transcription of mRNA, mRNA translocation to the cytosol, protein 
translation and post-translational modifications (a good example of the classical central 
dogma in biology), the Nfkb1 protein can heterodimerize with other proteins.  Activation 
of the Nfkb1 to induce transcription and translation of downstream target genes (―target‖) 
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requires extracellular signaling through a cascade of kinases and other molecules to 
eventually phosphorylate the attached I B monomer and allow translocation of the freed 
Nfkb1 protein into the nucleus.  There, Nfkb1 acts as a transcription factor and initiates 
the transcription of mRNA at a variety of target binding sites for various genes. 
In terms of computational modeling, this large sequence of signaling, 
transcription, translation, and translocation events can be simplified into a relatively 
smaller representation (Fig. 1.3B).  Namely, the Nfkb1 gene influences target, which is 
represented as Nfkb1target.  This relationship which is represented graphically as a 
grey box in (Fig. 1.3A-B) is assumed by computational models which associate and 
sometimes correlate the mRNA expression levels for the two genes obtained via gene 
expression microarray studies and other related approaches. 
 5 
 
 
Figure 1.1 Defining hypotheses and computational representations for biological 
networks.   (A) Schematic representation of molecular events linking transcription factor 
Nfkb1 to mRNA regulation of selected target genes. (B) Major hypothesis that Nfkb1 
influences or regulates target variable at the transcriptional level, as might be represented 
in a Bayesian network or other approach.  (C-D) Known members of the Nf- B protein 
signaling pathway which can be hypothesized to regulate the target gene and its mRNA 
expression.  (E) Hidden or unknown factors which may also influence the regulation of 
the target gene expression.  Note that not all interactions and entities shown in KEGG 
[1]or literature are represented in this conceptual model. 
 
However, the figure illustrates other important interactions.  For example, various 
signaling proteins may also affect the mRNA expression of the target if they are 
perturbed or absent (e.g. transmembrane proteins, various cytosolic proteins and 
macromolecules, other kinases and signaling molecules, transcriptional and translational 
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machinery, etc).  Hence, the possibility of other interacting proteins and their underlying 
mRNA expression profiles guiding the target expression must be considered (Fig. 1.3C-
E).  Thus, a major question is how to identify the most relevant interactions guiding 
target gene expression.   
1.2.3 Comparing Computational and Biological Models 
Defining computational and knowledge-based biological models can be problematic and 
relatively biased.  In general, biological models are reductionist representations of 
underlying biology based upon experimental studies and traditional experimental biology 
approaches.  These classical approaches are prevalent in literature and the various 
biomedical repositories in NCBI (http://ncbi.nlm.nih.gov), the European Molecular 
Biology Laboratory EMBL (www.ebi.ac.uk/embl/), and other online resources.  A major 
strength of the knowledge-based biological models is that they can generate strongly-
supported interactions within controlled environments.   
However, such reductionist and controlled studies can be problematic when 
attempting to identify novel interactions or behaviors, such as in different environmental 
contexts.  For example, predicting whether those interactions will occur in different 
experimental conditions not yet studied may prove problematic without computational 
analysis.  Furthermore, generating biological models for much larger phenomena, such as 
those interactions spanning multiple tissues, organs, and even organisms are generally too 
large and complex for integrated experimental analysis. 
Computational models allow additional insight into existing and potentially novel 
interactions.  The computational models, which encompass a variety of different 
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assumptions regarding biological behaviors and rules, can be used to model existing 
interactions, predict what effects may be observed if the existing rules, parameters, and 
entities in the model change (e.g. over time), and even bridge the analysis of changes 
across multiple biological compartments and hierarchical scales of organization. 
   
Figure 1.2 Venn diagram of computational versus knowledge-based networks and 
their relationship with underlying ‘real’ or existing networks.  The target in this 
thesis is to expand the central (red) region in the figure for more comprehensive and 
integrative biological understanding.  To achieve this goal, computational methods are 
introduced to identify new biological knowledge not yet present in existing repositories. 
 
Ideally, the biological and computational modeling approaches (Fig. 1.1) can be 
bridged to generate comprehensive models of biological phenomena and change.  This, 
however, cannot be accomplished until a detailed understanding of how the 
computational and biological models are similar to and different from each other.  Figure 
1.4 illustrates a conceptual overlap of biological and computational models and how they 
relate to their biological target realm.  In both approaches, the computational and 
biological models might focus upon understanding the roles of components of the Nf-kB 
signaling pathway (or another of the hundreds of known pathways in H. sapiens and 
other species).   
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Computational and biological models may sometimes disagree.  In some cases, 
the biological models will uncover interactions not predicted by the computational 
approaches.  Likewise, in some situations the computational approaches may predict or 
infer novel interactions not yet seen in existing biomedical studies or literature.  As 
mentioned earlier, Figure 1.1 lists common methods and resources for computational and 
biological modeling.  A common theme in computational biology and bioinformatics is in 
determining the extent to which one can recover known interactions.  This type of 
analysis, often referred to as benchmarking, assumes that a known gold standard is 
available for comparison.  However, whether or not these disparate interactions are 
actually ‗real‘ or purely a false positive result generated by the respective modeling 
technologies is itself another problem that surfaces in contemporary research, since the 
underlying biology is often hidden.  Furthermore, the absence of some entities (e.g. 
‗hidden players‘ or ‗hidden variables‘) may influence the results of either or both the 
computational and biological models and enhance such disparities.  These issues give rise 
to the major questions and aims present in this thesis. 
1.3 Specific Aims 
Specific Aim 1:  Develop the EdgeClipper algorithm to identify the most well-conserved 
or supported interactions from Bayesian networks trained on high-throughput data. 
Specific Aim 2:  Develop the BN+1 algorithm to identify novel hidden factors which are 
involved in the regulation of specified pathway entities using high-throughput data. 
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Specific Aim 3: Integrate the EdgeClipper and BN+1 algorithms to compare the 
mechanisms of genetic regulation in two kidney compartments during progressive kidney 
disease. 
The three major aims and their final products are illustrated in Figure 1.5.  Given 
some known biological information from existing biological pathway and public 
microarray repositories, starting networks are generated using Bayesian network analysis.  
These Bayesian networks are then refined and/or expanded to identify the most well-
supported interactions and novel factors, respectively, which relate to the pathway 
activities.   
 
Figure 1.3 Developed approaches for BN refinement and expansion.  An existing, 
underlying biological pathway is assumed to be present (A).  A priori, the set of known 
pathway components (B) are included as variables in a Bayesian network model (C).  
This core network can then be refined via EdgeClipper algorithm to identify the most 
well-supported interactions including novel testable interaction hypotheses (D), expanded 
via BN+1 algorithm to identify the most relevant and influential entities not yet ‗known‘ 
in the pathway (E), and refined and expanded using EdgeClipper and BN+1 to filter 
down to the most well-supported core network interactions and then identify novel 
factors (F). 
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Two major algorithms are introduced in this thesis.  The first approach is an algorithm 
which can prioritize sets of interactions from Bayesian network analyses from the most to 
the least likely and reduce false positive prediction rates.  This novel approach is 
comparable to E-value methods in BLAST analysis [2], and can be used to identify 
interactions which do not appear in literature yet have a high probability or affinity as 
predicted by the Bayesian networks.  Second, we introduce a powerful and novel 
expansion algorithm called BN+1 which can identify novel sets of interactors and their 
regulatory roles within a specified pathway context.  These approaches allow both the 
comparison of computational and biological networks, the initial aim of this thesis, as 
well as to extend the achievable knowledge in the computational and biological models to 
increase the amount of overlap with yet undiscovered biological reality. 
1.3.1 Selecting Biological Pathways for Analysis 
The definition of a pathway depends greatly upon dogmatic and contextual views.  One 
common method of defining pathways is identifying and associating the sets of molecular 
entities which are involved in specified biological processes.  For example, the NF- B 
signaling pathway includes a set of cytoplasmic proteins which, following a series of 
protein-level interaction events, induce a series of transcriptional regulatory changes in 
the nucleus.  The NF- B signaling pathway has many effects on cellular behavior and 
survival, and has been associated with many unfavorable effects on cellular survival 
when perturbed.  The naming of this pathway reflects the major molecular entities or 
‗players‘ which have a major role in the biological outcomes and not all of the possible 
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biological roles.  Other pathways are named specifically for their biological outcome(s), 
such as the apoptotic pathway.   
Classical definitions of pathway assume that a pathway has some input of 
information, a sequence of steps or processes, and some eventual outcome.  This 
definition is more generalized for a variety of computational and biological pathways, 
and parallels some of the definitions for information flow and Shannon entropy 
({Ma'ayan, 2006 #250;{Lungarella, 2006 #251};Gatenby, 2007 #229}).  In this thesis, 
the majority of pathways discussed are protein-level signaling pathways which interact to 
some measurable degree with an underlying transcriptional regulatory pathway.  This is 
an important distinction, since transcriptional regulatory and protein signaling pathways 
may have differential regulation and activities.  Several studies have focused on modeling 
the interactions and flow of information between the transcriptional regulatory and 
protein signaling pathways [3];[4].  Interestingly, in many of the traditional gene 
expression microarray studies, researchers have assumed that the expression levels of 
selected genes were sufficient to predict protein activities and phenotypic outcomes [5].  
As I will show later in this thesis, such assumptions are partially biased and naïve.  Other 
studies have shown that this assumption may not be valid [6,7]. 
The selection of pathways in this thesis was, admittedly, biased according to 
publicly or internally available datasets.  We selected an interesting set of such data from 
the Many Microbes Microarray (M3D) repository [8] which combined data from multiple 
published studies.  In their papers, oxidative stress pathway genes were a few of several 
types of genes which were differentially regulated either up or down in some of the 
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studies.  Our selection of the ROS pathway reflected our individual interests in the 
oxidative stress pathway and its roles in bacterial survival and defense. 
Many other approaches are available for the selection of pathways.  A common 
method for selecting pathways involves the identification of the most highly differentially 
expressed mRNA transcripts [9] across a set of microarray experiments.  In these studies, 
a set of control experiments are conducted along with some perturbation or other 
experimental modification.  The log difference between the two conditions is calculated 
to determine the extent of up- or down-regulation of the gene with respect to the control 
experiment.  These studies have often assumed that the most highly up or down-regulated 
genes were the most meaningful biologically.  
Other approaches have not even assumed pathway-specific contexts for sets of 
genes.  Instead, these approaches have either attempted to reconstruct entire networks 
starting with only a single seed gene or variable (e.g. bottom-up approach in [10,11,12]), 
or built entire global interactions networks (e.g. top-down ‗interactome‘ or ‗exome‘ 
analysis [12]) based on specified computational assumptions and then mined into local 
pathway-like subnetworks.  These approaches often do not assume any starting prior 
knowledge about what constitutes a pathway, though tend to rely on computationally 
naïve assumptions and often miss more complex hidden interactions and factors. 
However, we admit our bias towards studying known biological pathways of 
documented biomedical relevance and instead use this knowledge to our advantage.  The 
initial studies with synthetic and E. coli ROS pathways are used as gold-standard 
references to test our Bayesian network approaches.  Later applications of the approaches 
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are shown in the murine B cell receptor signaling and human progressive kidney disease 
studies.  By studying our approaches in the context of known biological pathways, it was 
possible to benchmark and validate the approaches, as well as offer insights towards their 
application to other biological pathways and high-throughput datasets. 
1.4 The Need for Innovative Computational and Experimental Approaches 
1.4.1 Extending beyond the genome sequence 
One of the most significant developments in biomedical research was the advent of the 
genome sequencing era.  This advent began with the whole-genome sequencing of 
Haemophilis influenza in 1995 [13], and after progressing through multiple species, 
resulted in the sequencing of the human genome.  Major competitive efforts between the 
Human Genome Consortium and Venter groups to generate the first human genome map 
resulted in a wealth of new knowledge for genomic analysis [14,15,16] at the onset of the 
new millennium.  One result of sequencing the various genomes was the applicable 
integration of approaches in genetics, comparative genomics, and bioinformatics to 
analyze health and disease in a variety of organisms [14].   
However, a major challenge following the generation of the genome sequences 
was how to interpret and understand the genome, such as characterization of the exome 
or functional sequences in each genome.  Collins et al. stated in 2003 that new 
technologies would be needed to catalogue all of the components in the human genome, 
interpret how those components interact to perform biological functions, as well as 
understand how genomes might change their components and/or functionality over 
(evolutionary) time [14].  At that time, a variety of new and existing experimental 
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approaches were implemented to assign biological functions to predicted genomic 
components, including microarray analysis, RNA-seq and other high-throughput 
sequencing technologies, mass spectrometry, cloning, PCR, microfluidics, and other 
relevant technologies [14].  Each of these technologies would later play important roles in 
establishing biological functions of the components and implicate them in various disease 
and pathway models, as well as provide potential links between the molecular 
components, their functional roles, their involvement in various pathways, and, most 
desirably, their interplay and potential causative roles in targeted diseases [14]. 
 Two grand challenges were posed by Collins et al. in the context of genomics and 
biomedical research [14].  The first goal was to comprehensively identify and 
functionally characterize components of the human genome.  One major initiative 
launched in this regard was the ENCODE project, which sought to characterize all of the 
genetic components for a targeted 1% of the human genome [14,17,18].  The second goal 
was to elucidate the organization and roles of protein pathways and genetic networks in 
the context of cellular and organismal phenotypes [14].  This was initially achieved by 
assigning genes and proteins to pathways given evidence from knockout or knockdown, 
gain of expression, and targeted small molecule experiments.  Figure 1.1 lists several 
databases which store these types of information in pathway-related contexts.  
Computational methods would also serve as an important method for achieving both 
goals.  Given that many high-throughput datasets would be acquired from different 
biological scales (e.g. molecular, tissue, organ) using a variety of experimental 
approaches and technologies, the need for computational approaches to analyze this data 
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was envisioned quite early.  This need is even more important today, as described in the 
future directions section of Chapter Seven. 
 
Figure 1.4  Methods and data resources for computational network analysis.  Listed 
knowledge-based pathway databases include Kyoto Encyclopedia of Genes and Genomes 
[1,19,20], Biocarta [21], RegulonDB [22], EcoCyc [23], and the Michigan Molecular 
Interactions (MiMI) portal [24].  These pathway repositories incorporate a variety of 
information from different biological levels and experimental methodologies, as well as 
some inferred information from existing computational approaches. 
 
 These early driving goals in the human genome highlight the major concepts in 
this thesis.  First, the definition and refinement of a biological pathway given certain 
types of biological data is necessary and important in understanding organismal biology, 
health, and disease.  Pathways are defined using selected types of interactions and 
molecular entities, though they are often incomplete and require additional investigation.  
The identification of novel interactions and components could be achieved 
computationally, though more work is needed to both develop and verify such 
approaches. 
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1.4.2 Reactive oxygen species (ROS) detoxification pathway in E. coli 
We hypothesized that Bayesian networks derived from microarray gene 
expression data are largely consistent with known pathway models and can be used as a 
basis to predict novel factors and interactions that influence a given pathway.  In this 
study, the hypothesis was examined using the Escherichia coli reactive oxygen species 
(ROS) pathway.  The E. coli ROS pathway has been well studied [25,26,27,28] and 
includes a variety of catalases and superoxide dismutases which are regulated at the 
transcriptional level by several known transcription factors and are involved in the 
processing of oxygen stressors such as oxygen ions, superoxides, and peroxide which are 
harmful to bacteria and living cells. 
This particular pathway which was identified using the EcoCyc database [23], a 
BioCyc database designed specifically for Escherichia coli annotation and other 
knowledge.  This particular pathway is especially interesting, since it relates protein-level 
interactions directly to transcriptional information.  The model provides a more simple 
transition when comparing transcriptional regulatory networks generated by the Bayesian 
networks and microarray data to the pathway represented in EcoCyc.  Twenty-seven 
variables or nodes were identified at the time of analysis, which included the five 
catalases and superoxide dismutases and twenty-two transcription factors represented on 
the corresponding gene expression microarray platform. 
1.4.3 B cell receptor signaling pathway 
As another example of the challenge of merging a pathway model and gene 
expression data, one study in this thesis focuses on the B-cell receptor pathway (BCR) as 
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described by KEGG [1,19].  The BCR pathway is an integral component of the adaptive 
immune response mechanism by which B cells respond to foreign antigens [29].  While 
the KEGG pathway database includes a manually curated BCR pathway, this pathway is 
still considered incomplete [29].  
A subset of genes was selected from the BCR pathway and studied using our 
developed BN+1 expansion algorithm.  One question we addressed was whether the 
BN+1 algorithm could recover all components of the BCR pathway given the selected 
subset of genes.     
1.4.4 Progressive Kidney Disease and Diabetes 
One of the major focuses of systems biology and bioinformatics is on the analysis of 
complex biomedical phenomena such as diabetes.  Roughly 2.3x10
8
 humans (and an 
estimated 5.1% of the global population) currently have Type 1 or 2 diabetes [30,31], 
establishing diabetes types 1 and 2 as major and prevalent diseases in the world.  
Furthermore, despite multiple treatment and preventative initiatives, there is no cure yet 
available for either form of diabetes [31]. 
Many biological processes in different tissues and organs, such as the immune 
system, are perturbed in diabetes.  For example, both forms of diabetes involve the loss of 
beta-cells (differing in cause and rate of loss) with some concurrent inflammatory 
processes in the pancreatic islet [31].  It has been proposed that various regenerative and 
anti-inflammatory treatments which target the beta-cells could benefit patients with types 
1 and 2 diabetes [31].  Other important complications following from diabetes include 
 18 
 
diabetic nephropathy and progressive kidney disease (a major focus of this thesis), as 
well as diabetic neuropathy. 
Progressive kidney disease, a major complication of diabetes, includes a sequence 
of detrimental effects to the afflicted human patient.  Progressive kidney disease is 
defined into classes based upon histological markers which represent the respective stage 
of disease progression.  One significant aspect of the kidney disease progression is the 
order of histological changes in the distinct kidney microarchitecture.  Major changes to 
the glomerular compartment are observed followed by changes to the interstitial tubule 
architecture [32].  Diabetes nephritis is considered a major cause of progressive kidney 
disease [32]. 
In terms of the progressive kidney disease (PKD), we are most interested in how 
the kidney compartments change their mRNA expression and regulation during the 
disease.  Do the glomerular and tubulointerstitial compartments share the same predicted 
interactions between Jak/Stat pathway genes and hence not perturbed as a function of 
disease state, or are they different and reflective of the different stages of progressive 
kidney disease?  What additional biological entities or factors, such as genes and 
proteins, are likely involved in the regulation or downstream activities of the Jak/Stat 
signaling pathway for each compartment and are yet unknown or not implicated in the 
disease?  Figure 1.2 illustrates these two questions. 
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Figure 1.5 Jak/Stat regulation in two compartments during PKD. 
 
In order to understand these questions and provide a systematic means of analysis, 
a set of computational approaches will be introduced and implemented to study the 
selected biological system.  One major challenge is the selection of an appropriate set of 
molecular entities such as genes which can be compared fairly and methodologically 
between the two compartments.  Another challenge is the identification of both novel 
entities and interactions may be important for either of both compartment.  I will 
introduce two major methods which can be used independently or in combination to 
refine and/or expand the selected computational networks and allow comparison across 
the two compartments.   Before that final analysis, simpler synthetic, prokaryotic, and 
eukaryotic networks are used initially in order to benchmark the developed approaches 
and to identify their advantages and caveats. 
1.5 Major Biological Studies in This Thesis 
The driving philosophical questions listed in Section 1.2 are studied in the context of 
several biological and conceptual studies.  First, synthetic networks, a set of 
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computational models, are used to test or benchmark some of our derived algorithms.  
Second, we acquired several publicly-available datasets from prokaryotic and eukaryotic 
studies involving gene expression microarray data.  The most widely-studied biological 
system in this thesis is that of the prokaryotic Escherichia coli reactive oxygen species 
(ROS) detoxification pathway.  This pathway, which was relatively well-studied yet still 
missing important interactors, was used as a representative system to test our developed 
algorithms.  In a more complex organism, Mus musculus, the BN+1 algorithm was 
implemented to better understand mechanisms of genetic and protein-level regulation of 
the Nf- B subnetwork in B cell receptor signaling.  Finally, the approaches were 
combined and used to study an important and complex system, two major kidney 
microenvironments which change during progressive kidney disease.  This disease is a 
major complication of Diabetes types I and II. 
In all of the four studies, we asked which molecular entities not yet appearing in 
the known literature or knowledge repositories were most likely interacting with the 
selected biological pathways.  In the synthetic, ROS, and progressive kidney disease 
pathways, we asked which known interactions were recovered by the Bayesian networks, 
and which disparate edges were best supported by the Bayesian networks and worthy of 
further investigation.  We also asked whether the two microcompartments within the 
kidney showed similar genetic regulation for a selected pathway, and whether the 
predicted lists of novel interactors for each compartment were similar or different.  In this 
regard, we were able to test whether the two compartments undergo similar or perturbed 
and different genetic regulation during progressive kidney disease.  Our results suggest 
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that not only are the two compartments different in terms of their gene regulatory 
network for the same set of pathway genes, but that their predicted interactors are also 
fundamentally different and follow known biological roles and functions already listed in 
the literature.    
1.6 Summary of Chapters 
In Chapter 2, the notion of Bayesian networks is introduced along with the two 
developed major algorithms, EdgeClipper and BN+1 approaches.  Major assumptions 
and computational formulas are introduced, though described more formally in later 
chapters. 
In chapter 3, EdgeClipper network refinement is described in detail and applied to 
the E. coli ROS pathway and developed synthetic networks. A novel equation which 
incorporates both posterior-based and frequency-based methods for edge weighting and 
prioritization was developed which allows direct comparison across these traditionally 
disparate methods. The approach was shown to be significantly faster computationally 
and comparable in performance to bootstrapping analysis. 
In Chapter 4, the BN+1 algorithm is described in detail for three of the major 
biological studies in this thesis.  BN+1 was benchmarked using synthetic networks. Then, 
BN+1 was used to expand and identify novel factors regulating the prokaryotic reactive 
oxygen species (ROS) and later the Nf- B subnetwork in murine B cell receptor 
signaling.  Novel findings included the identification and validation of genetic 
interactions between genes uspE and gadX, as well as their involvement in biofilm 
formation and activities. 
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In Chapter 5, the EdgeClipper and BN+1 approaches were combined to revisit 
previous models of the ROS detoxification pathway and then study progressive kidney 
disease in the two compartments of H. sapiens’ kidney.  The effective combination of 
these two approaches was established through an EC refinement and BN+1 expansion of 
ROS pathway genes which resulted in identification of an entire known acid fitness 
island. 
  In Chapter 6, the online implementation of the EdgeClipper and BN+1 approaches 
in MARIMBA is described.  MARIMBA was implemented for all of the previous 
approaches, including three published BN+1 papers and an upcoming EdgeClipper paper.  
Furthermore, the two approaches are being developed as open-source Python code for 
greater public used. 
 In Chapter 7, a discussion of the major approaches and findings from the thesis 
appears.  The various methods are then described in the context of their future 
applications and directions.  References follow chapter 7. 
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Chapter 2  
 
Introduction to Bayesian Networks 
2.1 Introduction 
One exciting development in bioinformatics research was the advent and application of 
Bayesian networks (BN) in biological research. Basically, BNs are graphical 
representations of statistical interdependencies amongst sets of nodes. BNs model 
interactions amongst sets of variables (e.g. genes, proteins) as probabilistic dependencies 
or influences. Judea Pearl introduced the notion of Bayesian networks in 1985 [33,34] to 
emphasize three aspects: (i) Often subjective nature of the input data information; (ii) 
Reliance on Bayes‘s conditioning as the basis for information updating; and (iii) 
Distinction between causal and evidential modes of reasoning. Bayesian networks were 
later implemented by Heckerman et al, Friedman et al, and various other research labs 
towards biological research [35,36,37].  
Specifically, a BN for a set of variables X = {X1, X2, ...,Xn} consists of (1) a 
network structure S that encodes a set of conditional independence assertions about 
variables in X, and (2) a set P of conditional probability distributions associated with 
each variable [38]. Together, these components denote the joint probability distribution 
for X. The BN structure S is a directed acyclic graph, meaning that the network is 
hierarchical and has both top-level and terminal nodes and no directed paths which 
eventually return to them. We use Pai to denote the parents of node Xi in S as well as the 
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variables corresponding to those parents. Given structure S, the joint probability 
distribution for X is given by      
.                                                 (2.1) 
However, the scoring for the overall network can vary depending upon the input data and 
assumptions used to generate the conditional probabilities for the child nodes and their 
parents.  This concept as well as the implementation to handle this issue is described later 
in the chapter.  In the next section, different methods developed to learn BN structures 
are introduced in detail.  
2.2 Learning Bayesian networks (BNs) 
The problem of learning a Bayesian network (BN) can be stated as follows: given a 
training dataset of independent instances, find a network that best matches the dataset. 
The common approach to this problem is to introduce a statistically sound scoring 
function that evaluates each network with respect to the training dataset and to search for 
the optimal network based on this score.   
To dissect the processes of learning BNs, we summarize five major steps as follows:  
 Data selection and pre-processing   
 Prior definition (including variables and edges) 
 Network searching strategy selection (e.g., simulated annealing, greedy)  
 BN execution with a specific scoring method 
 Results output and analysis 
These steps will be introduced in detail here for gene expression data analysis. 
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2.2.1 Data selection and preprocessing  
BN analysis is a powerful tool for analyzing high throughput data, e.g., DNA microarray 
data. Pre-processing is usually required to normalize raw data and possibly filter out 
those genes that do not show significant changes over all conditions.  Some probes or 
probesets appearing in the microarray dataset may be considered uninformative if their 
signal-to-noise ratio is especially low, such that no significant changes in the overall 
expression of the biological entity (here, expressed and measured mRNA abundance) are 
observed across the set of microarray experiments or samples.   
One method to filter out such uninformative microarray probes or probesets is by 
using a coefficient of variation (c.v.) [39] greater than at least 1.0.  The coefficient of 
variation is generally defined as the absolute value of the standard deviation divided by 
the mean of the expression values for the microarray set.  It has been demonstrated and 
assumed that the variation of transcripts when compared to other transcripts across the 
genome is relatively fixed, and that the c.v. is appropriate in this situation when 
considering signal-to-noise levels [39].  The inclusion of such cutoff criteria is important 
when later considering the discretization of the same datasets, since a faithful and 
accurate binning of the data cannot be achieved for data assumed to be ordered at random 
(e.g. not extending beyond the noise).  Other filtering approaches assume minimum 
allowable values for log fold expression changes when comparing control and 
experimental groups in the data. 
In this thesis, we analyze a variety of static datasets.  Static datasets are assumed 
to be independent of each other, even if temporal data are present.  One reason for this 
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assumption is that we generate static Bayesian networks (BNs) which do not infer 
temporal relations between genes.  More amenable approaches for temporal modelling 
include dynamic Bayesian networks (DBNs)  and neural networks (NNs) [40].   
2.2.2 Prior definition (including variables and edges) 
After selecting appropriate data and variable sets for investigation, settings for the BN 
simulation must be chosen.  Initially, assumptions must be made as to whether structural 
priors (e.g. the requirement of certain interactions to appear in a model) should be 
included or not in the BN analysis. It is not necessary to assume any structural priors for 
the initial set of variables. However, structural priors can be implemented, especially in 
cases where the biological interactions to be represented are well-established and also 
fully represented in the underlying biological data used for modelling.  
2.2.3 Set up network searching strategy 
Once the prior is specified, the BN learning becomes finding a structure that maximizes 
the BN score according to a BN scoring function. This problem is proven to be NP-hard 
[41]. Thus heuristic search is needed. The decomposition of the score is crucial for the 
optimization problem. For example, a local search procedure that changes one edge at a 
time can efficiently evaluate the gains of a specified score made by adding, removing, or 
reversing an edge. An example of such a procedure is a greedy random search algorithm 
with random restarts. Although this procedure does not necessarily achieve a global 
maximum, it reaches a local maximum and does perform well in practice [36]. Another 
commonly used method is simulated annealing search algorithm with a temperature 
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schedule that allows for ―reannealing" as the temperature is lowered [37].  Other BN 
searching strategies include stochastic hill-climbing and genetic algorithm [36]. 
2.2.4 Bayesian network scoring approaches 
The key part of BN learning is to determine a scoring metric that compares networks and 
identifies the most likely or ‗best supported‘ networks. Bayesian network scoring is based 
upon conditional probabilities. One commonly used scoring method is the Bayesian 
Dirichlet (BDe) score [35,37], which is a posterior probability defined as: 
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where n is the number of variables, qi is the number of parent configurations for given 
variable i, ri is the arity of variable i, Nij is the number of observations with selected 
parent configuration qi, Nijk is the number of observations of child in state k with parent 
configuration qi [35]. The calculation of this score is implemented in many software 
programs such as BANJO [40]. 
Another BN scoring method is the Bayesian Information Criterion (BIC), which 
was specifically designed to compensate for overfitting [42].  In the BIC method, the  
data is exponentially distributed, and the BIC is computed as: 
 -2 ln p(x|k) ~ -2 ln L + k ln(n)                                               (2.3) 
Where x is the observed data, n is the number of observations or data points, L is the 
maximized likelihood for the model, and k is the number of parameters to estimate.  The 
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BIC is closely related to other information criterion such as Akaike, deviance, and 
Hannan-Quinn information criterion [43,44].  
2.2.5 BN result output and analysis 
To visualize BN results, different methods can be performed. For example, BANJO uses 
DOT type of BN result output. MARIBMA uses DOT and can also export networks as 
*.sif format for use in Cytoscape (http://www.cytoscape.org). Since different BNs are 
available, it is crucial for a user to select ‗best-scoring‘ networks and/or generate 
consensus networks. Often methods are also needed to build weighted networks based on 
computational analysis or from literature and other database queries.  
2.3 Bayesian network refinement methods 
Although the BN provide are robust framework for biological pathway modeling, 
many factors such as insufficient or noisy data [19] and the influence of hidden variables 
(e.g., unknown miRNAs and genes) can still generate missed or erroneously-included 
interactions in Bayesian and other network models [12,19,45]. To generate a reliable 
network given noisy data, consensus networks can be generated to increase the modeling 
specificity. A consensus network is defined as a network topology with edges that are 
conserved based on a list of calculated networks. Two basic approaches can be used to 
generate consensus BNs: (i) bootstrapping-based BN method with resampling of the 
original data [46,47,48], and (ii) identification of conserved edges within top ranked BN 
networks without data resampling [49]. The bootstrapping-based BN method obtains a 
consensus network by generating the best BN networks via sampling the original data 
with replacement and calculating the frequency of an edge present in the best networks 
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obtained from BN modeling with different resampled datasets. This bootstrapping 
method has been proven to be reliable and consistent in consensus network generation 
and edge prioritization [46,50,51,52]. However, the central disadvantage of bootstrapping 
is that it is computationally intensive. This restriction limits the wide usage of 
bootstrapping in consensus network generations.  
The other approach that uses the same data without resampling requires saving 
more than one top network. In this strategy, consensus networks include those variables 
and edges which appear at or above some selected frequency or weighting cutoff across a 
set of stored ―top-scoring‖ networks with posterior probability scores. While this method 
has been frequently used as an ad hoc technique, the details of why it works and how it 
can be optimized with specific cutoffs have not been thoroughly studied. For example, by 
scoring 8 billion possible networks, a consensus network of the Her2-Neu signaling 
pathway was obtained by analyzing top 500 networks using proteomics and protein–
protein interaction data [49].  Those edges that were conserved in >400, >300, and >200 
of the 500 highest scoring networks were then recorded in the final consensus network. 
However, this method has not been justified rigorously. In addition, these numbers were 
chosen empirically, and each interaction edge in the consensus network was not assigned 
any score to indicate the prediction accuracy.     
2.4 Bayesian network expansion methods  
Bayesian network (BN) expansion is an approach that is built on the BN method and 
aims to identify new pathway elements that participate in a specified network. In this 
section, we will introduce basic BN expansion methods and then focus on describing our 
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internally developed BN+1 algorithm and its implementation. Compared to the other 
network expansion methods described above, Bayesian network-based expansion 
methods provide distinct advantages, such as prediction of both linear and nonlinear 
functions, robustness in noise data analysis, and identification of causal or appearly 
causal influences representing interactions among genes. In general, Bayesian network 
expansion can be defined as the addition of new variables to an existing network, 
followed by rescoring and ranking of those variables.  
BN-based expansion has been used for gene expression data analysis [11,53]. For 
example, Pena et al. reported an algorithm AlgorithmGPC that also grows BN models 
from seed genes [11]. This approach starts with one single gene and builds networks 
around this gene through expansion and pruning with a set number of genes. Gat-Viks et 
al. also generated a Bayesian network-based refinement and expansion method [53]. A 
main limitation of this approach is that it requires high-quality prior knowledge on the 
signaling pathways. The topology of the biological pathways may not be consistent with 
networks learned from transcriptional gene expression data obtained via DNA microarray 
studies. Therefore, a fixed topology as initial seed network may not be appropriate for 
robust network expansion simulations.   Other BN expansion methods have also been 
published [54,55]. These approaches differ from each other but all showed different 
levels of success in identifying new pathway elements. In the following two sections, we 
will introduce our BN+1 algorithm [56,57], and how it can be implemented in the 
MARIMBA software.     
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 Recently, we developed an algorithm termed ―BN+1‖ which implements Bayesian 
network expansion to predict new factors and interactions that participate in a specific 
pathway. Broadly, the BN+1 algorithm  iteratively tests to see if any single variable 
added to a given pathway will significantly improve the likelihood of the overall network.  
This approach is based on the observation that those variables which are hidden and 
regulate or are regulated by a network are more likely ranked with high posterior 
probability scores. Using a compendium of microarray gene expression data obtained 
from Escherichia coli, the BN+1 algorithm predicted many novel factors that influence 
the E. coli reactive oxygen species (ROS) pathway. Some of the predicted new ROS and 
biofilm regulators (e.g., uspE and its interaction with gadX) were further experimentally 
verified [56]. In another study, a synthetic network was also designed to further evaluate 
this algorithm. Based on the synthetic data analysis, the BN+1 method is able to identify 
both linear and nonlinear relationships and correctly identify variables near to the starting 
network [57].  
 Two major assumptions are included in my implementation.  These include:  
(1) The selection of seed (or called core) genes is an important step. The seed genes can 
be selected from an existing pathway database, from literature survey, or from internal 
experimental results. Since it is computationally expensive to calculate BNs using a large 
number of variables, it is often necessary to filter out some genes from an initial list using 
different criteria, for example, filtering out those genes that do not have significant 
changes among all microarray chips.  
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(2) While we use a top network structure generated from initial core gene simulation as 
prior, we prefer not to fix the core network structure for next network expansion. This 
preference makes our approach differ from a commonly used method of fixing the prior 
structure. One argument is that the prior structure is often determined by many layers of 
studies, including DNA, RNA and protein data analyses. When only RNA transcriptomic 
data are used, such prior structure may not hold. The fixture of a prior structure would 
result in obtaining suboptimal networks that do not match the datasets used for BN 
simulation.  
These assumptions have important ramifications for some of the biological 
entities and behaviors predicted by our system.  Comparison to some of the existing 
approaches may be limited due to the nature of these imposed assumptions. 
2.5 Bayesian network refinement and expansion 
The designed refinement and expansion algorithms were designed to be independent 
approaches to answer separate questions about how to refine the BN models generated 
for selected pathway entities (EdgeClipper, EC) or to expand the network representation 
to include novel hidden factors (BN+1 expansion).  In this regard, our combination of 
refinement followed by expansion algorithms presents an approach similar to the Pena et 
al. AlgorithmGPC that also grows BN models from seed genes [11], with several distinct 
advantages. 
First, our approach allows a target analysis of the pathway of interest.   The Pena 
et al. algorithm [11] can continually contract and constrict to change the core network for 
expansion.  However, this approach may also lose some sense of biological 
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meaningfulness or function.  An extreme case could involve losing all of the original core 
network genes after multiple iterations of refinement and expansion.  A second advantage 
of our approach includes a more thorough analysis of the neighborhoods around the core 
network, which includes many of the top predicted expansion genes for each core 
network.  This type of approach can be used to verify conserved biological functions and 
activities using annotation information and a naive natural language processing (NLP) 
technology.  Such considerations were vital to the identification of novel genetic 
regulatory mechanisms and their directed biological funcions and  later experimental 
validation. 
In order to tackle the progressive kidney disease question of differential Jak/Stat 
pathway regulation in two compartments assuming minimal data (described in detail in 
Chapter 5), the EdgeClipper and BN+1 approaches would need to be combined in 
sequence (refinement first followed by expansion).  The choice of ordering was selected 
to first establish the set of most conserved interactions shared in the pathway models for 
the two compartments, and then use those models as well-supported core networks for 
subsequent expansion.   
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Chapter 3  
 
The EdgeClipper Algorithm for BN Refinement 
3.1 Overview 
To increase the specificity of Bayesian network (BN) modeling, consensus networks are 
often generated to identify the best supported edges in an empirically-generated set of 
top-scoring BNs. For better identification of consensus BNs and prioritization of 
predicted edges (i.e., interactions), we developed an algorithm called EdgeClipper that 
sorts and analyzes the posterior distribution of high scoring BNs and identifies the most 
well-supported influences or edges across the posterior distribution.  The EdgeClipper 
algorithm includes a unique B-value for network selection and a separate C-value for 
edge or interaction weighting and ranking. 
As a cutoff for selecting the number of top BNs for inclusion in consensus 
network generation, a B-value score was defined as the right-tail cumulative density of 
the distribution of weighted posterior probabilities of selected top networks when 
considering all saved networks.  Since some edges may not appear with 100% frequency 
in all of the saved Bayesian networks and/or may not appear in the top-scoring networks, 
we devised three versions of the EdgeClipper algorithm (EC-L, -R, and –F) with different 
criteria for network selection and edge inclusion.  The loose EdgeClipper (EC-L) 
approach assumes all networks are included (B-value = 0) and no cutoff regarding edge 
frequency, whereas a restrictive EdgeClipper (EC-R) approach introduces more stringent 
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assumptions (e.g. sliding B-values).  The EC methods assign a C-value metric to each 
edge, based upon the weights and/or frequencies of the edges assigned during the 
respective approaches.  This C-value is then used to rank the respective edges.  
EdgeClipper was tested and validated using synthetic data and E. coli microarray data 
analyses.  
Our results indicate that decreasing B-values result in increased specificity and 
decreased sensitivity of predicting edges in consensus networks.  Furthermore, the 
developed formulas can also represent the existing frequency cutoff methods.  The edge 
ranking by C-values largely correlates with and is sometimes superior to the rankings 
produced by bootstrapping. EdgeClipper provides a systematic method for defining 
consensus Bayesian networks and assessing the relative support for edges in the network. 
3.2 Introduction 
In this study, we generalize the posterior probability-based method and develop a new 
algorithm called EdgeClipper for calculating consensus BNs and prioritizing edges in a 
network. The EdgeClipper algorithm can be adjusted to be more or less strict according 
to the number of BNs included in the consensus generation, as well as by defining the 
minimum frequency of edge occurrence in that set of networks.  A B-value is used to 
define how many top networks (e.g., 500 networks in the above example) to include in 
consensus network generation based upon the posterior distributions of networks.   
Two major implementations of the EdgeClipper algorithm for posterior-based 
weighting were designed.  The first method, the loose EdgeClipper (EC-L) approach, 
assumes all networks are considered or included during consensus network generation 
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(B-value = 0) and no minimum cutoff for edge occurrence is present.  In the restrictive 
EdgeClipper (EC-R) approach, a subset of networks can be selected using the B-value 
metric (sliding-window selection of networks) as a cutoff, followed by selection of only 
those edges appearing with 100% frequency.  The EC-R method also assumes that the set 
of considered interactions or edges is obtained from the top networks with the same best 
score.  To achieve edge ranking and prioritization, a novel equation was generated which 
is robust and can incorporate both posterior probability-based and frequency-based 
weighting methods.  The equation is significant since it can incorporate existing 
frequency methods into our EdgeClipper framework (as an EC-F function).  All versions 
of the EC algorithm generate a C-value which weights the edges in the selected Bayesian 
networks and can be used for edge prioritization or ranking and as a cutoff criteria for 
consensus network generation. 
Using synthetic network and E. coli pathway analyses with a compendium of E. 
coli microarray data, the EdgeClipper algorithm was verified to successfully predict 
consensus networks and conserved edges.  The EC-L and EC-R approaches were 
compared to the prevalent bootstrapping approach in both synthetic and biological cases 
to benchmark and understand the algorithm, as well as to better understand the 
predictions generated for the ROS detoxification pathway.  
3.3 Methods  
3.3.1 Bayesian network scoring and top network search 
In our study,  the probability of a particular Bayesian network given a set of data was 
scored using log of the BDe score [35,37] which is the natural log of posterior probability 
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( DMPS |ln ) and is listed in Equation 2.2 in Chapter 2.  A random sampling 
approach (e.g., simulated annealing) can be used to provide a broad search of possible 
networks during the BN analysis [56,57]. In the reported study, the calculation of the 
BDe score and network sampling by simulated annealing were implemented using the 
open source software BANJO [40].  Other searcher approaches have been used in other 
studies though were not explored in this analysis. 
3.3.2 Derivation of B-value metric for constructing consensus BNs 
The Bayes factor describes the relative improvement or loss of score for one network 
relative to another network.  In this regard, the Bayes factor is represented as the ratio of 
posterior probabilities for two models, Mm and Mn.  Given that Scorex = ln(P(Mx|D)), the 
Bayes factor (BF) can be represented as follows for two candidate models: 
(3.1) 
(3.2) 
After saving a set of top-scoring Bayesian networks, the set of unique (non-
redundant) scores {Si | i=1..x} are saved and then sorted from the highest to the lowest 
posterior probability.  A Bayes factor is then calculated for each score to the top score 
(i.e., 
jnm ScoreScore ee ,1, ) in the saved set.  Each Bayes factor is marginalized to give a 
weighted probability, such that for each score k, 
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where x is the number of unique scores in the saved set.   
A unique B-value is introduced by considering all considered networks using each 
of the weighted probabilities.  The B-value represents the right-tail cumulative density of 
the distribution of weighted posterior probabilities: 
(3.4) 
 
Here j is the number of top unique scores (natural log of posterior probability) chosen for 
inclusion in the consensus network calculation, while x is the number of all unique scores 
saved for network analysis.  Sk is the natural log of posterior probability for a unique 
score k that appears for at least one saved network.  P = 1-Bval is the sum of posterior 
probabilities for the top j scores normalized across all unique posterior probabilities 
(scores); i.e. P is a cumulative density function (CDF) value that represents the coverage 
of the best networks relative to all possible networks. Pk is defined above in Equation 3.3.  
The B-value measures the strictness of a ―top‖ network compared to the total networks 
stored.   
3.3.3 The EdgeClipper Algorithm 
The EdgeClipper algorithm is shown in Figure 3.1, with pseudo-code presented in Figure 
3.2.  First, the algorithm requires as input a set of top-scoring networks from some 
Bayesian network analysis results.  The networks are grouped according to identical log 
posterior scores, and then the scores are ranked from best to worst (where best is defined 
as closest to the value zero).  This set of networks is used in total for the loose analysis 
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(EC-L), whereas a subset of networks is used for the restrictive approach (EC-R).  The 
set of networks with log posterior score mapped to B-values greater than some specified 
input B-value is the subset obtained for the EC-R approach.  The classical frequentist 
approach for edge selection is represented as a third method, EC-F, and also appears in 
the figure (more details described later in this chapter).  After network selection, the set 
of all edges or interactions appearing in the selected networks is determined, as well as 
their frequency of occurrence in the set and their overall C-value weight.  C-values are 
only assigned to those edges appearing in a selected network set.  Finally, following C-
value assignment, a consensus network is derived by including all edges with C-value 
above some selected threshold.  
 
Figure 3.1  Schema for the EdgeClipper algorithm. 
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3.3.4 Defining C-values for representation of edge consensus level 
B-values were defined previously to select sets of best-scoring networks from large-scale 
Bayesian network simulations.  However, another approach was needed to prioritize 
edges given the support from the best-supported networks.  C-values were designed to 
show the overall weight for each network edge given certain assumptions on the set of 
networks and posterior probability distributions.  The C-value for a given edge is 
generalized for the loose and strict assumptions as follows: 
EdgeClipper  
Input: Networks N from a BN analysis with unique scores S, method: EC-L,R, or F, B-
value cutoff  B (B-value = 0 for EC-L method), c-val cutoff 
Data Preprocessing (Optional) 
Group networks by unique scores in S 
Computing C-values for edges in BNs 
Save edges appearing in all included networks N as edge set E. 
For each edge e in E, 
 Compute C-value using N and e  using 
Equations 3.6 and 3.7 if EC-L 
Equations 3.6 and 3.8 if EC-R 
Equations 3.6, 3.9, and 3.10 if EC-F 
(Optional, e.g. EC-R): For each edge w not_contained_in E, 
C-value = ―NA‖ or not defined 
Generating consensus networks 
For each edge e, 
 Include edge in consensus if C-value > cutoff  
Output: C-values defined for selected edge sets, consensus network generation 
Figure 3.2 Pseudocode for the BN+1 expansion algorithm 
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                                                         (3.5) 
where i represents the indexes into the respective scores for included networks (with 
maximum index Nmax), Wi is a weight calculated for each edge, and function f generates 
a binary value of zero or one depending on the presence of the edge ( ) in the networks 
with same score.   
The EC-R, EC-L, and EC-F approaches define Wi and  differently 
(Equations 3.6-9 and Figure 3.3).  In EC-L, Wi is defined as the normalized probability Pi 
(Equation 3.3) for a selected score.  This weight is then added to the cumulative 
weighting if the edge does not appear in one of the networks with that score, as 
determined by Boolean function : 
 if , else 1.                                          (3.6)   
This procedure is repeated for all scores (and hence mapped networks) to give a 
cumulative reverse weighting for an edge given the set of saved networks.  Those edges 
with defined C-values closest to zero have the most support.  This formulation allows 
direct comparison to the EC-R approach and B-value metric (which attempts to minimize 
the right-tail distribution of normalized posterior scores). 
In the EC-R formulation, Wi is also defined as the normalized probability for a 
given score.  However, the Boolean function  is defined iteratively as follows: 
  if  ( , and  ( )), else 1.      (3.7) 
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Here, the Boolean function incorporates all previous decisions about an edge‘s presence 
when traversing from highest log posterior score (best supported) to lowest (least 
supported).  The weights in Equation 3.5, representative of the right-tail cumulative 
density function, accumulate after encountering the first network set lacking the edge of 
interest.  Those interactions not appearing in the top-scoring network are currently not 
defined (e.g. ―NA‖), since we assume that the set of edges to consider come from the top-
scoring networks (another possibility is to assume that the Boolean function always gives 
value 1). This formulation allows direct comparison of the EC-R and EC-L approaches. 
 The above methods and Equation 3.5 are also applicable towards describing the 
predominant frequency-based edge selection.  We define this method as EC-F, and 
generate a simpler representation of the Wi and  as follows: 
 if , else 0                                                (3.8) 
Wi  =                                                         (3.9) 
Hence, assuming that =1 for all I, .  Then, the C-values generated are 
bounded between 0 and 1 and contain equal weights for all of the networks.  Thus, the 
EC-F method is exactly the frequency of edge occurrence across the set of uniquely-
scoring networks assuming equal weights of networks (independent of posterior 
distribution). 
 After computation of the C-value for each method, the edges can be ranked 
according to their computed C-values.  C-values are sorted from 0 to 1 (reflecting the 
weights of networks either not including an edge or not deemed significant in weight 
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such as in the EC-R design) since it is easier to compare C-values such as 1x10
-6
, 1x10
-7
, 
etc. and not 0.999999 and 0.9999999 (though they related by subtracting each from the 
value 1.0).  Those edges which have C-values greater than some cutoff can then be 
included as undirected edges in the consensus networks. 
 
Figure 3.3 Comparison of EC-L, -R, and –F methods for two edges.  Plots are shown 
for nine hypothetical networks sorted by log posterior scores.  Two edges are selected 
from the networks, such that an edge may either appear in a network (box) or not 
(ellipsoid).  Then C-values are calculated for each edge (A-C and D-F, respectively) 
using the three EC methods and listed in the top-right corner of each plot.  For EC-L and 
EC-R, the C-value is computed using the sum of the area under curve for the indicated 
plot regions.  For EC-F, this is instead the frequency of edge presence (or number of 
boxes divided by nine).  In this example, interactions (or edges) #1 and #2 share the same 
frequency (EC-F) yet differ greatly in EC-R and EC-L values.  Edge #2 will be ranked 
higher than #1 due to its smaller C-value in EC-R and EC-L. 
 
3.3.5 EdgeClipper software   
We have developed an EdgeClipper software package in Python to interpret Bayesian 
network simulation results and generate both B- and C-values for networks.  This 
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software uses a BANJO (http://www.cs.duke.edu/~amink/software/banjo/ [40]) output 
file as the input to the EC algorithms, and calculates C-values for each possible edge.  
BANJO provides both static and dynamic Bayesian network analysis.  Both EC-L and 
EC-R methods are implemented for the static Bayesian network analysis. The  Python 
source code for the EdgeClipper software program is available at: 
http://code.google.com/p/edgeclipper/. In addition, the MARIBMA program 
(http://marimba.hegroup.org) implements both EC-L and EC-R methods in PHP code. 
This program is open-source software with the Apache License version 2.0.  
3.3.6 Synthetic data generation 
A synthetic network with nine variables was designed for simulating microarray gene 
expression data. The synthetic data were generated based on a previous study by Luo et 
al. [58] with modifications. Specifically, the following mathematical formulae were used: 
A= N(0, 1)         (3.10) 
B = N(10, 5)         (3.11) 
C = N(0, 10)         (3.12) 
D = A
3
+ N(0, 0.1)        (3.13) 
E = A + N(0, 0.1), while (A+10>=B); E = B/10 + N(0, 0.1) otherwise. (3.14) 
F = (B-C)/(B+10) + N(0, 0.1)       (3.15) 
 G = A + sin(C) + N(0, 0.1), while (A+10>=B);       
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else E = B/10 + sin(C) + N(0, 0.1).       (3.16) 
H = log(e
A
 + e
F
) + N(0, 0.1)       (3.17) 
I = (D + H) * (F/2) + N(0, 0.05)      (3.18) 
Separate datasets with 10, 50, 100, 250, 500, and 1,000 observations were 
sampled independently using the synthetic network topology and rules encoded in R 
[59].  These data were used in the subsequent synthetic network analysis. The five 
synthetic datasets with different numbers of observations or conditions were used in 
separate Bayesian network simulations.  The EdgeClipper algorithm was applied 
towards refining the network results from each of these five BN analyses.  
Sensitivity and specificity were plotted as a function of the B-value cutoff variable 
for the different simulations.   
3.3.7 E. coli ROS pathway data analysis using EdgeClipper  
A compilation dataset comprising 305 gene expression microarray observations and 
4,217 genes from Escherichia coli MG1655 was obtained from the M3D database [8]. A 
coefficient of variation threshold (c.v. ≥ 1.0) was used to select 4,205 genes for analysis.  
Twenty-seven genes were identified from the EcoCyc ROS detoxification pathway 
(downloaded on March 26, 2008) and matched to unique features found in 305 available 
gene expression microarray chips.  Expression profiles for each gene were discretized 
using a maximum entropy approach that uses three equally-sized bins.  To maximize the 
network search space, 4,000 independent simulations with random starts were used to 
search 2.5 x 10
7
 networks per start for a total of 1 x 10
11
 networks.  Five top networks 
were saved from each run, thereby generating a final list of 20,000 top-scoring networks. 
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To reduce the large 27 gene network down to medium and small networks, we trimmed 
the networks using different B-values.   
3.3.8 Analysis of selected EcoCyc pathways using EdgeClipper algorithm  
All EcoCyc pathways were checked for the number of genes or corresponding proteins 
which successfully mapped to genes on the microarray platform.  Seven pathways were 
then randomly selected from sets of pathways with 5, 10, 15, and 20 genes.  These genes 
were then included as variables in the EdgeClipper analyses. 
3.3.9 Bootstrapping analysis of consensus networks and edge prioritization  
The standard bootstrapping method [60] was used to generate multiple datasets given 
some starting datasets from the synthetic and E. coli datasets. Specifically, bootstrapping 
with replacement was used to generate multiple data files with the same number of 
conditions or observations as the starting dataset.  Each condition had an equal chance of 
being selected (uniform probability across all of the conditions), with the possibility that 
each condition could be selected zero, one, or more times and represented in the 
bootstrapped data file.   
For synthetic data bootstrapping simulations, five major analyses were conducted.   
A set of 1,000 bootstrapped datasets (bootstrap with replacement) was generated for each 
synthetic datasets (10, 25, 50, 100, 250, and 500 conditions) to give 5,000 total 
bootstrapped datasets. Each set of 1,000 observation data files with identical numbers of 
observations was used in independent Bayesian network simulations.  In each simulation, 
5 x 10
7
 networks were searched using simulated annealing for the nine variables and one 
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of the 1,000 data files.  The top 1,000 networks from the simulated annealing approach 
were then saved.  Bootstrap results were compiled for the 1,000 independent simulations 
with selected data size, giving a total of 1x10
6
 saved networks per data size. 
A bootstrapping test was also used to compare the result obtained from 
EdgeClipper for the analysis for E. coli ROS pathway.  For this bootstrapping analysis, a 
―re-shuffled‖ dataset was first generated from the original dataset using the method of 
resampling with replacement. The new dataset was used for BN analysis by simulating 
2.5 x 10
7
 networks. In each of the independent BN simulations with resampled data, the 
top one BN model was saved. This procedure was also repeated 1,000 times. Confidence 
in a particular edge is defined as the frequency of how often an edge actually appears in 
the set of reconstructed top BN models [60]. 
3.3.10 Comparison between EdgeClipper and bootstrapping in consensus network 
generation and edge prioritization  
The correlation between results obtained from EdgeClipper methods EC-L and EC-R, 
and the bootstrapping was measure via Spearman rank correlation analysis [61].  
Specifically, the cor.test function in the R ‗stats‘ library was used [59].  Approximate P-
values were recovered since some ranking ties were observed for the top results in both 
EdgeClipper C-values and bootstrap rankings.   
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3.4 Results 
3.4.1 EdgeClipper algorithm  
EdgeClipper was developed to increase the specificity (i.e., reduce false positive rate) in 
the prediction of edges appearing in a selected consensus network while retaining as 
many true positive edges as possible.  Furthermore, a key question in biological modeling 
is which of the many interactions predicted by the Bayesian network are likely to be 
verified experimentally, and which networks should be included when assigning these 
interaction weights and priority.  At the start of the EdgeClipper workflow, a standard BN 
analysis is first used. Specifically, high throughput data (e.g., microarray data) are pre-
processed, various network topologies are searched (e.g., by simulated annealing), and 
the posterior probability of each network topology given the data is calculated (e.g., BDe 
score) (Figure 3.4). Instead of selecting only one network with the best score, 
EdgeClipper requires the storage of a large number of top ranked BNs to generate a 
posterior probability density (Figure 3.4).  
Based on the set of non-redundant ranked scores from those saved networks, a B-
value is computed as a normalized probability that gives a relative weighting for a BN 
score. The B-value can be considered as the relative or normalized weighting of networks 
scoring worse than a selected score. Specifically, the B-value represents the right-tail 
cumulative density of the distribution of weighted posterior probabilities, i.e., the 
cumulative weighting from the best score (and hence best-scoring networks) to a BN 
score is subtracted from one to give a unique B-value. The primary reason of the 
selection of the right-tail instead of the left-tail cumulative density is that the right-tail 
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density is more sensitive to the change in the number of networks selected for consensus 
network generation. Figure 3.4 illustrates the concept of B-value as compared to the 
original BDe distribution. When B-value = 0, all saved networks are selected for 
consensus network generation. A B-value of 1 represents that no saved network is 
selected. In practical application, at least one top network score is selected. In this case, 
the B-value is directly associated with the weighting of the first top network score. In a 
typical sorted BN result, the top networks have much higher posterior probabilities than 
the networks with low scores.  
     
(A)                      (B)              (C) 
Figure 3.4 Comparison of B-value and BDe distributions.  (A) BDe score distribution 
from a set of BN simulations sorted from best to worst score with score index i.  (B-C) B-
value distributions for the same scores with index i plotted using standard (B) and semi-
log (C) y-axis.  Here, (B) illustrates the severe drop-off of B-values (<<0.1), while (C) 
shows the close relationship of the B-value distribution with the original log posterior 
distribution. 
 
After the set of networks is selected by B-value for inclusion in consensus 
network computation, conserved edges among the saved top networks will be identified 
and kept in the final consensus network.  Edges which have an accepted C-value are 
specifically included in the consensus network.  Other approaches, including the 
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implemented bootstrapping method, have used edge frequency cutoffs which do not 
directly incorporate the log posterior distribution as support or weight. 
One important assumption in the approach is the inclusion of both edge directions 
cumulatively as equal representation of an interaction (hence influences AE and EA 
are assumed equal mathematically).  One reason why we consider both directions for an 
edge is that many BN networks are often score equivalent, i.e., there are multiple 
equivalent toplogies differing only in edge direction that have identical probabilities 
given an observational dataset [62]. Two equivalent BN structures with the same scores 
and edge topology may have different directions in many edges. An equivalence class of 
network structures can be uniquely represented by a partially directed graph (PDAG), 
where a directed edge XY  denotes that all members of the equivalence class contain 
the arc X Y, and an undirected edge X—Y  denotes that some members of the class 
contain the arc X Y and the others contain the arc YX [36]. This PDAG 
representation is applied in EdgeClipper. Specifically, EdgeClipper defines directed 
edges in the consensus network as those edges that appear with 100% frequency in one 
direction in all stored networks for the B-value selected above [63].  Undirected edges 
represent those edges appearing 100% of the time in both directions in all stored 
networks.  Other approaches such as that in Bose et al. [49] will define an intermediate 
value between 0 and 1 for the frequency of edge occurrence. 
Once a consensus network is generated, a C-value is defined to rank the edges in 
the consensus network according to their level of support from the data.  The C-value of 
an edge represents a minimal B-value at which this edge disappears from the consensus 
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network. Edges are next ranked according to their C-values.  Those edges (representing 
interactions) with C-values closer to 0 are expected to be more conserved and specific 
than other edges with C-values closer to 1. Any C-value of an edge in a consensus 
network is always greater than or equal to the B-value used for generation of the 
consensus network. A C-value of zero for an edge indicates that all saved networks 
contain the edge, and hence the cumulative weight of zero networks lacking the edge is 
zero. Those top-ranked edges with their C-values being zero are the most conserved and 
well-supported interactions.   
Based on the filtering ability of the B-value for network refinement, two 
EdgeClipper methods have been developed: EdgeClipper-Loose or EC-L (loose cutoffs 
with B-value = 0 a) and EdgeClipper-Restrictive or EC-R (restrictive cutoffs with B-
value sliding) (Figure 1). The EC-L method contains all save networks (i.e., B-value = 0) 
and does not have any restriction on the accumulative frequency of edge occurrence in all 
selected networks. The consensus network in EC-L includes all possible edges that have 
ever present in any saved BN. Therefore, these conditions are the loosest as we can ever 
expect when including posterior-based weighting. One advantage of EC-L is that after C-
value calculation, every possible encountered edge will have a C-vale prioritization score. 
One disadvantage of this approach is that it is computationally expensive compared to 
EC-R. In contrast, EC-R requires that any edge in the consensus network should be 
present in all networks selected by the B-value cutoff. In EC-R, the differences between 
different consensus networks will indeed be determined by B-value. If the B-value is 
zero, the consensus network will be a PDAG that is formed using all save networks. 
When the B-values are increased from zero, a decreasing number of networks from the 
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right-tail distribution will be used for consensus network generation, leading to more and 
more edges present in the consensus network.  
3.4.2 Evaluation of EdgeClipper using synthetic networks  
To benchmark the overall performance of the EdgeClipper algorithm, the algorithm was 
first applied to a synthetic network dataset generated with different data sizes (Equations 
3.10-18).  Figure 3.5A illustrates the synthetic network used in the analysis.  Our initial 
analysis was focused on the impact of B-value in the final consensus network generation. 
Because EC-R has sliding B-values (e.g. a unique B-value cutoff mapped to each edge), 
it is natural to test the B-value impact using the EC-R method. In the synthetic data 
analysis, different data sizes ranging from 10 to 500 were used. With decreasing B-values 
from 1 to 0.01 (or increasing the X-axis –log10(B-value) value from 0 to 2 in Figure 3.6) 
for all data sizes, the usage of the EC-R method resulted in increasing gains in specificity 
in terms of edge prediction in the network. Meanwhile, the sensitivity decreases for each 
of the data sizes as the B-values decreases and approaches zero (or X-axis value 
approaching infinity).   
            
(A)                                          (B)                                           (C) 
Figure 3.5 Synthetic data analysis for benchmarking the EdgeClipper algorithm. 
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(A) The topology of the synthetic network. (B) A false positive interaction predicted by 
bootstrapping but ignored by EC-L and EC-R. (C) A false positive interaction predicted 
by all three methods.  
 
Figure 3.6 Performance benchmarking of EdgeClipper for a range of dataset sizes.  
The performance of specificity (A) and sensitivity (B) of edge predictions in predicted 
consensus networks based on the EdgeClipper EC-R method was studied. The tested data 
sizes include 10 (red), 25 (orange), 100 (green), 250 (grey), and 500 (blue).  
 
Besides the B-value, the data size is another factor that influences the specificity 
gain and sensitivity loss. With the same pattern of decreasing B-value cutoffs, the 
EdgeClipper analysis using smaller data sizes tend to have more gains in specificity. 
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However, the EdgeClipper consensus network analysis will also have quicker loss in 
sensitivity at the same time. In contrast, the EdgeClipper analysis with larger data sizes 
will have slower gain in specificity but also less loss in sensitivity when the B-values 
decrease. These results suggest that BNs trained using smaller data sizes will benefit the 
most in terms of finding specific edges using the EdgeClipper algorithm. In the synthetic 
analysis case, no noticeable gains in specificity were identified for B-value < 0.01 in all 
cases, suggesting an optimal B-value range could be determined in specific cases (e.g. 
0.1-0.01 as a cutoff in Figure 3.6).  
Using the same synthetic datasets, we also compared the performances of EC-R, 
EC-L, and bootstrapping in edge ranking (Table 3.1). In general, the results obtained 
from all three methods correlate well (P-value < 0.01). The three methods all predicted 
eight of the top nine edges with almost identical order. The one edge (E-G) was not 
predicted by any of the three methods. Because EC-R requires an edge to be present in all 
retained networks (including the top scoring network), those edges in the final consensus 
network will have to be in the top scoring network. Therefore, it is reasonable that only a 
portion of the edges were predicted by EC-R. In addition, we found that bootstrapping 
but not EdgeClipper sometimes predicted spurious or false positive interactions (Figure 
3.5B-C). Sometimes a spurious or false positive interaction, such as G-E, was predicted 
by all three methods.  Therefore, the synthetic data analysis indicates that EdgeClipper 
methods are equally good or better than bootstrapping in prediction of edges in consensus 
networks.  
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Table 3.1 Comparison of bootstrapping, EC-L, and EC-R in edge ranking in the 
synthetic data analysis.  The analysis of 500 observation was used. Only those edges 
appearing in both the bootstrapping and EdgeClipper EC-L and EC-R results are ranked 
in this table. Key: NA- not defined, Y – edge exists as direct connection in synthetic 
network. 
Edge 
Bootstrap 
Frequency 
EC-L C-value EC-R C-value Real? 
A-D 1000000 -5.36E-16 0 Y 
B-E 1000000 -5.36E-16 0 Y 
C-F 1000000 -5.36E-16 0 Y 
E-G 977309 -5.36E-16 0 
 
F-I 964218 6.83E-11 2.42E-09 Y 
B-F 922296 8.54E-10 1.23E-08 Y 
A-H 916495 7.28E-11 1.74E-09 Y 
H-I 825251 8.16E-05 0.000137 Y 
D-I 753223 9.28E-05 0.000208 Y 
C-H 540636 0.230169 0.14175 
 
D-E 495874 0.949087 NA 
 
F-H 471996 0.769831 NA Y 
A-E 465201 0.050913 0.037012 Y 
A-B 242656 0.999974 NA 
 
B-C 231985 1 NA 
 
B-D 228231 0.999997 NA 
 
A-G 225637 0.999986 NA Y 
A-I 204972 0.99999 NA 
 
D-H 151304 1 NA 
 
A-C 108918 0.999999 NA 
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C-G 98479 0.99995 NA Y 
C-D 76659 0.999998 NA 
 
C-E 67706 0.999997 NA 
 
D-G 65834 1 NA 
 
C-I 61692 1 NA 
 
A-F 47598 0.999999 NA 
 
B-G 34076 1 NA Y 
D-F 26489 0.999999 NA 
 
E-F 21164 1 NA 
 
B-H 17537 0.999996 NA 
 
E-H 12737 1 NA 
 
F-G 6889 1 NA 
 
B-I 4706 1 NA 
 
G-H 3674 1 NA 
 
G-I 1770 1 NA 
 
E-I 131 NA NA 
 
3.4.3 Results of E. coli ROS pathway analysis using EdgeClipper  
To evaluate EdgeClipper using biological data, we first tested the E. coli reactive oxygen 
species (ROS) detoxification pathway using a compendium of microarray gene 
expression data from the M3D database [8].  The existing ROS pathway from EcoCyc 
models five E. coli enzymes important for the resistance against ROS toxicity, as well as 
22 transcription factors that bind to targeted DNA sequences at the protein level. Using 
all 27 genes contained in the E. coli ROS pathway, a previous study was conducted to 
construct a consensus network with only the top one scoring networks among 20,000 
saved networks [56].  We hypothesized that with more restrictive B-values (i.e., more 
 57 
 
top-scoring networks used), more conserved networks could be generated with more 
conserved edges detected.  
To measure the relation between B-values and the specificity of predicted 
consensus networks, EC-R was first used. Based on three distinct B-values, three 
consensus networks were identified using the EC-R method (Figure 3.7). The large 
 
Figure 3.7 ROS consensus networks generated by B-values.  Three successive 
consensus networks were generated using different B-values, as described in-text.  The 
smallest core network was selected using the largest connected set of genes with B-value 
= 0.0.  These networks were later used as core networks in Chapters 4 and 5 for BN+1 
expansion and hidden factor identification.  
 
network with a B-value of 0.247 contains all 27 genes from the original ROS 
detoxification list in EcoCyc. The predicted topology of the large network is basically the 
same as the one shown in previous work [56], which was generated by using all 
equivalent networks with the same BDe score. By comparing all the EcoCyc, 
RegulonDB, and literature data, a 42% correlation was observed between the predicted 
and known edges [56]. The medium consensus network had a B-value of 10
-3
, which 
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corresponds to the selection of the top 3,644 simulated networks. By calculating the 
curated results from Supplemental Table 1 in Reference [56], this network contains 10 
edges, and  of them were verified to be true. The remaining edges are well supported 
hypotheses and deserve further investigation. When all 20,000 saved networks were used 
(i.e., B-value = 0) in consensus network generation, all seven edges were supported based 
on existing knowledge (Supplemental Table 1 in Reference [56]). This study also found 
that all edges shown in a more conserved network are also found in a less conserved 
network. For example, all edges shown in the small network (B-value = 0) exist in the 
medium network (B-value = 10
-3
) and large network (B-value = 0.247). In summary, the 
EC-R method can refine the consensus network down to the best-supported interactions 
appropriate to the underlying dataset used in the analysis.  The EC-L method provides a 
nearly identical list of ranked interactions, including those interactions which do not 
appear initially in the top-scoring network.  
One question was whether the bootstrapping or EdgeClipper predicted 
interactions most closely reflect the underlying biological interactions. Spearman rank 
correlation testing revealed that the edges in the E. coli ROS pathway network ranked 
according to EC-L and EC-R show a significant negative correlation (P-value < 0.01 in 
both cases) with the ranked bootstrap frequencies for those edges.  Table 3.2 shows the 
major interactions and their predicted weights and rankings according to the bootstrap, 
EC-L and EC-R methods.  Specifically, C-values are ranked from zero to one with zero 
being a score for the most conserved and specific edges. In contrast, the bootstrapping 
confidence values are ranked from one to zero, where zero for an edge represents no data  
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Table 3.2 ROS BN interactions predicted using three methods. 
Interaction Bootstrap 
Freq. (2-way) 
EC-L  EC-R Rank: 
Bootstrap 
Rank: 
C-value 
(EC-L) 
Rank: 
 C-value 
(EC-R) 
gadX-gadE 0.999 4.40E-15 0 1 1 1 
marA-marR 0.999 4.40E-15 0 1 1 1 
gadX-gadW 0.998 4.40E-15 0 3 1 1 
katE-sodC 0.996 4.40E-15 0 4 1 1 
fis-sodC 0.988 4.40E-15 0 5 1 1 
ihfA-ihfB 0.986 4.40E-15 0 6 1 1 
crp-oxyR 0.863 1.96E-07 6.55E-05 7 7 7 
sodA-soxS 0.756 0.0195 0.145 8 22 23 
cspA-ihfB 0.733 0.0118 0.0773 9 19 20 
gadX-fur 0.719 4.61E-06 0.000939 10 8 9 
ihfA-sodC 0.718 0.00482 0.0507 11 18 17 
katE-pheU 0.661 0.000831 0.0262 12 12 13 
evgA-gadW 0.66 0.423 0.437 13 30 30 
sodB-sodC 0.65 0.0399 0.192 14 26 26 
fnr-gadX 0.631 0.000108 0.00586 15 10 10 
gadX-rob 0.592 0.00207 0.0221 16 15 12 
ihfA-marA 0.564 0.0219 0.121 17 24 22 
hns-ydeO 0.557 0.00128 0.0422 18 13 16 
cspA-soxS 0.555 0.0441 0.215 19 28 28 
gadX-sodC 0.533 1.44E-5 0.000693 20 9 8 
rob-ydeO 0.532 0.0211 0.166 21 23 24 
torR-ydeO 0.53 0.00137 0.0344 22 14 14 
katE-ydeO 0.425 0.00429 0.0537 23 16 18 
cspA-gadX 0.394 0.0167 0.0773 24 21 20 
gadX-soxS 0.383 0.00432 0.0404 25 17 15 
arcA-cspA 0.358 0.000418 0.0141 26 11 11 
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katG-pheU 0.352 0.0855 0.259 27 29 29 
gadX-sodB 0.348 0.0417 0.192 28 27 26 
katE-oxyR 0.291 0.0333 0.174 29 25 25 
ihfB-soxR 0.28 0.434 0.590 30 31 31 
fnr-sodC 0.276 0.0128 0.0710 31 20 19 
 
support for this edge. Interestingly, all of the consensus edges appear in the top 57 
interactions listed by the ranked bootstrap results (top 57 out of 50,295 total interactions 
saved). However, one interaction, sodA-sodB, was missed by EdgeCliper but was highly 
ranked by bootstrapping. Because the sodA-sodB interaction did not appear in the top-
scoring Bayesian network, no C-value was assigned according to EC-R.  Furthermore, 
EC-L ranked the sodA-sodB as 35
th
 with a C-value of 0.935. 
3.4.4 Analysis of selected EcoCyc pathways using EdgeClipper algorithm  
Ten additional EcoCyc pathways were selected for additional analysis. The pathways 
were selected for having 5 to 25 genes which matched the microarray platform. BN 
analyses were conducted for each of the ten pathways, followed by subsequent 
refinement with the EdgeClipper EC-R method. The EC-R method was tested for 
sensitivity and specificity using B-value cutoffs of 0.1 and 0.01. Our analysis results 
indicate that the lower B-value a cutoff was used, the more specific interactions it 
predicted. The results are similar to the ones found in the E. coli ROS pathway analysis 
and further confirm that EC-R is able to increase the prediction specificity of edges in 
consensus networks.  
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3.5 Discussion 
This study reports the development and evaluation of EdgeClipper, a posterior 
probability-based algorithm for generation of consensus networks and prioritization of 
edges in a BN. Our synthetic and E. coli data analyses indicate that EdgeClipper 
improves the specificity of consensus network generation and provides an effective way 
to rank edges. 
EdgeClipper is a posterior probability-based algorithm developed to 
systematically construct consensus networks and rank the support for each edge in the 
network. The concept of consensus network generation based on analysis of a set of 
stored ‗top-scoring‘ networks has been conceived before. For example, many scientists 
have used such a method ad hoc [49]. The partial directed acyclic graph (PDAG) method, 
proposed to summarize the networks with equivalent classes [36], is a type of consensus 
network built on saved networks with the best posterior probability score. However, the 
PDAG method has not been associated with any systematic and quantitative measures. 
Hartemink also proposed an approach for BN edge prioritization by computing 
cumulative posterior probabilities based on all saved top-scoring networks [64]. This 
proposed method is similar to the C-value calculation based on EC-L. However, 
Hartemink‘s method does not consider equivalent networks, and the approach has not 
been tested. The major contribution of EdgeClipper is that instead of directly using 
posterior probabilities, we are the first to use the right tail of accumulated density in the 
posterior probabilities for consensus BN analysis. If posterior probabilities are directly 
used, it would be difficult to compare different scores (Figure 2). The switch of using the 
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right tail of accumulative posterior probabilities (i.e., B-value) allows us to use the 
posterior probabilities to generate consensus network. In addition, the introduction of B-
value in EdgeClipper allows us to consider a whole or a portion of saved top networks 
with a B-value cutoff. Furthermore, because many BNs are equivalent, the use of 
posterior probabilities in EdgeClipper allows us to group these equivalent networks with 
the same scores using the PDAG approach. An ignorance of those networks with the 
same scores due to equivalent or nearly equivalent network structures, may bias the 
results of edge prioritization.   
The EC-L and EC-R methods are two EdgeClipper methods with extreme settings 
(Figure 3.1). When we calculate consensus networks, EC-R only uses the top scoring 
networks based on B-value cutoff, while EC-L includes all networks ranging from high 
scoring to low scoring networks. Since EC-R uses the Fe-value of 100%, EC-R will not 
rank those edges that do not exist in the best scoring networks. In contrast, EC-L does not 
have any restriction of the Fe-value cutoff, so EC-L will assign a score for any edge that 
exists at least once in any of the saved networks (Table 1-2). However, for those edges 
present in the best scoring networks, these two methods correlate well. Those edges that 
are absent from the best scoring networks usually have low C-value scores. Therefore, if 
we are only interested in finding those most specific and conserved edges, EC-R is 
sufficient. While both EC-R and EC-L are computationally faster than bootstrapping 
because of the lack of the data resampling step, EC-R is slightly faster to compute than 
EC-L due to its restrictive settings.  
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In our synthetic and E. coli real data analyses, we found that the results of 
EdgeClipper and bootstrapping largely correlate, and in some cases EdgeClipper behaves 
better than bootstrapping in predicting an edge. We note that there are fundamental 
differences between bootstrapping and EdgeClipper. First, the underlying datasets used in 
the two approaches are different.  The original underlying dataset was used as a whole in 
the EdgeClipper approach. However, the bootstrapping method uses reshuffled data. The 
reshuffling may change the binning assignment from one sample to another. It is 
important to recognize this difference, since for relatively small data sizes, the 
bootstrapping approach may be extremely sensitive to the implemented sampling 
approach and loss/gain of selected data vectors. However, EdgeClipper uses all the 
original data and thus does not have this problem.   
Due to the differences in data processing, the primary questions addressed by 
these two methods become different. Based on the B-value derived from the posterior 
probability, EdgeClipper focuses on answering the question "How well does it fit in with 
the model with the data?" The B-value fits in line with density, statistical P-value, and 
BLAST E-value analyses in that all these values consider the weighting or significance of 
a set of results within a selected probability distribution. Significance is used loosely here 
since our B-value is based on the observed probability distribution. In contrast, 
bootstrapping answers the question "How sensitive is the fit of the model to specific data, 
or how robust is it?" Here, the bootstrapping confidence value can be grouped together 
with q-value and cross validation results. The bootstrapping can be used to identify 
whether the BNs are sensitive to certain data, such as in cases where datasets are small or 
sparse, or selected data are over-represented in the set and bias the overall 
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model.  Different bootstrapped data can give rise to unique posterior probabilities in the 
Bayesian networks, though we would expect similar overall distributions if the model is 
robust given the data. 
  EdgeClipper has basically two uses: consensus network creation, and edge 
ranking. Our studies indicate that EdgeClipper generates more specific and conserved 
consensus networks and the edges can be ranked accordingly with C-values, with EC-R 
giving the most specific interactions. Therefore, EdgeClipper can be used to confirm 
known interactions and identify new interactions with high specificity. For example, we 
identified many unknown but specific and conserved interactions (e.g., sodC – gadX) in 
the E. coli ROS pathway (Figure 6). Since BN modeling attempts to predict many new 
interactions, it is too expensive and most likely impossible for a wet-lab to test all 
possible interactions. Therefore, it is crucial to identify those most promising interactions 
for experimental verification. The EdgeClipper consensus network approach allows us to 
focus on a small network with high confidence. The C-value ranking provides a way for a 
research to experimentally investigate those predicted interactions with the best chance of 
success.  
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Chapter 4  
 
BN+1 Algorithm for Identification of Novel Pathway Members 
4.1 Overview 
Signaling and regulatory pathways that guide gene expression have only been partially 
defined for most organisms. However, given the increasing number of microarray 
measurements, it may be possible to reconstruct such pathways and uncover missing 
connections directly from experimental data.  To achieve the identification of novel 
pathway members and their biological roles in selected pathways, we developed a novel 
algorithm called BN+1 which incorporates Bayesian network computations to expand 
networks to include potentially important biological interactors.  BN+1 analysis enables 
the prediction of the most likely molecular interactors given some initial set of molecular 
entities (e.g. genes) and an existing biological dataset (e.g. gene expression microarray 
data).   
The BN+1 approach was tested and characterized using synthetically-derived networks 
which can mimic some biological interactions.  This approach was also applied to the 
analysis of the ROS pathway in Escherichia coli (partially described in Chapter 2) and B 
cell receptor signaling pathway in Mus musculus.  This expansion procedure predicted 
many stress-related genes (e.g., dusB and uspE), and their possible interactions with other 
ROS pathway genes.  A simple yet novel term enrichment method identified that biofilm-
associated microarray data usually contained high expression levels of both uspE and 
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gadX. The predicted involvement of gene uspE in the ROS pathway and interactions 
between uspE and gadX were confirmed experimentally using E. coli reporter strains. 
Genes gadX and uspE showed a feedback relationship in regulating each other's 
expression. Both genes were verified to regulate biofilm formation through gene 
knockout experiments.  Furthermore, the approach was successful in identifying known 
and putative interactors with the Nf- B subnetwork within the larger B cell receptor 
signaling pathway.  
These data suggest that the BN+1 expansion method can uncover hidden or 
unknown genes for a selected pathway with significant biological roles. Our results 
demonstrate the power of BN+1-based pathway augmentation or expansion in synthetic, 
prokaryotic, and eukaryotic systems.  Thus, the presently reported BN+1 expansion 
method is a generalized approach applicable to the characterization and expansion of 
other biological pathways and living systems. 
4.2 Introduction 
In this study, we explore how a biological pathway can be defined, and identify a set of 
methods to automatically learn a pathway from experimental data.  Although many 
biological pathways have been described in the literature, these pathways likely represent 
only a small portion of the known underlying network of interactions.  Recently, such 
pathway representations have been systematized in databases such as EcoCyc [23], 
RegulonDB [65], and KEGG [20]. The pathways represented in these databases are 
commonly used as a starting point (seed network) to analyze gene expression data and 
identify pathway activity using computational tools such as GSEA [66] and DAVID [67].  
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However, when an annotated pathway is used to analyze microarray gene expression data, 
the assumption is made that the ideal microarray derived network will be the same as that 
in the literature. This assumption may not hold since many pathways are defined based 
on observed protein-protein and protein-DNA interactions, metabolic fluxes, and subsets 
of particularly well-studied genes. Each of these factors may contribute to the substantial 
inconsistency between RNA-level microarray-based networks and currently defined 
pathways.  Furthermore, the selected pathway representation may be incomplete and not 
include relevant regulator or effector molecules, thus necessitating computational 
prediction and subsequent validation.  To address this issue, we introduce a method to 
systematically expand a pathway by identifying new genes that, from a gene expression 
perspective, better define the pathway itself. 
Biological pathways have been constructed from the existing literature and 
annotation information using a wide range of methods [12,36,45,68,69,70,71,72,73]. One 
method of pathway reconstruction uses Bayesian networks (BNs) to learn and model 
relationships between variables (e.g., genes).  Bayesian networks are graphical models 
that describe causal or apparently causal interactions between variables.  In this study, a 
Bayesian network is defined as a set of interactions (edges or arrows) between variables 
(nodes) selected from a set of known pathway genes.  High scoring BN topologies are 
learned from data based on scoring metrics such as the BDe scoring metric introduced by 
Cooper et al. in 1992 [35], that incorporates the joint probabilities for variables connected 
to one or more other variables.  In this context, the Bayesian model is a multinomial 
model with a uniform Dirichlet prior.  Bayesian networks such as these have been used to 
identify relationships from gene expression data [36,46], protein-protein 
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interactions[74,75], and the regulation of phosphorylation states [49].  Due to their 
flexibility, reliability, ability to model multi-variable relationships, and human 
interpretability, Bayesian networks are well suited for network modeling using high-
throughput data such as gene expression microarrays.       
Networks learned from datasets such as gene expression data can be used to 
expand our knowledge about a known pathway, by independently testing the effects of 
added genes or variables on the overall scores of the corresponding expanded networks. 
A general network expansion framework to predict new components of a pathway was 
suggested in 2001 [76]. Many of the pathway expansion methods use correlation or 
Boolean functions [10,76,77,78]. Compared to these methods, Bayesian network-based 
expansion methods provide distinct advantages, including prediction of both linear and 
nonlinear functions, identification of causal influences representing interactions among 
genes. Bayesian network-based expansion was also used for gene expression data 
analysis [11,53]. However, these expansion approaches are module-based methods that 
focus on identifying modules (or groups) of additional genes to one gene [11] or a group 
of genes with a fixed topology [53]. The mRNA-based networks were also merged with 
protein data which often do not agree with each other [53]. The topology of the biological 
pathways may not be consistent with networks learned from transcriptional gene 
expression data obtained via DNA microarray studies [77].   
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4.3 The BN+1 Algorithm 
 
 
 
 
BN+1 Algorithm  
Input: N variables (e.g., genes) from a dataset (e.g., microarray dataset) with L 
observations each. 
Data Preprocessing (Optional) 
Filter out m variables (e.g., via coefficient of variation (c.v.) <= 1.0).  Number of 
possible variables for analysis: N= N-m. 
BN Core Network Searching  
Select K variables from the set of N variables (e.g. from a pathway database). 
Construct matrix data file D with K*L observations using K variables and L observations. 
Select settings for BN simulation, including data discretization (e.g. q3 quantization), 
searcher strategy (e.g. simulated annealing), and structural priors. 
Execute BN simulation (e.g. using BANJO). 
Save top BN network topology C 
Iterative Core Expansion 
Assign the core topology C as unfixed structural prior for BN searching 
For each variable a in the set {N-K}, do: 
 Generate new data file D* by concatenating L observations for a to data file D 
 Select settings for BN simulation. 
 Execute BN simulation.   
 Save top network and its posterior probability for a.  
Rank each variable according to posterior probability. 
Output: Rank-ordered BN+1 results. 
Figure 4.1 Pseudocode for the BN+1 expansion algorithm. 
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The pseudocode for the BN+1 algorithm is represented in Figure 4.1 and its 
implementation is described as follows.  First, Bayesian networks are generated from 
discretized microarray data and ranked according to log posterior score.  A consensus 
network was then generated from the top-scoring networks and used for comparison with 
known pathway. Next, a top network used to generate the consensus network was 
randomly selected as a seed network for subsequent expansion.  Each gene not included 
in the top network yet appearing in the microarray dataset was independently tested for 
its ability to acquire the best log posterior score versus the other tested expansion genes.  
BN+1 variables were ranked according to the best posterior score of their respective 
networks as compared to the other BN+1 variables.  This approach was repeated for 
several distinct biological cases studies and is described below. 
4.4 Case Study #1: Synthetic Network Analysis Using BN+1 
4.4.1 Summary 
To further establish the validity and evaluate potential pitfalls of the algorithm, a 
synthetic regulatory network was developed for testing the BN+1 algorithm.  In terms of 
the previous ROS pathway analysis, the second most highly-ranked BN+1 gene 
appearing in the PLoS ONE paper, formate dehydrogenase fdhE, is further elucidated.  
Finally, cutoff criteria for selecting significant BN+1 genes and methods to improve the 
algorithm are discussed. 
 71 
 
4.4.2 Method 
A synthetic network was constructed by generating a set of mathematical functions which 
define the relationships amongst a set of variables (Fig. 4.2). In this model, eight 
variables are linked together in tandem (Fig. 4.2A) by the following functions:  
A= 5,10N                        (4.1) 
B= )3.0,0(log10 NAabsabs                  (4.2) 
C= 3.0,05 0.15 Neabs
B
        (4.3) 
D= 3.0,01/0.6 NCabs       (4.4) 
E= 15.0,0log NDabs         (4.5) 
F= 3.0,0
3 NEabs         (4.6) 
G= 17.0,0log NFabs         (4.7) 
H= 3.0,01/0.6 NGabs       (4.8) 
where ,N  represents normally-distributed noise with  as the mean and  as the 
standard deviation.  Biological data frequently include noise which can reduce the 
predictive capability of BNs and other modeling approaches.  To reflect this reality, 
various levels of noise are added to the functional relationships. The function abs( ) is the 
absolute value of the enclosed quantity. Synthetic data were generated from these 
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functions by sampling from the Gaussian-distributed variable A and subsequently 
sampling corresponding data values for subsequent variables in the pathway based on  the 
above functions (a similar approach appears in [58]).  This particular synthetic network 
contains different types of relationships amongst variables, e.g., nonlinear polynomial 
and biphasic relationships. 
 
Figure 4.2 Synthetic network and BN+1 results for two-variable core expansion. (A) 
A synthetic eight-variable network.  (B) Seven distinct core networks composed of two 
adjacent variables were used for BN+1 expansion analysis. In each row, integers identify 
the ranks of the BN+1 variables (where 1=top scoring gene, etc).  (C) The posterior score 
distribution of BN+1 variables identified in the first row of Fig. 1A. (D) Plot of absolute 
values of pair-wise Pearson correlations for all variables.  The black star denotes a 
relationship (between F and G) that has a poor Pearson correlation (coefficient = 0.056). 
and separated by at least one variable in the synthetic network (Fig. 1A). (E) A nonlinear 
relationship between variables F and G. 
 
To further evaluate the BN+1 algorithm, a series of BN+1 simulations were 
designed and analyzed (Fig. 4.2B). In each simulation, two adjacent variables from the 
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synthetic network are selected as a ‗core‘ network (i.e., a known seed subnetwork) and 
used to identify the other six variables in terms of their roles in the overall network.  The 
predicted variables, which are coined the BN+1 variables, are ranked according to their 
best log posterior scores obtained for the network containing a BN+1 variable and core 
network variables.  This experiment was repeated for each pair of core variables in the 
model (Fig. 4.2B).   
4.4.3 Results 
When the core sub-network is located at the end of the synthetic network (i.e., AB or 
GH), the BN+1 successfully identified those variables that are closely associated to a 
core network in sequential order (Fig. 4.2B). For example, when the core network is 
AB, BN+1 identifies the top four variables that are associated with this core network 
are C, D, E, F, in correct order. It is interesting that the last two variables G and H have 
the same score as F when they are individually added to the core network (Fig. 4.2C). A 
further examination indicates that none of the three variables F, G, and H is connected to 
A or B in the final BN network containing A, B, and one of the three variables. The 
disconnection of these three variables from the core AB makes it possible for the 
posterior probabilities to be the same.   
When the core subnetwork is located in the middle of the synthetic network (e.g., 
BC or CD), the variables identified by BN+1 are ranked in sequential order in either 
side of the core network. For example, for the core network CD, the BN+1 variables on 
the right side are ranked 1 (E), 2 (F), 5 (G), and 6 (H), and the BN+1 variables on the left 
side are ranked 3 (B), and 4 (A) (Fig. 4.2B).  It is interesting that top 2 (F) is located on 
 74 
 
the same side with top 1 (E) instead of direct association with C in the CD network. 
Despite the direct link between B and the core network, F has stronger association (with 
higher posterior probability) with the core network than B. This asymmetric pattern 
suggests that top ranked BN+1 variables are ranked based on their extent of associations 
with the core network instead of physical closeness to the core network.  
4.4.4 Discussion 
One advantage of BN+1 over many linear correlation-based methods is that our Bayesian 
network based approach is able to identify those interactions that show nonlinear 
correlations with core variables. Pearson correlation is a typical method for defining the 
extent of a monotonically increasing or decreasing relationship between the variables 
[79]. The correlation coefficients between all possible pairs in the original dataset were 
calculated using Pearson correlation method. Although all of the functions are nonlinear, 
over the rage of parameters tested, some may be approximately linear, while others may 
be more strongly nonlinear and deviate from monotonicity. Figure 4.2D shows a matrix 
representation of the Pearson correlations observed for each pair of variables and their 
synthetically-generated data.  In general, Pearson correlation coefficients decrease as the 
distance between variables (or the distance of one variable from the diagonal of the 
matrix) increases. Overall, Pearson correlations can not only detect those variables 
directly associated with one specific variable, but also identify those that are remotely 
associated with sequential order (white stars in Fig. 4.2D). However, Pearson correlation 
failed to identify the association between F and G. A further examination indicates that F 
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and G share a clear nonlinear relationship (Fig. 4.2E). Such a nonlinear relationship is 
correctly detected by BN+1 (Fig. 4.2B). 
In our synthetic data simulation, we found that the disconnected variables share 
the same score (Fig. 4.2). This cutoff shows that all subsequent BN+1 genes will be 
disconnected from the core gene network. Similar results were also observed in the ROS 
pathway simulation (further described in Section 4.5). The last 1,457 genes in the sorted 
BN+1 gene list were all disconnected from the core gene network. This suggests that 
these 1,457 genes have no relationship with the ROS pathway based on the selected 
microarray data and selected core network. However, the cutoff based on the loss of 
connection between a BN+1 gene and a core network is loose and may result in too many 
genes being included for further testing. 
4.5 Case Study #2: BN+1 Analysis of the E. coli ROS Pathway 
4.5.1 Summary 
We hypothesize that Bayesian networks derived from microarray gene expression data 
are largely consistent with known pathway models and can be used as a basis to predict 
novel factors that influence a given pathway.  In this study, the hypothesis was examined 
using the Escherichia coli reactive oxygen species (ROS) pathway.  Because E. coli and 
the ROS pathway had been well studied [25,26,27,28], we were able to test the 
effectiveness of our network expansion algorithm and to assess the ability to reconstruct 
and expand an accepted pathway using microarray data.  We identified many stress-
related genes potentially involved in the ROS pathway and predicted their interactions 
with known ROS genes. Our prediction was confirmed experimentally for one example 
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gene, uspE. Our single-gene expansion approach, termed ‗BN+1‘, was successful in 
predicting unknown stress interactions that can be verified through experimental analysis, 
and could demonstrably be applied to other biological systems of interest. 
4.5.2 Methods 
4.5.2.1 Data preprocessing 
A compilation dataset comprising 305 gene expression microarray observations and 
4,217 genes from Escherichia coli MG1655 was obtained from the M3D database [8]. A 
coefficient of variation threshold (c.v. ≥ 1.0) was used to select 4,205 genes for analysis.  
Twenty-seven genes were identified from the EcoCyc ROS detoxification pathway 
(downloaded on March 26, 2008) and matched to unique features found in 305 available 
gene expression microarray chips.  Expression profiles for each gene were discretized 
using a maximum entropy approach that uses three equally-sized bins (q3 quantization).  
4.5.2.2 Learning Bayesian network pathway models 
Given the set of 27 genes, Bayesian network analysis was used to learn the structure of 
the model which served as our core starting topology. To maximize the network search 
space, 4000 independent simulations with random starts were used to search 2.5x10
7
 
networks per start for a total of 1x10
11
 networks.  The five top networks were saved from 
each run, thereby generating a final list of 20,000 top-scoring networks.  These networks 
were used to estimate the posterior distribution.  During the search, each network was 
scored using log of the BDe score [35,37] which is the natural log of posterior probability 
( DMPS |ln ) and is defined previously in Equation 2.2 in Chapter 2  using the 
software package BANJO [40]. 
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A consensus network was generated using 33 networks which shared the maximum or 
best log posterior score (ln(P(D|M)). Specifically, directed edges in the consensus 
networks represent those edges that appear with 100% frequency in one direction in all of 
these top networks.  Undirected edges represent those edges appearing 100% of the time 
in both directions in all stored networks (Figure 4.3).   
4.5.2.3 Network expansion using BN+1  
To expand an existing network, a top network used to generate the consensus network 
was used as a starting topology for the BN+1 algorithm (Figure 4.3).  A set of 4,178 
genes (4,205-27), not included in the top BN, were tested for their ability to improve 
score of the initial core BN when added to the initial gene set.  In each iteration of the 
BN+1 simulation, the current BN+1 gene was added to the original data file.  This was 
followed by a simulated annealing search of 1x10
7
 networks for the top network 
expansion.  Although the top network was selected as a starting point or seed, during the 
learning round all edges could be modified such that the addition of genes could change 
the backbone structure of the resulting model (i.e., unfixed structural prior).  Genes were 
sorted based on their log posterior scores.  BN+1 searches for each of the top 200 genes 
recovered from the initial top network were rerun (2.5x10
7
 networks/simulation with 150 
replicate simulations) to allow sufficient convergence.  
All calculations, including the network expansion, were implemented in a publicly 
available, internally developed software program MARIMBA (available at 
http://marimba.hegroup.org/, described in Chapter 6).  
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4.5.2.4 Term enrichment for identifying relevant experimental observations 
A term enrichment program was developed to identify which descriptive terms in the 
experimental conditions show significant enrichment in selected regions of the 
microarray data. A 'term' here is defined as any individual word appearing in the names 
or descriptions for each microarray sample. For two selected genes, a p-value was 
introduced to determine the chance of observing a selected term in a selected bin. The p-
value was calculated using the Fisher's exact test for appearance of 'term' and 'non-term' 
data observations in a specific bin [80]. The bins used for microarray BN analysis were 
adopted in this text enrichment analysis. For example, the q3 quantization was used for 
the expression levels of gadX and uspE.  
4.5.3 Results 
4.5.3.1 Microarray-based Bayesian network overlapped with known ROS pathway 
Using a compendium of microarray gene expression data from the M3D database [8], 
networks were constructed for the 27 genes contained in the ROS pathway as defined by 
the EcoCyc database [23] (Figure 4.3). E. coli uses a complex detoxification pathway to 
protect against the oxidative stress posed by reactive oxygen species (ROS), including 
oxygen ions, free radicals, and peroxides [27]. The 27 genes identified in the EcoCyc 
ROS pathway include five ROS-processing enzymes (i.e., katE, katG, sodA, sodB, sodC) 
and 22 transcriptional factors that regulate transcription of these ROS-related enzymes. 
This E. coli expression dataset incorporates a variety of experimental conditions 
including time course studies, cell stress-inducing environments, over-expression, and 
single and double knockout strains.  These conditions perturb the ROS pathway and 
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provide a reasonable data set for the evaluation of our hypothesis. To include all results 
predicted from the top Bayesian networks, a consensus network was derived using the 33 
top networks that shared the best identical posterior probability. The consensus network 
contains all 27 genes from the original ROS detoxification list in EcoCyc.    
 
Figure 4.3 Consensus network for the ROS detoxification pathway.  Bayesian 
networks were generated using twenty-seven genes from the reactive oxygen species 
(ROS) detoxification pathway as variables or nodes and 305 gene expression microarray 
observations per variable.  Edges which appear in the consensus and are supported by 
external data (e.g. EcoCyc, RegulonDB, and/or literature) are indicated (*). 
 
A comparison of the consensus network to EcoCyc revealed that 29% of the 
edges in the consensus are supported by corresponding edges in EcoCyc [23] or 
RegulonDB [81].  However, inclusion of literature information in the comparison 
revealed that approximately 42% of the edges found in the consensus network were 
confirmed. The difference suggests that some new literature results have not been 
collected in current databases such as EcoCyc and RegulonDB. 
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4.5.3.2 BN+1 pathway expansions predict ROS-related genes and gene interactions. 
An expansion algorithm termed BN+1 was developed to identify those genes that provide 
the best network score when added to an existing core network topology (Figure 4.1).  
Each gene not yet included in the core network is individually added to the set of 
variables for the Bayesian network simulation (hence Bayesian network plus one gene, or 
‗BN+1‘). The edges in the initial core network topology are used as a ‗structural prior‘ or 
starting point, and are allowed to change over the course of the BN simulations.  The 
added node is initially disconnected from the existing core network and can become 
connected to other variables over the course of the simulation.  Those genes which best 
improve the network score when added to the existing core are expected to have the most 
direct biological influence and/or relevance to the core network genes. 
The BN+1 expansion algorithm was used to identify additional potential members 
of the ROS detoxification pathway.  The top-ranked results from these analyses are 
shown in Table 4.1. The algorithm identifies whether a gene is strongly associated with a 
particular network (e.g., the ROS detoxification pathway) and which genes in the 
network may influence or be influenced by the newly predicted gene. The predicted 
influences between core genes and the top ―+1‖ genes (including dusB and uspE) 
identified by BN+1 expansion are shown in Figure 4.4.   
Expansion of the consensus network revealed that many top predicted genes have 
known relationships with ROS and stress regulation (Table 4.1).  The tRNA- 
Table 4.1 Top 10 genes identified by BN+1 expansion of core network. 
Rank Top BN+1 gene hits Posterior BN score 
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1 dusB (tRNA-dihydrouridine synthase B)  S=-8295.81 
2 fdhE  (formate dehydrogenase formation protein) S=-8298.44 
3 uspE (stress-induced protein);  S=-8310.63 
4 yohF (predicted oxidoreductase with NAD(P)-
binding Rossman-fold domain) 
S=-8312.24 
5 yncG  (predicted enzyme);  S=-8313.04 
6 msyB (predicted protein);  S=-8318.20 
7 yedP (conserved protein);  S=-8320.30 
8 sra (30S ribosomal subunit protein S22) S=-8323.97 
9 ydcK (predicted enzyme);   S=-8325.91 
10 ynhG  (conserved protein);   S=-8326.20 
Note that the numbers shown after gene names are negative logs of posterior probabilities 
for each top network containing the respective predicted gene. 
dihydrouridine synthase B gene (dusB or yhdG) was predicted to be the top-scoring 
BN+1 gene and to interact with fis and sodC (Figure 4.3A).  Fis is an important regulator 
of oxidative stress [82].  Because all of the known enterobacterial fis genes are preceded 
by dusB (also called yhdG) within the same operon [82], it is reasonable that dusB is 
positioned as a parent of fis in our prediction. Both fis and sodC are crucial to bacterial 
defense against the deleterious effects of reactive oxygen species (ROS) [83,84]. The 
interaction between sodC and dusB is likely important for bacterial antioxidant reactions. 
The second top predicted gene fdhE encodes an E. coli formate dehydrogenase accessory 
protein that regulates the activity of catalytic sites of aerobic formate dehydrogenases and 
their redox activities [85].  A third gene, the universal stress protein uspE, is a known 
major regulator of motility factors and cell aggregation under stress conditions [86]. 
Several other predicted enzymes (yncG and ydcK) and proteins (msyB) found in the 
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BN+1 search have no currently known functions related to the ROS pathway and stress 
response.  
Pair-wise plots of the expression of BN+1 genes versus ROS pathway genes show 
simple (dusB vs fis, Figure 4.3A) or complex relationships (uspE vs. gadX, Figure 4.4B-
C).  The plots show that the relationships between these genes may be nonlinear. For 
example, a ―V‖ shaped pattern is observed between the expression profiles of gadX and 
uspE, where gadX is down-regulated at moderate levels of uspE and up-regulated in 
either increased or decreased levels of uspE (Figure 4.4C).  This special non-linear gene 
interaction pattern was not clearly demonstrated in a traditional hierarchical clustering 
heatmap (Supplemental Figure 1 in [56]). Gene gadX is a transcriptional regulator of 
glutamic acid decarboxylase system, which enables E. coli to overcome acidic stress, 
while uspE is a universal stress-induced protein. A term enrichment method was 
generated to identify words that are preferentially grouped and reflect most significant 
features of the interactions between two genes (e.g., gadX and uspE) as predicted by our 
BN method.   
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Figure 4.4 Top BN+1 predictions and their relationships with core network genes.  
Genes dusB(A) and uspE (B) were top results for large network expansion. (C) Scatter 
plot for uspE versus gadX highlighting experiments with the word ―biofilm‖ in the 
experiment title and/or description. High levels of uspE and gadX were observed for all 
conditions mapped to ‗biofilm‘. The dotted lines indicate boundaries for binning used in 
network learning.  A similar profile was observed for gene gadE (not shown). 
 
Based on our term enrichment analysis of gadX and uspE, one term that clustered 
the data particularly well was ―biofilm‖, which was demonstrated in the annotated scatter 
plot (Figure 4.4C). High expression of gadX was correlated with high expression of uspE 
in biofilms. Biofilms are aggregates of microorganisms that attach to and grow on a 
surface in contact with liquid, such as water or media. Induced expression of stress 
response genes, e.g., a universal stress regulater uspA, was a general feature of biofilm 
growth [87,88]. In fact, the biofilm microarray data used in the term enrichment were 
obtained from two studies. One study analyzed stress-oriented gene expression profiles of 
E. coli biofilm at various time points [89]. A second biofilm microarray study examined 
biofilm responses to acid resistance and oxidative stress using wild type and single gene 
knockout mutant strains of E. coli [90]. Our combined analysis of microarray gene 
expression and term enrichment indicated that uspE and gadX were both up-regulated in 
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many samples (chips) where ‗biofilm‘ was mentioned in the sample title and/or 
description (Figure 4.4B-C). These suggested a potential role of the uspE and gadX in the 
formation of E.coli biofilm. 
 To further evaluate the interactions between uspE and gadX and their 
regulatory roles in ROS stress and biofilm formation, several wet-lab experiments were 
conducted by Dongjuan Dai and Chuanwu Xi.  These results, appearing in [56], verified 
(1) the interactions predicted between uspE and gadX do exist in E. coli, (2) their 
responses to hydrogen peroxide stress and further implication in ROS activities, and (3) 
their direct control of biofilm-related activities.  Thus, the BN+1 approach is successful 
and can identify novel pathway members, biological interactions, as well as functional 
relevance. 
4.5.3.3 The challenge of identifying meaningful BN+1 cutoffs  
After all genes are ranked by the BN+1 simulation, what cutoff should be used to select 
the top ranked BN+1 genes for further analysis?  While the top few BN+1 genes prove 
important in the ROS pathway, many more shown in the list of top BN+1 genes are also 
related to ROS pathway (not shown). Our Gene Ontology (GO) enrichment analysis of 
the top 100 genes in the sorted BN+1 gene results (~2.4% of the total genes on the 
microarray) showed that they were enriched for ROS-related activities or functions 
(results and related discussion appear in [56]). This means that a certain number of top-
scoring BN+1 genes are all related to the core gene pathway.  However, if only the 
posterior scores are considered, the scores for the selected pathway tend to decline or 
drop off quickly before smoothing out after a small number of the top genes (Fig. 4.5A).   
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Figure 4.5 Analysis of top BN+1 genes in the ROS use case.  (A) Generic plot of best 
score for top 200 BN+1 genes. (B) Variation in scores for top 10 genes. The BN+1 genes 
are ranked by maximum scores of all networks containing the core genes plus one 
additional gene. Genes sorted by posterior scores are shown in horizontal axis.  Box plots 
for the set of scores pertaining to each gene are displayed. The variations are calculated 
based on various simulations in different computers. To perform each simulation, a 
simulated annealing approach was used with an unfixed structural prior (i.e. the core 
network edges) with multiple replicates and moderate simulation time to allow a 
comprehensive though non-exhaustive search. 
 
One feasible criterion is based on the possible loss of connection between a BN+1 
variable and the core network.  In our synthetic data simulation, we found that the 
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disconnected variables share the same score (Fig. 4.2). This cutoff shows that all 
subsequent BN+1 genes will be disconnected from the core gene network. Similar results 
were also observed in the ROS pathway simulation. The last 1,457 genes in the sorted 
BN+1 gene list were all disconnected from the core gene network. This suggests that 
these 1,457 genes have no relationship with the ROS pathway based on the selected 
microarray data and selected core network. However, the cutoff based on the loss of 
connection between a BN+1 gene and a core network is loose and may result in too many 
genes being included for further testing. For example, in our ROS example, 2,760 genes 
remain after the last 1,457 genes are excluded. While the loose cutoff removes roughly a 
third of the genes, there are still many genes which may or may not closely relate to the 
ROS pathway network.  
To make a tighter and possibly more useful cutoff, we analyzed the distribution of 
sorted posterior scores. In the ROS analysis, the sorted posterior scores of BN+1 genes 
quickly drop across the first ten variables, followed by a slowdown of score dropping 
(Fig. 4.5A). Therefore, it is possible to suggest a cutoff in the beginning of the slowdown 
of score dropping. However, these cutoffs are still artificial because we do not know 
which one(s) would be optimal for maintaining the real biological predictions.  
Furthermore, the ―best‖ posterior probabilities of BN+1 variables‘ networks often have 
variations across large amounts of simulations in different computers (Fig.4.5B).  Current 
variable rankings are based on the highest log posterior scores among all simulated 
networks for the selected BN+1 variable and core variables.  Multiple scores may be 
obtained and saved for a selected BN+1 variable and core variable set.  If the median 
scores for each set of BN+1 results were used instead, the rankings of BN+1 genes could 
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change (e.g. the 4
th
 and 5
th
 genes in Fig. 3B). It is unlikely the median scores would ever 
be used since the BN optimization approach always seeks the best (or most optimal) 
result. The resulting variation is probably due to the failed achievement of convergence. 
To achieve a final convergence, more execution time will be needed. More compute time 
will reduce the variation in scores for each individual BN+1 variable and improve our 
overall confidence in the rankings of the BN+1 variables.  Because our synthetic data use 
case only have eight variables, it is relatively easy to achieve convergence.  For example, 
Fig.1C shows no score variation in replicates for each of the BN+1 variables in our 
synthetic network (hence the box plots appear as lines denoting the median score), 
suggesting sufficient convergence was achieved by the algorithm.   
To make the experimental testing more meaningful, an empirical cutoff such as 
the top 10% of the score distribution or top 100 genes may be helpful. Although this type 
of cutoffs is heuristic and does not establish the statistical significance of those results, 
subsequent exploration of the top BN+1 results based on this cutoff may still lead to 
novel discoveries [56]. 
4.5.4 Discussion 
In this study, we addressed two questions: (1) Does a microarray-based Bayesian network 
reconstruction match with the known pathway from the literature and existing database?  
(2) Is a network expansion approach such as BN+1 useful in predicting new, biologically 
significant genes? 
For the first question, our studies indicated that the microarray-based Bayesian 
network reconstruction did not always agree with the known pathway from the literature 
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and databases. Our studies on the E. coli ROS pathway indicated that the network 
reconstructed by our Bayesian network overlaps at 29% with the known ROS pathway 
network in EcoCyc and RegulonDB. A 42% agreement was achieved when more 
evidences from the literature search was included. Inclusion of RegulonDB and literature 
resources made our comparison more comprehensive. The reason for the large mismatch 
is probably due to the fact that microarray-based transcriptional data may not reflect the 
complex biological pathways which involve complex interactions of genes in the protein, 
RNA, and DNA levels [91]. However, the Bayesian networks built from microarray gene 
expression data are transcriptional regulatory models that are predicted to reflect the 
complex ROS pathway.   
For the second question, the BN+1 expansion algorithm was found to successfully 
predict biologically significant genes to the ROS network that were further 
experimentally verified. Gene uspE was one of the top list genes selected by the BN+1 
algorithm. Its up-regulation in response to the exposure of hydrogen peroxide suggested 
that this gene was probably involved in the ROS network, along with the ROS-related 
gene gadX (Figure 4.4). Hierarchical clustering of the uspE gene showed a different 
connectivity pattern in the dendrogram for genes than the Bayesian network, suggesting 
that the Bayesian network identified a non-traditional (e.g. nonlinear) relationship 
between the genes.  Furthermore, the BN+1 algorithm suggested where the new genes 
could participate in the pathway, and in some cases the model even differentiated 
between the parents and children genes of a new gene (Figures 4.3-4). Specifically, the 
BN+1 algorithm found the ―V‖ shape relationships between expressions of genes, e.g., 
gadX and uspE, which would not have been identified using traditional clustering 
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approaches. The interaction between gene gadX and uspE was also confirmed 
experimentally. Expression of one gene was significantly affected when the other gene 
was knocked out from the wild type E. coli strain (Figure 4.4). Plot of the expression of 
gadX and uspE against each other under different tested experimental conditions showed 
a similar ―V‖ shaped pattern (Figure 4.4), which was in agreement with the finding using 
the BN+1 algorithm although the expression data from the experimental study were at the 
translational level.  
The term enrichment algorithm successfully identified experimental conditions in 
which genes might be involved and biologically related with each other. In this study, 
genes uspE and gadX were founded to be both up-regulated in the growth of biofilms. 
The involvement of the two genes in biofilms was confirmed by the fact that single gene 
knockout mutant strains gadX and uspE showed difference in the biofilm formation, 
either biomass or structures, as compared to the E. coli wild type strain (shown in [56]). 
Experimental confirmation of predicted term enrichment results indicates that term 
enrichment algorithm is a useful method to identify experimental conditions in which 
gene relationship may take place, or to propose additional areas of investigation.  
Performance of the term enrichment approach likely depends upon the quality of the 
experimental descriptions provided by researchers available from the M3D database.  The 
approach may perform better with controlled term or concept vocabularies, or could be 
further tested with Gene Ontology (GO) terms and other information in future studies. 
Bayesian network can be used to expand a pathway network based on microarray 
gene expression data. The BN+1 method expands a top Bayesian network by adding one 
 90 
 
gene at a time and running it iteratively based on microarray gene expression data. The 
BN+1 expansion algorithm showed the ability to predict important factors for a pathway 
network from thousands of genes in a microarray study.  The BN+1 approach is a 
generalized method to refine and expand biological pathways. Although a ROS pathway 
in E. coli was shown in this study, the BN+1 algorithm can readily be applied to other 
organisms, pathways, and data types.  Furthermore, the text enrichment-based 
identification of experimental conditions in the context of binned data for BN analysis 
can provide beneficial information in the interpretation of predicted expansion genes.  
4.6 Case Study #3: BN+1 Analysis of the Murine BCR Pathway  
4.6.1 Summary 
Signalling and regulatory pathways that guide gene expression have only been partially 
defined for most organisms. Given the increasing number of microarray measurements, it 
may be possible to reconstruct such pathways and uncover missing connections directly 
from experimental data.  One major question in the area of microarray-based pathway 
analysis is the prediction of new elements to a particular pathway. Such prediction is 
possible by independently testing the effects of added genes or variables on the overall 
scores of the corresponding expanded networks. A general network expansion framework 
to predict new components of a pathway was suggested in 2001 [76]. Many machine 
learning approaches for identifying hidden or unknown factors have appeared in the 
literature recently [10,11,53,54,55,76,77,78,92].  
 The BCR pathway is an integral component of the adaptive immune response 
mechanism by which B cells respond to foreign antigens [29].  The BCR pathway 
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involves in the activation of specific protein kinase C (PKC) isoforms that induces 
ultimate activation of the NF- B transcription factor. Multiple protein species accumulate 
at the cell membrane in a signalosome complex and are linked to the B cell receptor.  
Signal propagation from the BCR via kinase-mediated phosphorylation cascades to 
downstream effectors such as Nfkb, NFAT (nuclear factor of activated T cells), and AP1 
is either enhanced or reduced via signalosome interactions with co-stimulatory or co-
inhibitory complexes, respectively.  BCR signaling guides many important functions such 
as anergy, B cell ontogeny, and immune response, and is linked to the several imporant 
pathways: MAPK, coagulation/complement cascades, and actin cytoskeleton [1,19]. NF-
B plays a crucial role in the antigen-induced B lymphocyte proliferation, cytokine 
production, and B cell survival [29].   
We have recently developed an algorithm termed ―BN+1‖ which implements 
Bayesian network expansion to predict new factors and interactions that participate in a 
specific pathway [56,57]. This algorithm has been tested using E. coli microarray data 
[56] and verified with synthetic networks [57].  BN+1 is applied in this chapter towards 
understanding NF- B transcriptional regulation and interactions within the BCR 
signalling pathway. 
4.6.2 Method 
We used gene expression data from perturbed B-cells obtained from the Alliance for 
Cellular Signaling (AfCS) [93,94]. This dataset is especially attractive because the same 
tissues were treated with combinations of ligands that perturb different B cell pathways. 
The AfCS study gathered 424 microarray chips measuring gene expression in B cells 
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from M. musculus splenic extracts that are exposed to 33 different ligands [93,94,95]. 
Briefly, B cells purified from splenic preparations from 6- to 8-wk-old male C57BL/6 
mice were treated in triplicates or quadruplicates with medium alone, or one of 33 
different ligands for 0.5, 1, 2, and 4 h (AfCS protocol PP00000016). RNA was extracted 
following standard AfCS protocol PP00000009. An Agilent cDNA microarray chip that 
contains 15,494 cDNA probes printed on 15,832 spots was used. It represents 10,615 
unique MGI gene matches [93]. Each Agilent array was hybridized with Cy5-labeled 
cDNA prepared from splenic B cell RNA and Cy3-labeled cDNA prepared from RNA of 
total splenocytes used as an internal reference (AfCS protocol PP00000019). Hence, each 
Agilent microarray chip provides one unique observation of relative expression level per 
selected probe. The arrays were scanned using Agilent Scanner G2505A, and images 
were processed using the Agilent G2566AA Feature Extraction software version A.6.1.1. 
The microarray raw data were downloaded from the AfCS repository at 
ftp://ftp.afcs.org/pub/datacenter/microarray/.  
 Microarray data were discretized for each variable in the Bayesian networks using 
quantile normalization with three bins. Though triplicate or quadruplicate microarray 
experiments were available in most cases per unique treatment and time of drug 
administration, we assume that each experiment provides an independent source of 
information. In this analysis, we did not use all BCR pathway genes. We sought to 
answer here whether expansion of a sub-network from the BCR pathway would 
preferentially recover other BCR pathway genes. This assumption is advantageous in that 
the number of variables allows significantly faster simulation searches for the BN and 
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BN+1 simulations. Particularly, those genes most specifically involved in Nfkb-mediated 
transcriptional regulation were chosen from the KEGG BCR pathway.  
 A set of 10,000 top-scoring BNs was generated using the eight variables (the core) 
and 424 observations. Among the eight variables, two variables are Nfkbie (I B) probe 
sets, and two are Ikbkb (IKK) probe sets. In many cases, one gene has multiple probe 
sets. We chose to separate them as different variables in our BN analysis since often these 
probe sets have different values with low correlation (Fig. 4.6). This BN analysis was 
accomplished by running 100 independent simulations and saving the top 100 
simulations for each of those runs. 
    
Figure 4.6 Scatter plots for Nfkbie and Ikbkb probes from AfCS study.  Agilent 
probe identifiers are listed next to each respective gene. This figure indicates that the 
probe sets Nfkbie_10164 and Nfkbie_8911 correlate relatively well with a Pearson 
correlation coefficient of 0.69 (A). However, the correlation between Ikbkb_17300 and 
Ikbkb_10548 is low (Pearson correlation coefficient: 0.58) (B).   
4.6.3 Results 
Figure 4.7 depicts the shared set of interactions appearing in all of the top networks 
sharing the same best score.  Compared with the KEGG BCR pathway, the consensus 
network found in our BN analysis (Fig. 4.7) has an overlap with 75% of correlation (3 out 
of 4 were correctly predicted), with only one interaction missing (Fig. 4.8). 
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Figure 4.7 Consensus of top scoring Bayesian networks for eight probes 
representing BCR receptor signaling pathway genes.  Gene symbols and 
corresponding Agilent probe identifiers are represented in nodes in the network.  Directed 
edges represent those influences appearing in the same direction in all top-scoring 
Bayesian networks, while undirected edges appear at least once in the opposite direction 
though appearing cumulatively with 100% frequency in all of the top networks. 
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Figure 4.8 Schema of the BN+1 analysis results compared to KEGG BCR pathway. 
The three blue boxes represent three major sub-networks within the BCR pathway with 
distinct regulatory and functional roles.  The BN core network was defined using 
members from the third sub-network (dark grey boxes) which reflect major components 
of Nfkb signalling.  Bolded gene names are those genes which were not included in the 
core network, yet were recovered during BN+1 analysis in the top 100 results.  Note that 
not all members of the listed Nfkb signalling pathway were included in the core network 
(e.g. Ikbkg), and in some cases were not available on the microarray platform. 
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4.6.3.1 Defining BN+1 genes 
One of the top-scoring networks used to generate the consensus shown in Fig. 4.7 was 
used as a core network for subsequent BN+1 expansion. BN+1 searching was executed 
for 14,353 individual probes with 50 million networks searched per probe. If only those 
genes in close neighbourhood in the KEGG BCR pathway are considered, out of 19 
selected genes, nine genes were found to be connected to the core network in our 
analysis. Furthermore, four of these nine genes are in close proximity (within top 10% of 
top-scoring BN+1 genes with at least one connection to the core network) with these core 
genes in the KEGG protein signalling pathway: Card11, Prkcb1, Ikbkg, and Vav2. These 
results suggest that the neighbourhood of transcriptional regulation around the core 
network as well as distance between the elements in the protein signalling pathway are 
related to each other.  
Analysis of the top BN+1 variables recovered during simulation revealed several 
interesting results. First, the top set of BN+1 variables is listed in Table 4.2.  
Table 4.2 Top ten predicted BN+1 genes.  Identifier information for each ranked gene 
is provided, including Agilent probe ID (Agi_ID), Entrez gene ID (GENEID), and gene 
symbol.  Probe variables from the core network which directly connect to the BN+1 
variables in the top-scoring networks are listed in the ―Neighbors‖ column.   
Rank Agi_ID GeneID Symbol BN1_score Neighbors 
1 11062 77619 Prelid2 -3402.0 Nfkb2 
2 9502 20744 Strbp -3517.0 Nfkbie 
3 14138 20823 Ssb -3545.2 Nfkb2 
4 6276 12530 Cdc25a -3569.2 Nfkb2 
5 11361 108829 Jmjd1c -3586.8 Ikbkb(both), 
Pik3cg 
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6 14614 75964 Trappc8 -3587.8 Ikbkb, Pik3cg 
7 15876 108786 Cxcl13* -3593.1 Nfkb2 
8 10759 73132 Slc25a16 -3594.8 Ikbkb, Pik3cg 
9 5275 67887 Tmem66 -3596.0 Nfkb1, Pik3cg 
10 9036 109339 2700018L05Rik -3599.1 Pik3cg 
 
Many interesting findings were observed from this analysis. Many genes, for example, 
the Sjorgen syndrome antigen B gene (Ssb) [96], has been proven to be associated with 
the Nf-kB and BCR pathways. Ssb plays an important role in polysome translation [96], 
and is an early DNA-damage responder in apoptotic cells and those treated with cytotoxic 
chemicals [97]. Interestingly, we identified Jmjd1c, a member of the jumonji family 
proteins, as a top predicted gene in our BN+1 simulation. Jmjd1c is conserved in several 
mammalian species and has documented roles in metal ion binding, oxidoreductase 
activity, and transcriptional regulation [98].  The murine Jmjd1c mRNA is expressed in 
multiple tissues, including hematopoietic and undifferentiated ES stem cells, fertilized 
egg, pancreatic islet, etc [98]. Jmjd1c has a promoter region orthologous to humans with 
binding sites for the AP-1 transcription factor, which is considered a member of the BCR 
signalling pathway and is included in the KEGG representation as AP1 (downstream of 
the Raf/MEK sub-network in Figure 4.8 though not in our core network.  Fig. 4.9 
illustrates the strongly-correlated relationships uncovered between the Jmjd1c genes and 
connected core network members.  As another example, the Cxcl13 is a chemokine 
ligand in B cells with a C-X-C motif.  It has already been established that Cxcl13 
induction requires activation of canonical and non-canonical NF- B pathways [99], 
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which confirms the prediction of this gene in our network.  These data strongly support 
the predictions generated by our analysis.   
     
         (A)         (B)      (C) 
Figure 4.9 Scatter plot of expression values for core genes Pik3cg and Ikbkb (both 
probes) versus BN+1 gene Jmjd1c.  A non-linear association between Pik3cg and 
Jmjd1c is observed (A). A roughly linear relation is observed between Jmjd1c and 
Ikbkb(1) (Pearson correlation coefficient: 0.71) (B) and between Jmjd1c and Ikbkb(2) 
(Pearson correlation coefficient: 0.79) (C).  
  
One property of interest, as shown in the table, is that the core genes which recruit 
the top BN+1 genes are not always the same.  From this analysis and previous studies, we 
have observed that BN+1 variables which show high correlations to at least one core 
network variable often appear as top BN+1 results.  However, in some cases, the BN+1 
variable may connect to multiple variables in the core network, and yet show moderate to 
low correlations with each of them.  It is observed that many BN+1 variables have 
multiple core network variables as parent nodes in the predicted top network.  Multi-
parent relationships are less common though statistically more meaningful due to the 
nature of the implemented conditional probability tables in BDe scoring. 
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4.6.3.2 Clustering analysis of core genes and BN+1 genes 
Different methods, such as clustering and GO gene enrichment, can be used to further 
analyze BN+1 genes.  A clustering method provides a way to group BN+1 genes based 
on gene expression values. A heapmap clustering analysis was performed using 8 probe 
sets in the core network and 10 probe sets from the BN+1 analysis (Fig. 4.10). As shown 
in this heatmap, all NF- B genes (core genes in our BN simulation) are clustered 
together, indicating their close association. Our analysis also found that Jmjd1c is closely 
associated with these NF- B genes. This further strengthens our BN+1 prediction of the 
important role of this gene in the NF- B pathway in B cell signalling.     
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Figure 4.10 Heatmap of expression data for top BN+1 and core variables.  
Parentheses indicate specific probe identities.  
 
4.6.3.3 GO enrichment of predicted BN+1 genes 
Our previous studies indicate that the top few hundred BN+1 genes (i.e. Those genes 
predicted by the BN+1 algorithm) often interact with the seed gene network and 
biologically active relevant to the pathway of interest [56,57].  A GO gene enrichment 
analysis was performed using 250 top BN+1 genes (Table 4.3). Given the nature of the 
NF- B selected core network and their roles in nuclear localization and transcriptional 
initiation, it was not surprising that many of the recovered genes show some nuclear 
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compartmentalization. Interestingly, many apoptotic and death-related genes were 
enriched (Table 4.3).   
Table 4.3 GO enrichment results for top 100 predicted variables in BN+1 analysis.  
Entrez gene identifiers were input for the top 250 BN+1 results into the DAVID tool for 
GO analysis.  The 250 results mapped to 188 unique Mus musculus and seven unknown 
species genes, revealing that some of the top genes were represented by multiple Agilent 
probes in the top results.  Benjamini-derived p-values of 0.01 were used as cutoffs. 
Term Count P-Value Benjamini  
P-value 
Biological Process 
Cellular process (GO:0009987) 106 8.29E-06 0.00981 
Lymphocyte apoptosis (GO:0070227) 4 1.44E-04 0.0823 
Cell death (GO:0008219) 15 1.73E-04 0.0663 
Death (GO:0016265) 15 2.20E-04 0.0634 
Post-embryonic organ development 
(GO:0048569) 
4 2.36E-04 0.0546 
Apoptosis (GO:0006915) 14 2.65E-04 0.0512 
Programmed cell death (GO:0012501) 14 3.12E-04 0.0517 
Cellular Compartment 
Intracellular (GO:0005622) 125 2.93E-08 5.68E-06 
Intracellular part (GO:0044424) 119 4.32E-07 4.19E-05 
Intracellular organelle (GO:0043229) 105 2.76E-06 1.78E-04 
Organelle (GO:0043226) 105 2.84E-06 1.38E-04 
Intracellular membrane-bounded 
organelle (GO:0043231) 
93 4.08E-05 0.00158 
Membrane-bounded organelle 
(GO:0043227) 
93 4.24E-05 0.00137 
Nucleus (GO:0005634) 58 0.001749 0.0474 
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4.6.4 Discussion 
In this section, we first demonstrate the BN+1 algorithm‘s applicability to studying the 
BCR pathway, a eukaryotic signalling pathway. Our study shows that BN+1 can also be 
used to predict pathway elements and gene interactions in important eukaryotic pathways. 
Therefore, the BN+1 algorithm appears to be a generic BN expansion system that can be 
used to study other prokaryotic and eukaryotic pathways.  
 The BN+1 algorithm identified several known and previously undiscovered 
candidates relevant to NF-kB.  A variety of top-scoring BN+1 genes contributed to the 
overall enrichment of apoptotic and death-related processes.  This was not surprising, 
given that the experimental conditions used in the AfCS microarray dataset included drug 
perturbations which induce such processes.  These data suggest that the gene enrichment 
approach for assessing biological significance of multiple BN+1 candidates is possible in 
both prokaryotes and eukaryotes. 
 Furthermore, recovery of the Jmjd1c and Cxcl13 genes gave additional support to 
the biological validity of top-ranked BN+1 genes.  These genes are already implicated in 
the context of NF- B and BCR pathway activities via other experimental studies.  
Several other candidates were implicated in the BCR and/or NF- B transcriptional 
regulatory activities which are prime candidates for additional experimental investigation. 
 One unique finding from this study was the ability to generate novel predictions 
using multiple and separate probes as variables in our networks.  This type of approach, 
though naïve for some existing microarray platforms, may be amenable in future next-
generation dataset analysis.  Furthermore, such assumptions may be useful in studying 
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the behaviors of selected exons and transcripts in various biological contexts in either BN 
or BN+1 analysis. 
 The analysis did not include all members of the BCR pathway as represented by 
KEGG.   It is likely that expansion of another subset of genes from this pathway (e.g. 
Syk, Lyn, Blnk, Btk) that were not recovered as top BN+1 genes here will identify a 
different set of BN+1 genes.  Such a hypothesis could be tested by setting the Syk and 
other genes as the core network and rerunning BN+1.  This was not tested, but could be 
done easily. 
4.7 Discussion and Summary of BN+1 studies 
The BN+1 algorithm was demonstrated in the preceding examples to be generally 
applicable to a wide variety of biological systems in prokaryotes and eukaryotes.  We 
successfully identified novel genetic mechanisms relevant to biofilm formation and 
regulation which were later verified experimentally by our collaborators.   This was 
achieved by combining the expansion algorithm with a naïve natural language processing 
approach called term enrichment.  Many exciting predictions from all of the BN+1 
analyses have not yet been evaluated experimentally and await further validation, though 
will likely have major impacts on our understanding of pathway entities and their 
interactions with neighboring/interacting biological entities. 
Another method of assessing the significance of predicted results in the biological 
studies was through GO enrichment of the most well-supported and highest-ranked BN+1 
genes.  This approach was introduced in the prokaryotic ROS pathway and later applied 
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to the murine BCR pathway, with similar ability to recover pathway-relevant molecular 
functions and biological processes in the top-scoring BN+1 genes. 
Aside from extending across evolutionary scales from prokaryotic to eukaryotic 
pathways, the methods were also robust to the use of different analysis platforms for gene 
expression data (Affymetrix versus Agilent platforms).  Though this was not tested using 
platforms for different biological scales (e.g. protein expression, phosphorylation states, 
etc.), we can expect that BN+1 analyses can identify novel interactions with high 
significance using those other datasets.  It will be interesting to compare how the 
predictions generated using different dataset types (e.g. mRNA expression vs protein 
phosphorylation abundance data) compare in terms of their rankings.   
Many future directions are envisioned. For example, we can extend the BN+1 
algorithm to BN+2, BN+3, or BN+n algorithm by iteratively adding more than one 
variable to the seed gene network. The principle used in the development of the BN+1 
algorithm can also be used for dynamic BN analysis. We are currently in the processing 
of developing a DBN+1 algorithm and using it for dynamic data analysis.  
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Chapter 5  
Combined Bayesian Refinement and Expansion Towards Identification of Novel  
Molecular Interactors in Progressive Kidney Disease 
5.1 Introduction 
In this analysis, the developed methods from preceding chapters were applied towards a 
biomedically-prevalent and relevant disease in humans, progressive kidney disease.  
Progressive kidney disease is a complication that can occur in some diabetes patients and 
can include kidney failure and sometimes even death [100].   
In order to study the progressive kidney disease, data were analyzed from two 
different compartments within the kidney nephrons, the glomeruli and tubules.  These 
compartments specifically relate to the activities of the nephron, and have been shown 
previously to have differential pathological changes at different stages of the disease 
[101,102,103].  The Jak/Stat signaling pathway which has been implicated in the 
progressive kidney disease was selected as a starting point for our Bayesian network 
refinement and expansion algorithms [102,103].  We attempted to see whether the 
pathway has different regulatory roles or responses in the two compartments using 
existing microarray data, and whether novel or known regulators are implicated in either 
or both of the compartments.  By identifying the most likely pathway interactors, we 
hoped to implicate new genes in the different stages of the progressive kidney disease for 
future validation and eventual therapeutic development. 
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 Prior to the human progressive disease analysis, we tested whether a set of refined 
networks from the EdgeClipper approach could later be expanded to identify novel 
hidden factors in a simpler model.  Given that the ROS detoxification pathway had 
already been studied in detail in both the EdgeClipper (Chapter 3) and BN+1 (Chapter 4), 
the use of this pathway for testing the combinatorial application of EC and BN+1 for 
refinement and expansion, respectively, was a logical and simple extension.  The 
combined approach was tested using both moderate and strict consensus networks from 
the EdgeClipper analysis of the ROS pathway (Chapter 3).  The results from the 
expansion of both refined networks are described. 
5.1.1 Methods 
5.1.2 Selecting core networks from different consensus levels via EdgeClipper 
Two levels of consensus were selected from the ROS pathway using the EdgeClipper 
algorithm.  A medium consensus network of intermediate stringency (B-value=10
-3
) was 
derived from the top 3,644 simulated networks. The medium network contained 13 genes.  
When all the top 20,000 networks saved were included in our simulation, the B-value 
equaled zero. Under this condition, the consensus network was similar to the medium 
network except that two edges were absent, gadX-sodC and oxyR-crp. Three separate 
sub-networks remained.  These included gadE-gadX-gadW, fis-sodC-katE, and marA-
marR. In this thesis, the highly conserved network that connects the three genes gadE, 
gadW, and gadX was defined as the small network.  These three genes are members of a 
known ―acid fitness island‖ and are important regulators of E. coli resistance to extreme 
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oxidative acid stress [104]. The small network was chosen as the network starting point 
for our subsequent small network expansion study. 
5.1.3 BN+1 settings for medium and small core networks 
 In each iteration of the BN+1 simulation, the current BN+1 gene was added to the 
original data file.  This was followed by a simulated annealing search 5x10
6
 networks for 
the medium network expansion and 1x10
6
 networks for the small network expansion.  
Although the consensus network was selected as a starting point or seed, during the 
learning round all edges could be modified such that the addition of genes could change 
the backbone structure of the resulting model (i.e., unfixed structural prior).  Genes were 
sorted based on their log posterior scores.   
5.1.4 BN+1 Neighborhood Analysis. 
To display the genes in the core network that were strongly connected in the BN+1 
analysis, a heat map-based visualization method we termed consensus neighborhood 
analysis was introduced to characterize patterns of connectivity between the core BN 
genes and selected BN+1 genes.  Consensus neighborhoods represent conserved 
connections between core genes and BN+1 genes across a set of replicate BN+1 runs.   
For each BN+1 gene, the set of top networks with identical best score predicted for that 
gene were used to define the consensus network.  Edges were shown as directed arrows if 
the relationship appears in 100% of the selected top networks with specified 
directionality; otherwise, a relationship was defined as undirected if the cumulative 
frequency of parent and child relationships between the selected core and BN+1 gene 
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equaled 100%.  The relations of the core genes with respect to the BN+1 gene are  
defined as: 1) core gene is a parent node with an edge directed towards the predicted 
gene; 2) core gene is a child nodes with an edge directed inwards from predicted gene; 
and 3) core gene shares an undirected edge with the predicted gene.  The top fifty rank-
ordered genes from the 13-gene BN+1 analysis were selected for inclusion in the 
visualization.  Hierarchical clustering was generated using a binary distance metric and 
the Heatplus module in R.  Biological terms were manually curated using information 
from Entrez Gene and literature. 
5.1.5 Results 
All three consensus networks (including the 27-variable network identified in 
Chapter 2) with different levels of stringency were individually compared to the known 
ROS pathway. As stated earlier in this thesis, 29% of the edges in the consensus are 
supported by corresponding edges in EcoCyc [23] or RegulonDB [81].  However, 
inclusion of literature information in the comparison revealed that approximately 42% of 
the edges found in the large consensus network were confirmed.  The medium consensus 
network is more consistent with EcoCyc, RegulonDB, and information contained in the 
literature with 78% of the edges supported. The two missing edges were also supported 
when weak evidence was included. A detailed analysis revealed that the interactions 
involving direct transcription factor binding activities (e.g. marA-marR, ihfA-ihfB, gadE-
gadX-gadW) [23,105,106,107] were among the most highly-conserved edges in the 
medium consensus network.  The small consensus network (gadE-gadX-gadW) is a sub-
network of the large and medium consensus networks and is 100% consistent with 
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EcoCyc, RegulonDB, and information found in the literature. Specifically, it has been 
reported that gadX regulates gadE and gadW, and that gadE and gadW regulate gadX 
[23,65,104,107,108].  
A novel representation termed consensus neighborhood analysis was developed to 
test whether specific core genes have a preferential impact on the selection of BN+1 
genes. The consensus neighborhoods are derived from consensus BN analysis and 
applied to networks from replicate BN+1 simulations, and are comprised of those core 
network genes that strongly influence or are influenced by a specific BN+1 gene.  
Consensus networks for the fifty top predicted BN+1 genes and their connected core 
genes from the BN+1 expansion of the medium network were generated (Fig. 5.1). This 
analysis confirmed the capability of the BN+1 to predict the involvement of new genes 
and gene interactions related to ROS and other stress responses. Core genes on the left 
side of Fig. 5.1 (e.g. nearer to gadE) have more connections with the predicted BN+1 
genes than those on the right side (e.g. nearer to marR). This result indicates that certain 
genes play more important roles than others in prediction of new pathway genes. It also 
suggests that removal of some genes from a selected core topology during the B-value 
selection may have more important effect on subsequent ‗+1‘ recovery, because removal 
of those core genes with closest correlations to the ‗+1‘ genes will limit recovery of the 
‗+1‘ gene in the ―top‖ hits.  This analysis also identified seven ―acid fitness island‖ genes 
that are clustered together (boxed genes gadA, hdeB, hdeD, yhiD, gadB, hdeA, and slp) 
and are all connected to gadE, suggesting the important role of gadE in the selected 
experimental conditions and overall effects on the selected pathways. 
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Expansion of the small consensus network resulted in the selection of genes 
predominantly from a known acid fitness island [104]. The acid fitness island is a 
coordinately regulated gene cassette (shown in Fig. 5.2). Interestingly, nine of ten acid 
fitness genes not already included in the small network were recovered within the top 10 
BN+1 results (Table 5.1 and Fig. 5.1). The tenth acid fitness gene, mdtF, was the 80th top 
predicted gene from the small network expansion. The acid fitness genes have multiple 
functions, including decarboxylation of glutamic acid to remove intracellular protons 
(gadA), protection from organic metabolite products produced during fermentation (yhiF, 
slp, hdeA), recovery from protein damage induced by the diffusion of organic acids into 
cells (hdeA), direct processing of organic acids (yhiF, slp), and predicted membrane 
activity (yhiD, hdeD) [104].  The BN+1 search also identified the glutaminase ybaS, a 
gene that has been suggested to participate in acid resistance activity in E. coli [109].  
YbaS is outside of the physical acid fitness island [104]. These results indicate that the 
BN+1 algorithm is able to accurately predict acid stress regulatory genes within and 
outside the known acid fitness island.   
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Table 5.1 Top 10 genes with best log posterior scores predicted from BN+1 
expansion based on the large, medium, and small consensus networks.  Numbers 
shown after gene names are negative logs of posterior probabilities for each top network 
containing the respective predicted gene.  Highlighted cells represent known acid fitness 
genes. 
Rank Large Network (27 gene) Medium Network (13 gene) Small Network (3 gene) 
1 dusB (tRNA-dihydrouridine 
synthase B); S=-8295.81 
dusB (tRNA-dihydrouridine 
synthase B);  S=-3821.20 
slp (outer membrane 
lipoprotein); 
S=-949.65 
2 fdhE  (formate dehydrogenase 
formation protein); S=-8298.44 
sra (30S ribosomal subunit protein 
S22);  S=-3850.29 
hdeA (stress response protein 
acid-resistance protein); S=-
954.57 
3 uspE (stress-induced protein);  
S=-8310.63 
yodD (predicted protein);  S=-
3850.30 
hdeB  (acid-resistance protein) 
S=-958.11 
4 yohF (predicted oxidoreductase 
with NAD(P)-binding Rossman-fold 
domain); S=-8312.24 
fbaB (fructose-bisphosphate 
aldolase class I);  S=-3860.69 
gadA (glutamate decarboxylase 
A, PLP-dependent); S=-968.53 
5 yncG  (predicted enzyme);  
S=-8313.04 
slp (outer membrane lipoprotein); 
S=-3865.13 
gadB (glutamate decarboxylase 
B, PLP-dependent); S=-972.15 
6 msyB (predicted protein);  
S= -8318.20 
hdeA (stress response protein acid-
resistance protein); 
S=-3870.05 
hdeD (acid-resistance 
membrane protein); S=-973.65 
7 yedP (conserved protein);  
S=-8320.30 
msyB (predicted protein);  
S=-3871.68 
yhiD (predicted Mg(2+) 
transport ATPase inner 
membrane protein); 
S=-975.68 
8 sra (30S ribosomal subunit protein 
S22);  S=-8323.97 
hdeB (acid-resistance protein); 
S=-3873.59 
dctR (predicted DNA-binding 
transcriptional regulator); 
S=-993.91 
9 ydcK (predicted enzyme);   
S=-8325.91 
erfK (conserved protein with 
NAD(P)-binding Rossmann-fold 
domain); 
S=-3877.97 
ybaS (predicted glutaminase); 
S=-996.20 
10 ynhG  (conserved protein);   
S=-8326.20 
ynhG (conserved protein); S=-
3878.40 
mdtE (multidrug resistance 
efflux transporter); S=-1017.59  
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Figure 5.1 Consensus neighborhoods and functions of BN+1 expansion genes.  
Matrix representation was generated for the top fifty BN+1 genes predicted to interact 
with medium network by BN+1 analysis.  Each cell in the heatmap represents a 
relationship between a BN core gene (x-axis) and a particular BN+1 gene (y-axis) with 
selected grayscale shading that represents predicted relationships of core genes respective 
to the predicted genes. Biological functions and localization (obtained from Entrez Gene 
and PubMed) curated manually are indicated in margin of vertical axis. The boxed gene 
names show genes from the acid fitness island. 
 
 
Figure 5.2 Acid Fitness Island Genes Identified By Combining EC and BN+1.  
Genomic localization of acid fitness island genes presented in graphical form (genes not 
shown to scale), with order of the genes in BN+1 results listed as numbers (#).  Genes 
appearing in the core network included gadE, gadX, and gadW. 
m
a
rR
g
a
d
W fu
r
fi
s
c
rp
ih
fB
m
a
rA
ih
fA
g
a
d
E
k
a
tE
o
x
y
R
g
a
d
X
s
o
d
C
dusB
slp
hdeA
gadB
ygiW
yhiD
hdeD
hdeB
gadA
ybaS
yeaQ
rpmA
dps
yniA
yncB
mlrA
ymgE
dapF
yceK
rmf
ydhS
ynhG
erfK
arnT
yncG
yohC
asr
psiF
wrbA
msyB
yeaG
ycgB
elaB
ygaU
ycaC
tktB
fbaB
treA
yohF
yeaH
ydeI
ydaM
fdhE
murA
otsB
yedP
yodD
ydcK
sra
tam
None Parent Child Child‟s Parent
Acid
Resistance
Conserved
or Predicted
Ribosomal
Osmotic
Stress
Resistance
Inner
Membrane
Oxidative
Stress
Motility
Lipoprotein
NAD(P)
Activity
Stress
Response
Hydrolase
Carbon
Fixation
Anaerobic
Respiration
Oxidoreductase
1
1,12
1
1
1
1
1
1
1
1
1
1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
13
12
7,12
12
10
2
7
5
9,12
14
10
9,10,12
10
10,12
9
6
6
6,12
12
12
12
12
12
12
12
3,12
7,12
8,12
4
4
3
11
3
8,12
14
slp yhiUgadEhdeDhdeB hdeAyhiDdctR mdtF gadXgadW gadAgadY
#1 #2#3 #4#6#7#8 #10 #13
Rank
(BN+1)
CoreCore
Gene
Acid Fitness Island
Core
#80
 112 
 
These results suggest that BN+1 can be executed following an initial refinement 
of some existing network topology using the EdgeClipper algorithm.  In all three models, 
the results recapture many important biological functions and mechanisms related to 
those of the included set of genes in the respective model. The ability to further refine the 
functionality down to operon levels (arguably a genomic and not proteomic feature) is 
itself a novel and interesting finding.  However, in terms of general oxidative stress 
pathway activities, the expansion of only the gad genes gave a more restrictive set of 
biological functions that do not encompass the majority of molecular function and 
biological process GO terms relevant to ROS.  As listed in Figure 5.1, the biological 
mechanisms relevant to oxidative stress include a variety of mechanisms, including cold 
and osmotic shock, anaerobic respiration and NAD(P), and mitochondrial/inner 
membrane activities.  More investigation will be needed to infer whether these proteins 
have other oxidative stress pathway activities and roles aside from their known annotated 
functions.  However, the validity and power of combining our EC and BN+1 approaches 
was established with this preliminary study. 
5.2 Eukaryotic study: diabetic nephropathy and progressive kidney disease 
Diabetic nephropathy (DN) is an increasingly more prevalent and devastating 
disease worldwide.  Diabetic nephropathy develops in approximately 30% of patients 
with type 1  or type 2 diabetes [32].  This is significant, since the number of human 
patients worldwide with diabetes is expected to reach 380 million by the year 2025 [32].  
Diabetic nephropathy is the most common cause of end-stage renal disease, which itself 
is an important predictor of cardiovascular risk and mortality. The clinical progression of 
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diabetes nephritis is classified into 5 phases: hyperfiltration and renal hypertrophy, 
glomerular filtration and increased renal plasma flow, changes to the renal parenchymal 
basement membrane thickness as well as mesangial expansion, microalbuminuria and 
early hypertension, proteinuria formation, and end-stage renal disease [32]. Interestingly, 
there appears to be distinct regulatory processes occurring in the microstructures of the 
nephrons during progressive kidney disease and DN.  Most specifically, some evidence 
suggests differential regulatory processes in the glomerular and tubulointerstial 
compartments of the kidney at the genetic level.   
It has been proposed that the Jak/Stat signaling pathway may play a role in the 
events of progressive kidney disease [102,103].  The Jak/Stat signaling pathway directly 
targets the expression of mammalian genes following response to cytokine and growth 
hormone receptor signaling [110].  During Jak/Stat signaling, signaling by the effector 
cytokines or growth hormones will activate Jak, phosphorylate its receptor, recruit and 
phosphorylate STAT molecules which will dimerize and translate into the nucleus, and 
activate gene expression [110].  Jak/Stat signaling is known to be involved in various 
renal diseases, though the mechanisms by which the pathway interact in the various renal 
disease progressions is complicated  and can vary across various species (e.g. human vs 
murine) [110] and even different tissue types.  For example, the Stat3 protein shows 
differential regulation in multiple cell types (mesangial, podocyte, interstitial fibroblasts, 
tubular epithelial cells, macrophages, and lymphocytes), though it is unclear what the role 
of Stat3 might be in renal fibrosis and other processes [110].  It is also unclear as to 
which Stat gene is the major regulator of Jak2 signaling, which is also proposed to be 
important in humans [110]. 
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In this analysis, we implement a Bayesian network analysis to determine whether 
the Jak/Stat signaling pathway plays a role in the differential regulation of two kidney 
compartments during progressive kidney disease.  Kidney biopsy data from human 
patient for glomerular and tubulointerstitial compartments were used in learning distinct 
Bayesian networks for the Jak/Stat signaling pathway.  We hypothesized that if the 
mechanisms in the two compartments of kidney are distinct or different, and if the 
Jak/Stat signaling networks are also distinct for those compartments, then sufficiently 
different network models and interactions should be observed for the two models.  
Second, the expansion of the most well-supported interactions for each compartment 
should identify genes outside the Jak/Stat pathway which relate specifically to the disease 
processes inherent in each kidney compartment and should be distinct for those 
compartments.  Bayesian networks were generated, refined using our developed 
EdgeClipper algorithm and compared for the two compartments, and finally each 
expanded using the developed and tested BN+1 algorithm.  These methods were applied 
to better understand the role(s) of the Jak/Stat signaling pathway in two kidney 
compartments and hopefully identify new gene regulators of the pathway in the kidney 
compartments for eventual therapeutic development. 
5.3 Methods 
5.3.1 Microarray Analysis for Diabetes Study 
De-identified microarray data were obtained from the Kretzler laboratory (courtesy of 
Felix Eichinger and Matthias Kretzler).  In summary, the data were obtained from human 
(including Pima Indian) kidney biopsies in either glomerular or tubule compartments.  
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Data were obtained for the biopsies using an Affymetrix HGU133A microarray platform 
(12,025 features).  The microarrays were processed using individual normalization 
followed by ComBat normalization [111] by F. Eichinger prior to receipt of the data by 
A.P. Hodges.  During BN analysis, each gene was discretized using a q3 maximum 
entropy approach (which was also applied in previous chapters).   
Four distinct datasets were created using the available microarray data.  The full 
sets of glomerular and tubular data were used as two distinct data sets.  A subset of the 
full glomerular data set (74 out of 298 chips) was selected to specifically include only 
those microarray data from patients with either progressive kidney disease and diabetes 
mellitus (DM) indications or no disease as a third dataset (partial glomerular dataset).  
Identical rules were applied to the selection of a corresponding partial dataset (71 out of 
278 chips) from the full tubule set.  Thus, four data sets were generated which were used 
in the subsequent Bayesian analyses, two of which are more specific to the DM-based 
progressive kidney disease comparison. 
5.3.2 Pathway Selection and Bayesian network construction 
A set of 131 genes were identified for the Jak/Stat pathway within the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) database.  This set of genes represents the 
set of all genes participating in the Jak/Stat pathway as either genes, proteins, or another 
biological entity within the curated KEGG pathway.  Four distinct Bayesian network 
models were constructed using the four datasets generated above.   
In the preliminary simulation studies, the following identical rules were applied.  
For each of the two smaller datasets (partial glomerular, partial tubule), Bayesian 
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networks were generated using the following rules.  Runtimes were increased to a 
maximum of 50 minutes or 1 x 10
8
 maximum searched networks for each of 200 
independent simulations for the full tubule and glomerular studies to allow a more 
thorough search.  Standard searcher parameters from our previous studies were employed 
in these four major analyses, including maximum entropy (q3) quantization, maximum 
cap of three parent variables per any given variable, and simulated annealing search. 
5.3.3 BN Refinement and core network generation using EdgeClipper (EC-R) 
The set of top-scoring networks saved in each simulation were then refined using the 
restrictive EdgeClipper (EC-R) algorithm.  Network refinement was implemented to 
reduce the number of edges in saved networks and allow comparison of the most well-
supported interactions in the glomerular and tubule compartments.  In short, the 
restrictive EdgeClipper (EC-R) algorithm was implemented when modeling each of the 
four network sets.  Log posterior probabilities from the Bayesian network results were 
used to generate a distribution of B-values corresponding to each unique network score.  
Edges were filtered using B-value cutoffs of roughly 0.10 or stricter (e.g. 0.01 and 
smaller) for each of the four datasets‘ Bayesian networks.  Different B-values were 
required for each dataset to achieve a set of variables with count with fewer than 100 
variables, and were distinct for each dataset due to distinct B-value distributions for each 
dataset.  A B-value of 1 x 10
-3 
was initially sought to select the genes.  Additional 
selection was implemented to include at least 50 genes.  Genes were included based on 
the B-values beyond which the genes would not be connected to any other genes in the 
consensus networks.   Those interactions amongst variables which appeared within 100% 
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of the saved networks meeting the B-value criteria were included in the final consensus 
network as either directed or undirected edges. 
5.3.4 Core Network Expansion Using BN+1 
Core networks were selected for the two smaller datasets (glomerular and tubule) using a 
B-value cutoff criterion. The BN+1 expansion algorithm was implemented for each of the 
core networks and respective datasets to identify novel hidden factors.   Each of the genes 
not included in the pathway were tested for their ability to improve the respective core 
network when added to the model.  A total of 2 x 10
8
 networks were searched for each 
individual gene not already included in the core network (~13,000 genes).  After running 
the simulations, the genes were sorted and ranked according to best log posterior score.  
The top BN+1 genes identified for the partial dataset experiments were later compared 
and used to assess the respective neighborhoods around the consensus networks and core 
genes. 
5.3.5 Network Overlay and Comparison 
Core networks with the same underlying number of data observations (partial glomerular 
vs partial tubule, etc.) were overlain and compared to identify which interactions were 
shared for the two biological compartments.  Interactions represented as either directed or 
undirected edges in the network were compared for the two selected consensus networks.   
If the interaction appeared in both networks regardless of direction (e.g. directed in the 
first, undirected in the second), that interactions was counted as present in both networks.  
Directionality was not included as a criterium for assigning presence/absence of an edge.  
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Frequency of edge occurrence was considered within the rules of the applied EC-R 
approach. 
5.4 Results 
5.4.1 Few gene interactions (e.g., edges) are conserved in either compartment as 
revealed by EdgeClipper EC-R refinement analysis   
Results from EdgeClipper (EC-R) refinement of BNs trained using the four 
datasets are shown in Figures 5.3-5.6. The EdgeClipper algorithm was applied to refine 
our results due to several observed issues.  First, the Bayesian networks for each of the 
four datasets contained high numbers of disconnected nodes. This observation suggested 
that many nodes did not have sufficiently supported interactions with other genes in the 
list. It is possible that more links would be shown up given more execution time. 
However, the time performed in this study was considered sufficient to get basic 
interactions, and those disconnected nodes were likely to have no or very weak 
connection to any of the genes listed. Second, the number of data points in each analysis 
was relatively low when compared to the size of the network models (131 variables).  In 
the earlier chapters‘ ROS analysis, 305 data points were available and used when 
modeling interactions amongst 27 variables.  This issue of sufficient data, combined with 
the earlier results of 29-42% recovery of known interactions and arguably high false 
positive rates, suggests that an even higher incidence of false positive rates in the data can 
be observed.  Fourth, it is desirable to identify the most well-supported interactions 
observed in the two kidney compartments during the progressive kidney disease.  This 
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selection allows a more stringent comparison of the two compartments and their best-
supported interactions.   
Interestingly, the refinement of the networks trained on partial datasets using the 
EdgeClipper algorithm showed a significant drop-off in number of connections as B-
values were successively decreased towards zero.  These results suggest that the 
supported interactions in each BN analysis are only moderately supported given the small 
amount of data available in each dataset.  Hence, it is likely that the addition of more 
patient data could improve the robustness of these results and provide more confidence in 
predicted interactions.   
 
Figure 5.3 Consensus network of Bayesian networks using partial dataset selected 
from glomerular data. A subset of the full dataset (74 out of 298 chips) was chosen for 
this analysis using a regular expression (regex) match. Thirty-three nodes were 
disconnected from the network.  
 
 120 
 
 
Figure 5.4 Consensus network of Bayesian networks using partial dataset selected 
from tubulointerstitial data. A subset of the full dataset (71 out of 278 chips) was 
chosen for this analysis using a regular expression (regex) match. 42 nodes were 
disconnected from the network. 
 
 
Figure 5.3  Consensus network for Bayesian networks generated using the full 
glomerular dataset (298 chips). 8 nodes were disconnected from the network. 
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Figure 5.4  Consensus network for Bayesian networks generated using full 
tubulointerstital dataset (278 chips). 12 nodes were disconnected from the network. 
 
Furthermore, the number of disconnected nodes observed in each network 
analysis was relatively high for networks trained on smaller datasets.  A totally 
disconnected network is often the starting network for scoring comparison.  We expect 
that as more networks are searched, there is an increased expectation of any given node 
being connected with one or more additional variables in the network due to the number 
of searched networks increasing.  Comparison of the networks in Figures 5.3-5.6 revealed 
that as more data are added to the simulation, the number of disconnected nodes 
decreases (disconnected nodes not shown).  It is possible that some nodes which were 
previously connected to other variables can be disconnected following addition of more 
data (e.g. ―Spry2‖ in Figs. 5.4 and 5.6), though this is less common than the addition of 
edges to previously-disconnected nodes.   
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5.4.2 Glomular and tubule compartments show disparately low overlap, 
suggesting differential pathway activities 
The consensus networks generated by EdgeClipper for tubule and glomerular 
compartments with the same data size were compared in Table 5.2.  Overlay of the full 
tubule and glomerular dataset models revealed minor overlap with only seven shared 
connections in the follow-up simulation study using the full datasets.  Chi-square and 
Fisher exact tests revealed that the number of interactions shared between the two studies 
is indistinguishable from random chance, suggesting no significant overlap between the 
two sets of interactions.  These data suggest that the two compartments have different 
conserved interaction sets with selected biological functions for Jak/Stat pathway genes, 
suggesting differential regulation of the Jak/Stat pathway elements in the two 
compartments. 
Furthermore, no overlap was observed for the shared interactions of full dataset 
glomerular and tubule models and those of the partial dataset models.  This suggests that 
the inclusion or exclusion of roughly 150 data points has a major effect on the most well-
supported interactions.  One possibility is that patients with non-DM kidney disease 
and/or other conditions may have alternative mechanisms and biological events 
occurring.  However, this statement is weakened by the possibility that all of the 
simulations have not converged to optimal solutions (e.g. insufficient simulation time).  
More investigation is needed to elucidate this difference in shared interactions and 
varying datasets. 
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Table 5.2 Summary of shared interactions in the partial and full dataset analyses. 
 #GA 
interactions 
#TA 
interactions 
#overlapping 
Interactions 
%GA, 
%TA 
Shared interactions 
Partial 107 92 7 6.5%, 
7.6% 
EP300-PIAS1, 
CNTFR-IL13, CSF3-
IL13, IL2RB-IL10RA, 
IL5RA-MPL, IL2RA-
PTPN11, CCND2-
MYC 
Full 121 117 14 11.6%, 
12.0% 
IL10RA-PTPN6, 
STAT1-IRF9, IL12RB1-
IL21R, EPO-EPOR, 
AKT1-CCND3, IFNG-
IL5RA, IFNW1-PIK3R2, 
IL2RG-PIK3CG, IL6-
PIM1, IL12RB2-JAK3, 
LIF-MYC, CCND3-
PRLR, IL13-STAM, 
IL5-PIK3R2 
5.4.3 New Jak/Stat pathway elements were discovered through BN+1 expansion  
The top BN+1 results for the expansion of core network models with partial glomerular 
and tubule data  are show in Table 5.3.  Genes from the BN+1 analysis were ranked 
according to the best achieved BN score (scores closest to zero).  The top genes for each 
compartment appear to be biologically relevant to the compartment‘s known disease 
processes. For example, several genes with known roles in oxidative stress and redox, 
mitochondrial activities, or apoptosis were identified for the partial tubule dataset model, 
including TMSB10, DNAJC16, PRDX4, MAPK10, and ACADL.  Interestingly, the top 
results from the glomerular compartment expansion included genes with known roles in 
cell growth & differentiation, signal transduction, cytoskeleton remodeling, or membrane 
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transport, such as PLCE1, CCDC91, HPS5, SRGAP2, PHACTR4, ARHGAP19, and 
IQGAP2.    
Genes are ranked according to their maximum BN score generated during the 
BN+1 search procedure.  Other genes which connect to the BN+1 gene in the top 
networks are listed as ―Neighbors‖ or neighbor genes.  These neighbors constitute a 
portion of the Markov Blanket for the BN+1 gene (note: parents of child nodes are not 
included as neighbors due to their lack of direct connection to the BN+1 gene). 
 
Table 5.3  BN+1 expansion of glomerular and tubule compartments models 
identifies distinct novel regulators for the Jak/Stat pathway which are distinct to the 
respective compartmental disease mechanisms. 
BN+1 results for partial tubule dataset 
Rank Gene Symbol BN Score Neighbors 
1 9168 TMSB10 -4688.4523 CCND2, PRLR, MYC 
2 23341 DNAJC16 -4689.8864 IL4R, GHR, MYC, PIAS2, 
CCND3 
3 10549 PRDX4 -4692.432 MPL, MYC, SOCS7, IL13, 
JAK3, CNTFR 
4 11025 LILRB3 -4692.5516 GH1, IL3, LIFR, JAK3, MPL, 
IL2RA, IFNW1 
5 80339 PNPLA3 -4692.9465 IL13, CNTFR, PRLR, IFNGR1, 
BCL2L1 
6 11177 BAZ1A -4693.2419 MYC, CBLB, CCND2, IFNGR1, 
IL13, STAT1 
7 5602 MAPK10 -4693.2527 IFNGR1, PRLR, MPL, BCL2L1, 
IL13, CBLB 
8 1629 DBT -4694.5034 CCND2, SOS2, IL2RB, 
BCL2L1, IL2RG, IL4R 
9 33 ACADL -4694.9172 GHR, IL4R, IL2RG 
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10 51765 MST4 -4694.9276 MYC, CCND3 
BN+1 results for partial glomerular dataset 
Rank Gene Symbol BN Score Neighbors 
1 51196 PLCE1 -4942.4257 GHR, IL11RA, SOS2, CBLB, 
EPOR 
2 64398 MPP5 -4942.9408 GHR, IFNGR2, SOS2, IL11RA 
3 55297 CCDC91 -4945.3412 PIK3R1,SOS2, IFNGR2, 
IL11RA, GHR, IL6 
4 54463 FAM134B -4947.9157 GHR, MYC, EP300, SOS2, 
CBLB, IL11RA, IL6, IFNGR2 
5 9863 MAGI2 -4948.964 GHR, EP300, IL6, IFNGR2, 
EPOR, CBLB 
6 11234 HPS5 -4949.0538 GHR, IL11RA, PIK3CA, EPOR, 
IL6, SOS2, SOCS7, IFNGR2 
7 23380 SRGAP2 -4949.101 GHR, IFNGR2, CBLB, IL11RA 
8 65979 PHACTR4 -4949.6565 GHR, SOS2, IFNGR2, CBLB, 
EP300, IL6, IL11RA 
9 84986 ARHGAP19 -4951.9786 GHR, IL11RA, EPOR, CBLB 
10 10788 IQGAP2 -4952.731 GHR, IL6, IL11RA, SOS2, 
IFNGR2, CBLB 
 
The top genes identified in the tubulointerstitial and glomerular compartments were 
TMSB10 and PLCE1, respectively.  Comparison of the relationships between these top 
BN+1 genes and their interactors in the core networks (listed in Table 5.3) revealed 
compartment-specific relationships when plotted in a pairwise manner (Figures 4.6 and 
4.7).  Given the normalization method used in the two separate datasets, the max and min 
values for both compartments for any particular gene are not directly comparable.  
However, more obvious relationships are demonstrated in the tubule versus in the 
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glomerular data for TMSB10 and its core network interactors (and, similarly, for PLCE1 
in the glomerular over the tubule data).   
 
Figure 5.5 Scatterplots of TMSB10 with connected core genes and respective 
datasets in tubule and glomerular compartments. 
 
 
Figure 5.6  Scatterplots of PLCE1 with connected core genes and respective datasets 
in tubule and glomerular compartments. 
 
Thymosine beta 10 (TMSB10) has no known biological function, though has high 
sequence similarity between humans, rats, and other mammals [112].  The gene has been 
isolated from human kidney using cDNA cloning and has been used to show differential 
expression in the kidney [112].  In murine studies, TMSB10 was shown to be a 
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biomarker in the murine glomerular crescent when perturbed in a chronic graft versus 
disease modeling [113].  TMSB10 is generally downregulated in human pelvic lymph 
node metastasis (PLNM) and was proposed to have roles in other cancers [114].  
Interestingly, the entire network neighborhood around TMSB10 includes genes with 
cancer-related associations or functions. 
Mutations of phospholipase C epsilon 1 (PLCE1) has already been implicated in 
diffuse mesangial sclerosis and early onset nephrotic syndrome [115].  PLCE1 is a 
member of a phospholipase family which catalyzes hydrolysis of phosphotides to 
generate products which regulate cell growth, differentiation, and gene expression [116].  
The gene is expressed and enriched for protein abundance in the mature glomerular 
podocytes [116].  Hinkes et al. showed that recessive mutations in PLCE1 were causative 
for nephritic syndrome variants [116].  The PLCE1 gene was identified by LOD analysis 
for nephritic syndrome followed by haplotype analysis, and further implicated by cDNA 
identification of the 34 exons (distributed over 334.4 kb) and seven homozygous PLCE1 
mutations (6 truncating, 1 missense).  This finding was especially interesting, given that 
their demographic groups from Central Europe and Turkey are different than the Pima 
Indian group in our study dataset and represent an independent source of verification for 
our findings. 
Thus, these findings strongly establish the predictive power of the combined 
EdgeClipper and BN+1 approaches for characterizing the roles of know pathways in 
different compartments or tissues, as well as further expanding those pathways to include 
novel interactors.  We again expect that members of our BN+1 lists with no known 
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functions are viable candidates for additional functional assessment and analysis in future 
studies. 
5.4.4 GO Enrichment for BN+1 Results Reveals Relevant and Specific BN+1 Gene 
Functions for the Selected Compartments 
The results were further confirmed using GO enrichment.  The top 250 variables 
in each BN+1 analysis were tested using GO enrichment to see which biological 
functions were most strongly conserved for those genes (Tables 5.4 and 5.5).  Similar to 
what was observed in Chapter 2 for BN+1 expansion of the ROS pathway, the top set of 
genes for each expanded compartment model relate biologically to the functions and 
activities of the core gene network.  Redox and mitochondrial-related functions were  
Table 5.4 GO enrichment terms for top 250 BN+1 genes from glomerular expansion 
model meeting Bonferroni-corrected p-value < 0.05. 
Term Count % P-value Bonferroni 
Biological Process 
Vasculature development 
(GO:0001944) 
15 6.024096 2.03E-05 0.033463 
Molecular Function 
Protein binding (GO:0005515) 158 63.45382 6.49E-07 3.03E-04 
Glycosaminoglycan binding 
(GO:0005539) 
12 4.819277 7.72E-06 0.003589 
Pattern binding (GO:0001871) 12 4.819277 1.91E-05 0.008844 
Polysaccharide binding 
(GO:0030247) 
12 4.819277 1.91E-05 0.008844 
Carbohydrate binding 
(GO:0030246) 
17 6.827309 8.10E-05 0.037052 
Cellular Compartmentalization 
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Cytoskeleton (GO:0005856) 39 15.66265 5.16E-05 0.01384 
 
Table 5.5 GO enrichment terms for top 250 BN+1 genes from tubule expansion 
model meeting Bonferroni-corrected p-value < 0.05. 
Term Count % P-value Bonferroni 
Biological Process 
Carboxylic acid metabolic 
process (GO:0019752) 
27 10.84337 2.72E-07 4.68E-04 
Oxoacid metabolic process 
(GO:0043436) 
27 10.84337 2.72E-07 4.68E-04 
Organic acid metabolic process 
(GO:0006082) 
27 10.84337 3.12E-07 5.37E-04 
Cellular ketone metabolic 
process (GO:0042180) 
27 10.84337 3.96E-07 6.82E-04 
Oxidation reduction 
(GO:0055114) 
26 10.44177 1.13E-05 0.019288 
Molecular Function 
Coenzyme binding 
(GO:0050662) 
13 5.220884 9.74E-06 0.005693 
Oxidoreductase activity 
(GO:0016491) 
25 10.04016 3.94E-05 0.022826 
Cofactor binding (GO:0048037) 14 5.62249 5.24E-05 0.030242 
Nucleotide binding 
(GO:0000166) 
54 21.68675 7.30E-05 0.04188 
Cellular Compartment 
Mitochondrion (GO:0005739) 38 15.26104 5.30E-07 1.56E-04 
Cytoplasmic part (GO:0044444) 105 42.16867 7.00E-07 2.07E-04 
mitochondrial part 
(GO:0044429) 
26 10.44177 1.19E-06 3.52E-04 
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Cytoplasm (GO:0005737) 140 56.2249 1.23E-06 3.62E-04 
Organelle part (GO:0044422) 91 36.54618 8.97E-06 0.002643 
Intracellular organelle part 
(GO:0044446) 
90 36.14458 1.30E-05 0.003821 
Mitochondrial matrix 
(GO:0005759) 
14 5.62249 2.14E-05 0.006299 
Mitochondrial lumen 
(GO:0031980) 
14 5.62249 2.14E-05 0.006299 
 
enriched in the tubular BN+1 gene set, whereas cytoskeleton development and 
vascularization were enriched in the glomerular BN+1 gene set.  Thus, these data provide 
further support to the claim that the Jak/Stat pathway shows differential regulation 
depending upon which compartment is considered (and hence which disease processes 
and/or stages are included). GO enrichment terms for top 250 BN+1 genes from tubule 
expansion model meeting Bonferroni-corrected p-value < 0.05. 
5.5 Discussion 
Bayesian network analysis coupled with network refinement and expansion 
algorithms revealed differential roles of Jak/Stat pathway members in two kidney 
compartments during progressive kidney disease.  First, the set of network interactions 
predicted for each compartment and refined using the EdgeClipper were disparately low 
and indistinguishable from noise, suggesting that gene expression of Jak/Stat members is 
distinct for the two compartments and reflects different biological mechanisms.  This 
finding implicates the Jak/Stat pathway in at least one (if not both) of the compartments.  
Second, expansion of the two refined network models using our Bayesian network 
expansion identified novel sets of genes with biological roles distinct for the glomerular 
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and tubule compartments corresponding to known disease mechanisms in those 
compartments.  Thus, these results suggest that the Jak/Stat pathway is in fact involved in 
the different glomerular and tubule methods, and that our approach can identify relevant 
genes for additional validation and analysis in multi-tissue experimental studies. 
One interesting aspect of this analysis was the effect of selecting a known 
pathway and investigating its regulation using data from two different biological 
compartments with differential disease regulation.  Our results from the BN+1 analyses 
revealed that those compartments show differential patterns of interactions when 
considering genes from the same pathway.  These results suggest that despite a 
preferential selection of an existing known pathway for biological analysis, the resulting 
predictions for the BN and BN+1 analyses will more closely and specifically reflect the 
underlying data and hence biological conditions.  The most convincing results came from 
the BN+1 results, where it was demonstrated via GO enrichment that the neighborhood of 
genes (with best BN scores and hence top ranks) predicted around the core network 
specifically reflect the disease processes in the glomerular and tubule compartments. 
Another interesting observation from the BN+1 analysis was the preservation of 
selected modular structures or sub-networks for the partial glomerular and tubule dataset 
models in the shared core network to BN+1 gene connections.  Each BN+1 simulation 
included an initial structural prior from one of the top-scoring core networks in the initial 
BN searches.  This core network was often modified during the BN+1 search for any 
given BN+1 gene‘s network, though only a handful of interactions were removed.  The 
majority of interactions from the core network were preserved.  This conservation of sub-
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network structures during BN+1 was consistent with what was observed during our other 
analyses, such as the E. coli ROS detoxification pathway analyses in Chapters 2 and 5.   
However, an important note is that BN+1 genes sometimes drew from multiple 
disconnected modules.  These results suggest that the expansion of only small biological 
cores or modules may be an inherent modeling bias which may not necessarily reflect the 
biological complex or important regulators across large biological pathways.  It may be 
possible to identify genes and other biological entities with multiple roles in complex 
biological systems and disease. This area of computational analysis could be explored in 
future studies. 
The most exciting finding was the prediction of PLCE1 in the glomerular 
compartment.  This gene has already been implicated in the progressive kidney disease, 
so our prediction is supported by these previous data.  We hope to continue investigation 
of this gene and its role in kidney disease.  Another interesting result was the discovery 
that several genes from the glomerular model have known neuropathy functions (e.g. 
FAM134B).  Hence, there may be similar regulatory or effector genes which may be 
involved in another diabetic complication: diabetic neuropathy.  This claim would need 
to be investigated further for additional support and confidence. 
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Chapter 6  
 
Enabling Enhanced BN Approaches Online in MARIMBA 
6.1 Introduction 
In the preceding chapters, Bayesian network expansion and refinement algorithms were 
introduced.  The purpose of this chapter is to explore the software infrastructure which 
was developed and used to achieve those previous studies‘ goals.  The web-based tool, 
called MARIMBA, was designed to permit fast formatting, execution, and analysis of 
Bayesian networks when using high-throughput biological datasets.   
MARIMBA, the Molecular Annotation Resource for Integrating Microarrays with 
Bayesian Analysis, was originally designed as an annotation resource to map microarray 
features to corresponding genes and proteins.  Over the course of this thesis, MARIMBA 
was redesigned to answer specific questions in each of the previous chapters for the 
Bayesian analysis.  Thus, MARIMBA has evolved, albeit painstakingly, into a web-based 
tool for Bayesian network expansion and refinement (Figure 6.1).   MARIMBA is 
accessible at http://marimba.hegroup.org.  The welcoming page of MARIMBA is shown 
in Figure 6.2.  The general design and workflow of the system is described, and future 
developments are suggested. 
6.2 MARIMBA Software Pipeline 
The main MARIMBA system architecture and pipeline for analysis of project data is 
described in Figure 6.2 and contains the following steps:  (1) Data Selection, (2) Variable 
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Selection, (3) File writing, (4) Preprocessing/Clustering, (5) BN settings selection, (6)  
BN execution, (7) Visualization and analysis, (8) EdgeClipper analysis, and (9) BN+1 
analysis. 
 
Figure 6.1 Overview of the implemented methods for BN, BN+1 and EdgeClipper in 
the MARIMBA web pipeline. 
6.2.1 Data selection 
Biological or other data can be uploaded into MARIMBA for BN, BN+1, and 
EdgeClipper analyses.  Currently the data must be formatted as a tab-delimited text file 
with ―ID‖ entered in the first cell (first column, first row) of the text file.  Transpose  
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Figure 6.2 Screenshot of MARIMBA home page. 
 
options are available for selecting the appropriate conditions and variables in the analysis.  
Existing data files, such as previously-uploaded user data or featured MARIMBA data, 
can also be selected and used for analysis. 
Note that in this step of the analysis, all of the data to be included in the BN, BN+1 
and/or EdgeClipper analyses must be included in the same tab-delimited data file.  
Subsequent steps in the MARIMBA workflow assume that data will be taken from this 
‗master‘ data file. 
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6.2.2 Variable selection 
Several options are available for variable selection.  First, users can directly select which 
variables to include by copying and pasting data into a text field or uploading a file with 
those variable names.  A second option is the selection of variable from existing 
databases such as KEGG.  Users are required to enter a valid KEGG pathway ID.  
MARIMBA returns existing information from the KEGG database and attempts to match 
those identifiers to the user data fields.  The KEGG selection option was deprecated 
recently to allow more expert data file generation and preprocessing by the users. 
6.2.3 Write step for BN and BN+1 files 
The basic MARIMBA-formatted files are then generated dynamically for use in static 
Bayesian modeling.  Individual conditions (user-generated identifiers) can be specified 
using an interactive webpage.  Conditions, included genes, and analysis method (BN, 
BN+1, or SYNTH) were selected at this step.   
The write step webpage allows verification of all settings, such as method of gene 
combination (averaging or top probe selection) and type of file write (BN or BN+1 write).  
During the writing process, BANJO-format [40] data files are generated.  In the cases of 
multiple or redundant probeset identifiers per specified gene, averaging was employed.  
Thus, multiple occurrences were treated as replicates, and were averaged at the respective 
treatment and time.  In summary, the final dataset was a BANJO-format data file with 
rows being unique observations and columns being uniquely-identified genes. 
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6.2.4 Data processing 
Data can be preprocessed with available fold change or clustering tools. A custom python 
script was created to permit fold change comparison of user-selected treatment versus 
control samples.  Users may select one or more samples for each control and treatment 
groups.  The selected control and treatment chips are averaged separately prior to 
calculating the fold-change between these two groups.  The GUI allows specification of 
both groups, as well as the threshold for probeset inclusion.  Selected probeset results are 
listed on a subsequent page.  
Clustering tools were selected from Pycluster, a Python-version of the C 
clustering library (http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/ 
software.htm).  MARIMBA currently permits k-means and k-median clustering of the 
working dataset.  Graphical results are displayed dynamically for each cluster using 
Matplotlib (http://matplotlib.sourceforge.net/) and R, including a jpeg image of the 
individual cluster, checkbox selection of individual clusters, and lists of probesets with 
links to annotation information.  Individual probesets are selected subsequently after 
cluster selection on a second page. 
6.2.5  BN parameter selection 
BN simulation settings were selected after completing the data and gene selection 
processes, respectively.  A static Bayesian network simulation was created to analyze the 
microarray data.  Simulated annealing is most commonly selected as the searcher method, 
due to its improved performance over greedy searches when no prior knowledge of 
underlying structure is available [64] and is the recommended strategy in MARIMBA.  A 
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relatively low cooling factor was implemented to allow less restrictive searching of the 
sample space and potentially identify as many equivalence classes for the top-scoring 
network as possible.  The simulation included storage of 1,000 networks for comparative 
purposes.  Note that this number of networks is restricted to smaller numbers (assumedly 
~100-500) to limit report file size.   
6.2.6 Execution of Bayesian network modeling 
BN files are submitted via the online interface in MARIMBA.  In an earlier version of 
MARIMBA, each dataset was transferred to a server at the University of Michigan prior 
to Xgrid simulation.  In XGrid, a query is based from a controller to one or more agents.  
The XGrid is used to pass new BN and BN+1 analyses to free agents on the server.  
MARIMBA was upgraded to use resources from the Center for Applied Computing at the 
University of Michigan (CAC), and is under further development for other cloud-based 
computing strategies.  However, in each submission infrastructure, each available agent 
runs a unique BANJO simulation (e.g. the 1,000 bootstrap simulations in the synthetic 
network EdgeClipper analyses). 
Individual data are passed to the Xgrid or similar submission grid with all 
conditions and variable labels removed in order to protect the identities of user 
information.  In this regard, the observational file, settings file, and prior knowledge file 
are tarred and passed to the Xgrid server.  Individual variable lists are retained on the He 
Group servers to protect the integrity and identity of variables and conditions included in 
an individual analysis.  The controller on the opposing grid posts status updates to the 
primary MARIMBA server via a MySQL table and SSH.  After completion of an 
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individual BN or BN+1 analysis, individual report files are returned to the He Group 
servers.  The BN+1 analyses are completed after successful updating of all BN+1 
probeset simulations. 
6.2.7 EdgeClipper analysis 
EdgeClipper is integrated in a convenient fashion within a consensus network tool in the 
visualization interfaces.  Users may select either the top-level consensus, or specific a B-
value or C-value cutoff for edge pruning.  The current implementation of EdgeClipper 
returns the most well-supporting interactions meeting the imposed cutoff.  The 
EdgeClipper approaches were recently established and validated, and as such are 
undergoing additional updates for a more seamless user experience in MARIMBA. 
6.2.8 BN+1 analysis 
The core BN network is employed as a fixed topology/prior knowledge network in the 
BN analysis.  Probeset selection will be designed as above for the standard BN analysis.  
In addition, probesets not included in the BN structural file are included in the BN+1 list.  
BN core files, including the BN settings, dataset, probeset list, and report file are required 
for BN+1 analysis.  A unique BANJO analysis is created for each BN+1 probeset.  The 
BN core files are copied from a previous analysis if not present in the current analysis.  
Users may select whether the BN core network is a required fixed topology or unfixed 
starting network. 
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6.2.9 BN Result display and interpretation 
Model averaging and equivalence class searching were then implemented to determine 
the ―core BN‖ network model.  Here, model averaging was defined as inclusion of an 
edge between two genes if that edge appeared in more than X percent of the top-scoring 
networks with identical score (with X bounded between 0 and 100), and is most oftenly 
implemented with X = 100. 
MARIMBA provides several unique features versus the standalone BANJO 
system.  First, MARIMBA is exclusively web-based and allows seamless integration of 
user project management, analysis construction, BN submission to a distributed 
computing environment, and analysis and visualization of results.  User-friendly GUI 
environments simplify the dataset selection, probeset/gene inclusion, observational file 
processing, and settings selection for BANJO.  Such features are necessitated for efficient 
querying by biologists who wish to use such BN tools to analyze their data.  The user 
interface and project/analysis management approach permit large-scale analyses such as 
BN+1.   
Top-scoring networks are displayed as jpeg images on-the-fly, such that the 
images are converted directly from their original dot files.  Furthermore, MARIMBA 
displays top-scoring networks of BN, BN+1, and combined networks to the user.  The 
BN+1 display environment provides plots for probability of each network in the query, 
thus enabling comparison of networks for relevance and likelihood.   
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After selection of modeling parameters, Bayesian networks are searched in 
BANJO (http://www.cs.duke.edu/~amink/software/banjo) by simulated annealing or 
greedy algorithm. Top-scoring networks or consensus networks shared by top networks 
are displayed graphically in a web based GUI using DOJO software 
(http://www.dojotoolkit.org).  To determine if the addition of any single gene would 
improve the top network score when added to the network, a ―BN+1‖ approach was 
developed to recalculate the Bayesian networks by iteratively adding a gene from a 
defined gene list to an existing top network (prior structure) and subsequent BN 
recalculation for the new gene list.  Each new ―BN+1‖ query per gene is recalculated 
individually on an individual XGrid agent in the Woolf lab Mac cluster. 
As described in Chapter 3, the currently-implemented tools in MARIMBA are 
being rewritten in Python for direct access and self-utilization by scientific researchers.  
These new approaches will allow individualized tailoring of EdgeClipper and BN+1 for 
different groups‘ requirements and computing interests on a variety of computing 
platforms.  The tools are being tested both on standalone laptops and personal machines, 
and will be tested in the future with other cloud-based computing architectures.  These 
changes will make EdgeClipper and BN+1 even more power and amenable to massively-
high throughput and next-generation dataset analysis and global interactome studies. 
6.2.10 Hardware configureation 
MARIBMA is built on one Dell Poweredge 2580 server which runs the Redhat 
Linux operating system (Redhat Enterprise Linux ES 4) and Apache HTTP Server. 
MySQL database and different programming languages including PHP, Perl, and Python 
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are used for development of a variety of MARIMBA components. The MARIMBA data 
is backed up in another Dell Poweredge 2580 server regularly. A three-tier system 
architecture is implemented with two Linux servers.   
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Chapter 7  
Future Directions and Conclusions 
7.1 Summary and Discussion of Previous Sections 
7.1.1 Overview of Chapters 
In this thesis, I have described the development, implementation, and interpretation of 
two novel Bayesian network approaches for biological pathway expansion and 
refinement, EdgeClipper and BN+1.  Chapter 1 described the driving motivation for 
developing new approaches to refine and expand networks such as Bayesian networks.  
Chapter 2 provides an overview of the major theory and assumptions associated with our 
Bayesian network approach. In Chapter 3, the novel EdgeClipper algorithm was designed 
and tested to refine existing Bayesian networks to identify the most likely interactions 
supported by the models and the underlying biological data.  The BN+1 algorithm was 
then developed and tested to identify novel hidden variables which likely participate in 
selected pathways such as ROS detoxification, B cell receptor signaling, and synthetic 
networks in Chapter 4.  After establishing them as valid approaches, EdgeClipper and 
BN+1 combined and applied to the refinement and expansion of the E. coli ROS and 
human Jak/Stat signaling pathways in Chapter 5.  In Chapter 6, I briefly summarize the 
infrastructure used to generate all of the analyses.  And in the current chapter, I 
summarize many of the findings described previously as well as new areas of exploration. 
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7.2 Summary of algorithms and major findings 
7.2.1 Summary of EdgeClipper algorithm and findings 
A unique feature of this analysis was the inclusion of the probability distributions for the 
top scoring Bayesian networks when assigning ranks to network edges.  The approach 
itself is robust to a highly-parallelized search procedure, which is itself an important 
consideration, and can be more easily interpreted via an expectation-value metric or B-
value.  One of the most exciting aspects of the EdgeClipper analysis was its ability to be 
incorporated along with the BN+1 algorithm to initially refine, and later expand, the 
pathway network and identify new BN+1 genes for selected pathway genes.  I 
demonstrated that not only is the approach comparable to existing bootstrapping and 
frequency-based methods (and even inclusive of the frequency method in the EC-F 
derivation) but also computationally much faster than the traditionally bootstrapping 
approach.  Comparison of the different EC derivations to bootstrapping and existing 
knowledge from pathway databases can also identify novel interactions which are 
strongly supported by the underlying data and warrant additional experimental and 
computational analysis. 
The EC-based analysis can help us understand the question of overlap between 
computational models and knowledge-based pathway networks.  From our results, the 
extent of overlap between the computational networks and biological networks depends 
on the ability of the algorithm to recapture complex relationships as well as the sufficient 
representation of those relationships within the underlying dataset.  For example, the 29-
42% concordance between our networks and the known ROS pathway (Chapter 3) 
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suggest that the Bayesian networks may only be able to identify some known 
interactions.   
One possible reason for this is the types of data used in the modeling, namely 
transcriptional expression data.  If the expression profiles for selected genes in a pathway 
do not correlate well with the levels and activities of their translated protein products, 
then the mRNA data may not give adequate support when used to make conditional 
probability tables and inferences in the Bayesian networks.  Someone might argue that 
protein expression profiles instead may present a better candidate dataset for training the 
BNs when considering the pathway-level activities. However, these datasets are harder to 
obtain experimentally. Their argument may be appropriate for selected pathways, 
assuming that no major feedback occurs between the transcriptional regulatory network 
and protein signaling pathway.  The NF- B sub-network in BCR signaling is a poor 
example, since the downstream transcriptional changes induced after NF- B 
translocation to the nucleus have major effects on the protein-level signaling pathways 
(even to the extent of cellular death or apoptosis).  It may even be possible to generate a 
BN trained on protein-level data (e.g. protein-protein interactions) which underperforms 
the mRNA-trained BN network if the transcriptional network has a greater effect on the 
pathway activities, or if a variety of biological responses from different hierarchical 
levels provide moderate contributions to the pathway activities and regulation. 
It may still be possible to identify other interactions in the protein-level signaling 
network using other complementary datasets for independent BN analyses.  I hypothesize 
that some though not all interactions will be recovered using the different datasets, most 
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specifically in the cases where transcriptional and translational machinery (and other 
processes) are well coordinated and regulated.  Where these machinery do not act in 
concert, we can expect that different Bayesian networks trained on different datasets 
representing different biological scales will show lower overlap though more distinct 
interaction hypotheses.  However, care must be exercised when comparing models based 
on different datasets, since the meanings of the statistical influences in a biological 
context may be interpreted differently. 
7.2.2 Summary of BN+1 algorithm and findings 
The BN+1 algorithm was introduced and tested using both synthetic network analysis 
and a relevant genetic regulatory pathway in E. coli.  Synthetic networks were designed 
to test the overall performance of the BN+1 procedure.  Those simulations successfully 
benchmarked the BN+1 procedure and illustrated several useful considerations when 
conducting BN+1 analyses.  The BN+1 expansion of the ROS detoxification pathway 
using publicly-available gene expression data successfully identified known and 
unknown interactors or regulators for ROS core genes.  One of the major findings was the 
prediction of an influence or interaction between GadX and UspE, followed by the 
prediction and later verification of their direct involvement in biofilm formation.  Hence, 
the BN+1 procedure directly identified a new biological mechanism for this novel ROS 
gene which can be further investigated in future studies.  Many other exciting predictions 
were generated in the BN+1 procedure which can be studied in future projects. 
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7.2.3 Summary of Combined EC and BN+1 findings 
The ability to combine the EdgeClipper refinement algorithm along with the BN+1 
approach was investigated in Chapter 4, when both approaches were applied to the 
analysis of different datasets for progressive kidney disease in glomerular and tubule 
kidney compartments from H. sapiens.  Four major datasets were generated, either using 
all available data for a respective compartment, or only those data per compartment 
which were known diabetes mellitus or normal data from Pima Indians.  Bayesian 
networks were generated for 131 genes from the known Jak/Stat signaling pathway, and 
refined using the EdgeClipper algorithm.  The EdgeClipper algorithm served a vital 
function in reducing the number of genes for the subsequent BN+1 algorithm, since the 
number of genes in each simulation was roughly the same as the number of data 
observations.  The number of observations was too small for the relatively large network 
size, and hence EdgeClipper was required to refine the networks and identify the most 
conserved or well-supported interactions to include in the BN+1 core network.  This 
behavior was supported by properties of the networks in our preliminary simulations 
which had unexpectedly shorter run times.   
Most significantly, the BN+1 expansion of the core networks (despite lower 
runtimes for generating core networks) were able to identify distinct sets of BN+1 genes 
for each compartment which reflect the different stages of progressive kidney disease in 
those compartments.  The simulations also identified previously-hypothesized gene 
interactors which are likely involved in the progression of the kidney disease in those 
compartments.  This is an exciting finding, which suggests that the incorporation of 
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refinement and expansion algorithms is both achievable and applicable for studying 
complex biomedical phenomena in multiple tissues or compartments. 
7.2.4 Integrated analysis in MARIMBA 
Finally, the integration of the EdgeClipper and BN+1 algorithms into a web-based 
infrastructure was described in Chapter 5.  The Molecular Annotation Resource for 
Integrating Microarrays with Bayesian Analysis (MARIMBA) was introduced.  
Formatted microarray or other high-throughput datasets can be uploaded into MARIMBA 
or selected from the site for BN analysis.  Variables (e.g. genes, proteins) in the data can 
be selected for inclusion in the initial BN run.  Some tools for processing and additional 
variable selection are available, though these pipelines are a work-in-progress.  Bayesian 
networks can be constructed and analyzed, followed by EdgeClipper refinement, BN+1 
execution, and results visualization.  MARIMBA was developed for and applied to the 
major topics in this thesis, and has been used for several collaborative projects not 
discussed in the thesis (with several publications in process). MARIMBA is constantly 
undergoing updates and will also be submitted for publication soon. 
7.2.5 Revisiting the computational versus knowledge-based networks 
This thesis was successful in better understanding the overlap between computational and 
knowledge-based networks, as well as in uncovering new biological entities and 
interactions which do not yet appear in the existing knowledge repositories (e.g. pathway 
databases).  Hence, the developed approaches further increase the shared overlap between 
the computational networks (e.g. BNs), knowledge-based networks  (e.g. pathway 
representation in EcoCyc or KEGG), and the ‗real‘ underlying biology.  Experimental 
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validation following the computational predictions further establishes our confidence in 
this overlap with reality. 
There are some cases where Bayesian networks will identify spurious 
interactions, though these are likely removable using the developed EdgeClipper 
approaches.  On a related note, all of the approaches rely upon sufficient data for reliable 
predictions.  Insufficient quantities of data and even biased representation of selected 
experimental conditions may have major effects on the recovery of known and putative 
novel interactions.  Furthermore, the somewhat biased selection of experimental 
conditions and their sufficient representations may have an effect on which biological 
pathways  and systems are best modeled using the BN, EdgeClipper, and BN+1 
approaches.  
7.3 Future work and extensions 
7.3.1 Investigation of other novel ROS pathway genes 
In one of the BN+1 analyses described in Chapter 4, we identified a ranked list of BN+1 
genes for a ROS pathway network.  A subset of the top-ranked genes was investigated 
using literature searching and comparison to existing databases to investigate their role in 
ROS activities.  However, in Chapter 3, three major consensus networks identified using 
the EdgeClipper algorithm were also expanded and used to identify distinct sets of genes 
with implicated roles in ROS activity.  Many of these genes were only superficially 
investigated, and could be studied in much more detail. 
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For example, one question regarding the preferential selection of the BN+1 genes 
is whether those genes share common gene regulators.  Many genes in the E. coli genome 
are regulated by global factors called sigma factors [117].  Some sigma factors have 
specified roles in oxidative and cellular stress, so one might expect these sigma factors to 
have overrepresented sets of target genes in the top BN+1 results.  A simple method to 
determine this behavior would be to generate the average rank of the top 10 genes for 
each sigma factor, and rank the sigma factors according to the average rank of their target 
genes. 
7.3.2 Modular behaviors of the BN+1 and EdgeClipper algorithms 
In this thesis, the BN+1 and EdgeClipper algorithms were implemented to expand and 
refine, respectively, Bayesian network models trained using gene expression data.  One 
interesting property of both algorithms was the appearance of modular architecture in 
networks at different times.  Several existing approaches have studied modules which 
share genetic regulation and/or conserve biological functions.  Here, I discuss the 
preliminary data which suggested that both of our developed algorithms do relate to a 
modular prediction framework. 
In terms of the BN+1 analysis framework, I investigated which genes in the 
selected ROS detoxification pathway genes were most likely involved in the recruitment 
and preferential ranking of BN+1 genes.  The hypothesis for this analysis was that certain 
genes in the selected core network would share edges in the BN+1 networks with the 
added BN+1 expansion gene.  Furthermore, those core genes would more often connect 
to the top-scoring BN+1 genes.  A matrix representation of the connections between 
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BN+1 expansion and core genes was generated to show preferential connection to a 
subset of core pathway genes.  As expected, some core network genes show multiple 
connections to the BN+1 genes, whereas others show few to no connections.  A 
surprising property was that multiple genes with similar biological roles would share 
many of the same connections to targeted core genes.  These data suggest that the 
selection of the core network genes may have an important effect on both the ordering as 
well as conserved biological roles of BN+1 genes during the expansion algorithm.  
 Some modular architecture was also implied by the fragmentation of networks 
during EdgeClipper‘s generation of consensus networks.  From the preliminary analysis, 
it was observed that those interactions which tended to have the best Pearson correlations 
or most definitive nonlinear patterns were least likely to disappear from the more 
conserved or well-supported consensus networks with smaller B-values.  Hence, it is 
likely that many members of a biological pathway may not interact at the genetic level, 
and that only subsets of genes within the pathway do interact with each other.  Other 
influences from different biological scales, such as protein, sRNA, and miRNA may 
complicate the ability to predict such interactions.  This behavior is more likely if the 
gene expression patterns do not correlate directly with the behavior of those post-
transcriptional and post-translational entities. 
7.3.3 Applications to miRNA prediction 
An exciting area of research is the prediction of novel microRNA (miRNA) targets using 
BN+1.  MiRNAs are often 22-nucleotide RNA species which are cis- or trans-regulators 
for a gene, binding upstream or downstream of the gene and controlling its expression by 
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targeting the product mRNA and either degrading or down-regulating that target.  It is 
known that many miRNAs share similar genetic targets and often target similar members 
of the same pathway.  This prior knowledge could be used to select appropriate core 
networks for subsequent expansion.   For example, in Section 6.2, the BN+1 was 
demonstrated to preferentially identify BN+1 targets for certain genes with conserved 
biological roles and regulation.  We expect that the selection of known pathway genes 
with either similar regulation or overlapping sets of miRNA regulators could be 
established as a core set of genes for BN generation and subsequent BN+1 expansion.  
An underlying assumption here is that unknown miRNA regulators which operate in 
similar biological contexts to the known miRNA regulators for those pathway genes 
should preferentially score better than other putative miRNA targets with no direct 
interaction in the pathway.   Some miRNAs with few pathway targets may still appear in 
the top BN+1 results assuming relatively high correlations or conserved nonlinear 
interactions.  Similar patterns were observed during the ROS pathway expansion for 
selected genes, lending some support to this claim.  A major challenge is obtaining a 
representative dataset with paired miRNA and mRNA expression data and sufficient 
observations in order to conduct this exploratory analysis. 
7.3.4 Applications to next-gen sequencing technologies 
Another exciting area of research is the analysis and incorporation of next-generation 
sequencing technologies with Bayesian networks for biomarker discovery, disease 
analysis, and translational applications for personalized medicine.  The exciting aspect of 
this research is the ability to measure an individual‘s expression profiles for hundreds of 
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thousand of putative expressed transcripts.  These new technologies can allow 
investigation of the effects of individual mutations and individualized genome on disease 
progression and response to drugs, food, and the environment.  There are many studies 
ongoing at the NIH and other institutes which are specifically implementing next-gen 
sequencing for biomedical research (e.g. drug responses, the microbiome, etc.). 
A major challenge in this field is the size and quantity of data generated by the 
technologies.  In our recent analyses, we have explored those biological networks with a 
semi-reductionist approach.  We have often designed networks to include less than 150 
variables (genes), and to reflect specific biological pathways with known documented 
interactions.  Upcoming analyses will require 10-100 times as many variables to be 
included in the network analysis, which presents a major computational issue.  Some of 
the problems with generating large-scale network models are the amount of run-time for 
simulations and the amount of data needed to give an accurate prediction.  Towards this 
regard, it is expected that similar refinement and pathway-based selection approaches will 
be needed to make BN simulations computationally feasible.  Furthermore, distributed 
and highly-parallelizable simulation architectures with a cloud-based computing 
infrastructure will be required.  The MARIMBA infrastructure in this thesis is a 
preliminary model and has provided many useful insights into the requirements for such 
analyses in future web systems. 
7.3.5 Bayesian networks and natural language processing 
The availability of prior knowledge is often advantageous as a source of validating 
knowledge, or as starting structural priors.  There is an abundant source of interesting 
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correlative data, hypotheses, and documented interactions buried within published 
literature in the form of text, tables and figures.  Current natural language processing 
(NLP) technologies can generate on-the-fly relationships amongst genes, proteins, and 
other variables using defined semantic rules when parsing textual documents.   
Many challenges, unfortunately, remain.   For example, not all documents are 
currently available to researchers for full textual searching, and are often restricted to the 
publicly-available resources at PubMed Central.  Intellectual property rules have also 
limited some document searching to abstract searches, which may significantly limit the 
extent of biological knowledge to be extracted automatically from these sources.  
Furthermore, the availability of searchable and automatically interpretable figures and 
tables using new representations and semantics is significantly lower than that of textual 
information.  New algorithms for automatic figure interpretation and network or model 
generation would be highly desirable for computational and experimental researchers 
alike. 
7.4 The future and beyond 
It will be interesting to see how the BN framework as well as other approaches (MI, 
ODE, neural network, fitness functions, etc.) will adapt to the onslaught of next-
generation (next-gen) sequencing technologies and parallelized experimental protocols 
across multiple biological scales.  Bioinformatics is a constantly evolving field. Despite 
its infancy, bioinformatics is providing major changes to our conceptualization of health, 
disease, and individuality.  Unfortunately, the traditional microarray analyses are being 
phased out in larger studies as the new sequencing and assay technologies are adopted by 
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major institutions.  Thus, several of the issues which were discussed and targeted in this 
thesis will be replaced by many other issues and considerations.  However, our 
approaches can be modified in future studies to incorporate the new protocols, pipelines, 
and assumptions.  Reductionist strategies such as the selection of known pathway genes 
may yet be implemented for these future technologies and serve as a starting point to 
benchmark newer pipelines and analyses.  It is an exciting time in biomedical research, 
and many new findings are expected throughout the next several decades for prokaryotic 
throughout the higher eukaryotes.  
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